ES2436590T3 - Embolic braid ball devices and placement systems - Google Patents

Embolic braid ball devices and placement systems Download PDF

Info

Publication number
ES2436590T3
ES2436590T3 ES11173659.1T ES11173659T ES2436590T3 ES 2436590 T3 ES2436590 T3 ES 2436590T3 ES 11173659 T ES11173659 T ES 11173659T ES 2436590 T3 ES2436590 T3 ES 2436590T3
Authority
ES
Spain
Prior art keywords
implant
braid
ball
aneurysm
placement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11173659.1T
Other languages
Spanish (es)
Inventor
Frank P Becking
Arturo S Rosqueta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
Covidien LP
Nfocus Neuromedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covidien LP, Nfocus Neuromedical Inc filed Critical Covidien LP
Application granted granted Critical
Publication of ES2436590T3 publication Critical patent/ES2436590T3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12027Type of occlusion
    • A61B17/12031Type of occlusion complete occlusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12159Solid plugs; being solid before insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/1215Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02Dilators made of swellable material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00862Material properties elastic or resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12068Details concerning the detachment of the occluding device from the introduction device detachable by heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00404Blood vessels other than those in or around the heart
    • A61B2018/00416Treatment of aneurisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3966Radiopaque markers visible in an X-ray image
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10Methods of surface bonding and/or assembly therefor
    • Y10T156/1002Methods of surface bonding and/or assembly therefor with permanent bending or reshaping or surface deformation of self sustaining lamina
    • Y10T156/1051Methods of surface bonding and/or assembly therefor with permanent bending or reshaping or surface deformation of self sustaining lamina by folding

Abstract

Un sistema (330) separable de empujador de implantes que comprende: un implante (10, 40, 60, 62, 64, 70, 72, 140, 300, 342) que incluye una sección de puerto proximal (276); un manguito empujador alargado (338); y una pluralidad de miembros alargados (332, 336) recibidos dentro de una luz del manguito empujador, que sale enunos extremos proximal y distal, y los miembros alargados son recibidos a través del puerto de implante,en donde el manguito es bloqueado al implante hasta que al menos un miembro alargado sea llevado al interior delmanguito; caracterizado porque uno de los miembros alargados (336) incluye un extremo del terminal ampliado situado fuerade la sección del puerto; y en donde el otro miembro alargado (332) incluye un extremo ampliado.A detachable implant pusher system (330) comprising: an implant (10, 40, 60, 62, 64, 70, 72, 140, 300, 342) that includes a proximal port section (276); an elongated pusher sleeve (338); and a plurality of elongate members (332, 336) received within a light of the pusher sleeve, which exits at proximal and distal ends, and elongated members are received through the implant port, where the sleeve is locked to the implant until that at least one elongated member be taken inside the sleeve; characterized in that one of the elongate members (336) includes an end of the extended terminal located outside the port section; and wherein the other elongated member (332) includes an enlarged end.

Description

Dispositivos embólicos de bola de trenza y sistemas de colocación Embolic braid ball devices and placement systems

ANTECEDENTES BACKGROUND

La tendencia clínica dominante en el tratamiento endovascular de los aneurismas intracraneales ha cambiado poco desde que en la década de 1990 se extendió el uso de la espiral vasooclusiva. Ciertamente, los catéteres improvisados y otros dispositivos auxiliares (por ejemplo la endoprótesis vascular) han ayudado a hacer los procedimientos de colocación de espirales más seguros y/o más efectivos. No obstante, la técnica para conseguir un empaquetamiento de la espiral del aneurisma adecuado y apropiado es la más realizada por los médicos más especializados. The dominant clinical trend in the endovascular treatment of intracranial aneurysms has changed little since the use of vasoocclusive spiral was extended in the 1990s. Certainly, improvised catheters and other auxiliary devices (for example, the stent) have helped make spiral placement procedures safer and / or more effective. However, the technique to achieve a suitable and appropriate aneurysm spiral packing is the most performed by the most specialized doctors.

Donde es posible, puede preferirse la exclusión del aneurisma mediante dispositivos de tipo cubrición (por ejemplo, descritos en la Solicitud de Patente de EEUU Nº 12/397.123 al cesionario de ella). Ciertos otros grupos están intentando desviar la idea del empaquetamiento de la espiral del intraaneurisma para conseguir la embolización por medio del despliegue de una endoprótesis vascular rompedora/desviadora del flujo de un extraaneurisma en el vaso principal. Estos dispositivos densamente trenzados y/o dispositivos de trenzas múltiples en capas unas sobre otras están situados en el vaso principal a lo largo del cuello de un aneurisma con el fin de alterar la hemodinámica para efectuar la embolización. Where possible, exclusion of the aneurysm by means of covering devices may be preferred (for example, described in US Patent Application No. 12 / 397.123 to the assignee thereof). Certain other groups are trying to divert the idea of the intraaneurysm spiral packing to achieve embolization by deploying a stent / diverter stent to the flow of an extraaneurysm in the main vessel. These densely braided devices and / or multiple braid devices layered on each other are located in the main vessel along the neck of an aneurysm in order to alter the hemodynamics to effect embolization.

Estos dispositivos similares a una endoprótesis vascular de pared son los más adecuados para la colocación a lo largo de aneurismas de la pared lateral. Además, los aneurismas terminales (por ejemplo los aneurismas de bifurcación) son estimados por algunos que son causa de entre aproximadamente el 60% y el 80% de todas las ocurrencias de aneurismas. En un cálculo más optimista sólo aproximadamente el 40% de los aneurismas intracraneales pueden ser tratados mediante el uso de dispositivos mencionados similares a las endoprótesis vasculares. These devices similar to a vascular stent are the most suitable for placement along aneurysms of the lateral wall. In addition, terminal aneurysms (for example, bifurcation aneurysms) are estimated by some that cause approximately 60% to 80% of all aneurysm occurrences. In a more optimistic calculation only about 40% of intracranial aneurysms can be treated by using mentioned devices similar to vascular stents.

Numerosos otros dispositivos han sido concebidos para tratar los aneurismas terminales. El despliegue complicado y/o impracticable es común en muchos casos. Otros simplemente sirven como complementarios a las espirales o a los agentes embólicos líquidos. En estos últimos ejemplos los procedimientos pueden llegar a ser más complicados y requieren incluso una mayor habilidad del médico que en un procedimiento de espiral normal. Numerous other devices have been designed to treat terminal aneurysms. Complicated and / or impracticable deployment is common in many cases. Others simply serve as complementary to spirals or liquid embolic agents. In these latter examples the procedures can become more complicated and require even greater physician skill than in a normal spiral procedure.

Una solución más simple y más prometedora es la propuesta en el documento PCT/US 2007/0076232 por Dieck y otros. Se describe un miembro cónico de trenzado/malla para desviar el flujo de sangre del cuello del aneurisma. Una base del dispositivo se coloca dentro del aneurisma mientras que una parte desviadora del flujo se extiende al interior del vaso principal para dirigir el flujo de sangre hacia las ramas laterales contiguas y alejándolo del aneurisma. El implante puede ser colocado dentro del aneurisma como un dispositivo independiente o ser soportado por un cuerpo de tipo endoprótesis vascular conectado. A simpler and more promising solution is the proposal in document PCT / US 2007/0076232 by Dieck and others. A conical braiding / mesh member is described to divert blood flow from the aneurysm neck. A base of the device is placed inside the aneurysm while a diverting part of the flow extends into the main vessel to direct the blood flow to the adjacent lateral branches and away from the aneurysm. The implant can be placed inside the aneurysm as an independent device or be supported by a connected stent-like body.

Los documentos USP Nos 6.168.622 y 6.506.204 de Mazzochi y otros describen otro tipo de interruptor del flujo trenzado colocado al menos parcialmente dentro de un aneurisma. Una parte bulbosa está adaptada para ajustar dentro de la caperuza del aneurisma y está anclada en el exterior por una aleta que cubre el cuello. Dada la forma en la que los aneurismas de bifurcación a menudo incorporan la anatomía del vaso secundario, tal parche interferiría a menudo con y/o la “aleta” libre suscitando importantes problemas de una potencial formación de trombos dentro del vaso principal. USP Nos. 6,168,622 and 6,506,204 of Mazzochi et al. Describe another type of twisted flow switch placed at least partially within an aneurysm. A bulbous part is adapted to fit inside the aneurysm cap and is anchored on the outside by a fin that covers the neck. Given the way in which bifurcation aneurysms often incorporate the anatomy of the secondary vessel, such a patch would often interfere with and / or the free "fin" causing significant problems of potential thrombus formation within the main vessel.

El documento EP 1.621.148 A1 describe un sistema de despliegue de un dispositivo embólico vasooclusivo para su uso en la colocación de un dispositivo embólico en un lugar predeterminado dentro de un vaso. Un catéter flexible alargado tiene un lumen que se extiende a lo largo de él y tiene unos extremos proximal y distal. Un miembro empujador alargado tiene unos extremos proximal y distal y está dispuesto de forma deslizante dentro del lumen del catéter. Un dispositivo embólico tiene una pluralidad de vueltas que enganchan de forma liberable el extremo distal del miembro empujador. Un filamento de separación se extiende desde una posición proximal del extremo proximal del catéter a través del lumen del catéter y alrededor de una vuelta del dispositivo embólico. Cuando el dispositivo embólico está colocado apropiadamente en un lugar predeterminado dentro del vaso se puede tirar proximalmente del filamento de separación para desacoplar el filamento de separación de la vuelta del dispositivo embólico para de este modo liberar el dispositivo embólico en el lugar predeterminado. EP 1,621,148 A1 describes a deployment system of a vasoocclusive embolic device for use in placing an embolic device in a predetermined place within a vessel. An elongated flexible catheter has a lumen that extends along it and has proximal and distal ends. An elongated pusher member has proximal and distal ends and is slidably disposed within the lumen of the catheter. An embolic device has a plurality of turns that releasably engage the distal end of the pusher member. A separation filament extends from a proximal position of the proximal end of the catheter through the lumen of the catheter and about one turn of the embolic device. When the embolic device is properly placed in a predetermined place within the vessel, the separation filament can be pulled proximally to disengage the separation filament from the return of the embolic device to thereby release the embolic device at the predetermined place.

El documento US 2007/221230 A1 describe un sistema de reducción del volumen del pulmón que comprende un dispositivo implantable adaptado para ser colocado en una vía respiratoria del pulmón de un paciente en una configuración de colocación y para cambiar a una configuración desplegada para curvar la vía respiratoria del pulmón. El dispositivo implantable tiene una configuración de colocación curvable elásticamente y la configuración desplegada tiene una forma rígida. El sistema comprende además un accionador adaptado para ser operado desde fuera del paciente para cambiar el dispositivo implantable de la configuración de colocación a la configuración desplegada. El accionador comprende un elemento de accionamiento conectado a un extremo distal del dispositivo implantable y adaptado para ser movido proximalmente para doblar el dispositivo y un bloqueo para bloquear el dispositivo en la configuración desplegada. US 2007/221230 A1 describes a lung volume reduction system comprising an implantable device adapted to be placed in a patient's lung airway in a placement configuration and to change to a deployed configuration to bend the pathway. respiratory lung The implantable device has an elastically curved placement configuration and the deployed configuration has a rigid shape. The system further comprises an actuator adapted to be operated from outside the patient to change the implantable device from the placement configuration to the deployed configuration. The actuator comprises a drive element connected to a distal end of the implantable device and adapted to be moved proximally to bend the device and a lock to lock the device in the deployed configuration.

COMPENDIO DE LA INVENCIÓN SUMMARY OF THE INVENTION

De acuerdo con la presente invención se ha proporcionado el sistema de empujador del implante separable de la reivindicación 1. In accordance with the present invention, the removable implant pusher system of claim 1 has been provided.

A continuación se describen e ilustran implantes de bola de trenza de alambre para la oclusión del flujo de sangre en lugares endovasculares, así como los sistemas de colocación y los métodos de realización de las bolas. Las bolas son útiles para el tratamiento de defectos neurovasculares. Un uso es en la embolización/oclusión de aneurismas intracraneales y otro es en la oclusión del vaso principal (PVO) o su sacrificio. Next, wire braid ball implants for occlusion of blood flow in endovascular sites are described and illustrated, as well as the placement systems and methods of making the balls. The balls are useful for the treatment of neurovascular defects. One use is in the embolization / occlusion of intracranial aneurysms and another is in the occlusion of the main vessel (PVO) or its sacrifice.

Hablando en términos generales, los implantes vasculares expuestos son dispositivos trenzados que utilizan una combinación de materiales bioestables seleccionados de Acero Inoxidable, Cobalto Cromo, Nitinol, Titanio, Aleaciones de Titanio, Zirconio y Aleaciones de Zirconio, PET (u otro material de sutura) y de adhesivos de grado médico. La densidad del dispositivo es capital en aplicaciones en las que la trenza propiamente dicha tiene como fin afectar al flujo de sangre, que permite la trombosis dentro de un volumen formado por la bola para ocluir un lugar. De este modo, normalmente se requiere una alta densidad de trenza/malla. Es decir, se puede emplear una trenza que tenga al menos aproximadamente 48 extremos, normalmente colocados a aproximadamente 90 grados o más, en diámetros de aproximadamente 4 a 8 mm. Con diámetros mayores (por ejemplo, de aproximadamente 6 mm a 12 mm o más) se pueden emplear más extremos del alambre (por ejemplo, múltiplos comunes de 64, 72, 96, 128, 144) para formar las bolas. También se pueden emplear unas cantidades de alambres normalmente mayores. Se puede emplear cualquiera de las trenzadoras normales de soporte de 192 y 288 comercialmente disponibles. También se puede emplear la tecnología de trenzado tridimensional (tales servicios los proporciona 3Tex, Inc) para la formación de la matriz de trenzas a partir de la cual se forman las bolas. Además, se puede utilizar cualquier combinación de diámetros de alambre, cantidad de alambre, ángulo de la trenza, y de cruces por pulgada para realizar la trenza con el fin de configurar un dispositivo oclusivo del flujo de sangre considerado apropiado para un determinado lugar vascular. Generally speaking, the exposed vascular implants are braided devices that use a combination of biostable materials selected from Stainless Steel, Cobalt Chromium, Nitinol, Titanium, Titanium Alloys, Zirconium and Zirconium Alloys, PET (or other suture material) and of medical grade adhesives. The density of the device is capital in applications where the braid itself is intended to affect the flow of blood, which allows thrombosis within a volume formed by the ball to occlude a place. Thus, a high braid / mesh density is usually required. That is, a braid having at least about 48 ends, normally placed at about 90 degrees or more, can be used in diameters of about 4 to 8 mm. With larger diameters (for example, about 6 mm to 12 mm or more), more wire ends (for example, common multiples of 64, 72, 96, 128, 144) can be used to form the balls. Normally larger amounts of wires can also be used. Any of the commercially available standard 192 and 288 support braiding machines can be used. Three-dimensional braiding technology (such services are provided by 3Tex, Inc) can also be used for the formation of the braid matrix from which the balls are formed. In addition, any combination of wire diameters, wire quantity, braid angle, and crosses per inch can be used to make the braid in order to configure an occlusive device of blood flow deemed appropriate for a particular vascular site.

Se puede emplear un intervalo de tamaños de alambre o una combinación de tamaños de alambre, que típicamente van desde aproximadamente 0,0008 (0,02 mm) hasta aproximadamente 0,0015 pulgadas (0,04 mm), y hasta aproximadamente 0,003 pulgadas (0,08 mm) dependiendo del perfil de colocación deseado (que típicamente se desea que sea menor de aproximadamente 0,050 pulgadas (1,3 mm) –al menos para indicaciones neurovascularesy más generalmente hasta aproximadamente 0,070 pulgadas (1,8 mm) para indicaciones de PVO periférica). Un único tubo de trenza puede tener todos los alambres del mismo diámetro, o puede tener algunos alambres con un diámetro ligeramente más grueso para dar una resistencia adicional a la capa de la trenza. Por ejemplo, la mitad de los alambres de un tubo de 96 alambres (es decir, 48 extremos) pueden tener por ejemplo un diámetro de 0,001” (0,025 mm) y la otra mitad de los alambres pueden tener un diámetro de, por ejemplo, 0,0015” (0,04 mm). En este caso los dos tamaños del alambre podrían típicamente ser entrelazados uniformemente para formar la trenza. Los alambres más gruesos dan una mayor resistencia a la trenza sin aumentar significativamente el perfil de colocación del dispositivo, con los alambres más delgados que ofrecen alguna resistencia mientras se completa la densidad de la matriz de la trenza. A range of wire sizes or a combination of wire sizes, typically ranging from about 0.0008 (0.02 mm) to about 0.0015 inches (0.04 mm), and up to about 0.003 inches ( 0.08 mm) depending on the desired placement profile (which is typically desired to be less than about 0.050 inches (1.3 mm) - at least for neurovascular indications and more generally up to about 0.070 inches (1.8 mm) for indications of Peripheral PVO). A single braid tube may have all wires of the same diameter, or it may have some wires with a slightly thicker diameter to give additional strength to the braid layer. For example, half of the wires of a 96-wire tube (ie 48 ends) can have for example a diameter of 0.001 "(0.025 mm) and the other half of the wires can have a diameter of, for example, 0.0015 ”(0.04 mm). In this case the two wire sizes could typically be intertwined evenly to form the braid. The thicker wires give greater resistance to the braid without significantly increasing the positioning profile of the device, with the thinner wires offering some resistance while completing the density of the braid matrix.

El alambre es preferiblemente de una aleación de NiTi que es superelástica a la temperatura del cuerpo. El metal puede ser una aleación binaria o una aleación ternaria para proporcionar una radioopacidad adicional. Como alternativa se pueden incluir en la trenza unas fibras de platino radioopacas, o el alambre puede comprender un DFT de Nitinol o un núcleo de platino u oro. De otro modo, los bujes, bandas o arrollamientos (preferiblemente de Pt) usados para fijar el alambre de la trenza (en cualquiera o en ambos extremos distal y proximal), y también entre los casquetes en donde sea conveniente) pueden servir como el único elemento o elementos radioopacos. The wire is preferably of a NiTi alloy that is superelastic at body temperature. The metal can be a binary alloy or a ternary alloy to provide additional radiopacity. Alternatively, radiopaque platinum fibers may be included in the braid, or the wire may comprise a Nitinol DFT or a platinum or gold core. Otherwise, bushings, bands or windings (preferably of Pt) used to fix the braid wire (at either or both distal and proximal ends), and also between the caps where convenient) may serve as the only radiopaque element or elements.

Para mejorar la resistencia a la corrosión del alambre del implante y/o la resistencia a la biocompatibilidad despuésde la fijación térmica de la forma los implantes pueden ser grabados en una solución de Ácido Sulfámico “AYA”, pasivizada a continuación en una solución de Ácido Nítrico. Alternativa o adicionalmente, el alambre pregrabado y/o pulido puede ser empleado en el trenzado de la matriz del implante. La fijación de la forma de la trenza en la forma del implante puede ser realizada en una estufa/horno, en un baño fluidificado o en una olla con sal. Todo este proceso está dentro de los conocimientos de las personas con una experiencia normal en la técnica. To improve the corrosion resistance of the implant wire and / or the biocompatibility resistance after thermal fixation of the shape, the implants can be etched in a solution of "AYA" Sulfamic Acid, then passivated in a Nitric Acid solution. . Alternatively or additionally, the prerecorded and / or polished wire can be used in braiding the implant matrix. The fixation of the shape of the braid in the shape of the implant can be done in an oven / oven, in a fluidized bath or in a pot with salt. This whole process is within the knowledge of people with a normal experience in the art.

Especialmente después de la fijación térmica de la forma, el alambre puede ser recubierto con un agente para facilitar un efecto biológico deseado. Por ejemplo, el alambre puede ser recubierto con un agente trombógeno o un agente de endotelización, u otro agente capaz de promover un proceso biológico deseado en el lugar pretendido. Las bolas de trenza pueden también estar parcial o totalmente recubiertas en el exterior (por ejemplo, con un recubrimiento tal como uretano) para aumentar el efecto oclusivo de la bola, siempre que el recubrimiento no haga que el perfil de colocación del dispositivo final no supere los límites permitidos. El recubrimiento con hidrogel ofrece también una opción atractiva, tal como una red de polímero con una base de hidrogel capaz de atrapar los agentes terapéuticos, descrito en el documento USPN 6.905.700 de Won y otros. Especially after thermal fixation of the form, the wire can be coated with an agent to facilitate a desired biological effect. For example, the wire can be coated with a thrombogenic agent or an endothelializing agent, or another agent capable of promoting a desired biological process in the intended place. The braid balls may also be partially or fully coated on the outside (for example, with a coating such as urethane) to increase the occlusive effect of the ball, provided that the coating does not cause the placement profile of the final device does not exceed Allowed limits Hydrogel coating also offers an attractive option, such as a polymer network with a hydrogel base capable of trapping therapeutic agents, described in USPN 6,905,700 to Won et al.

Igualmente, mientras que las bolas comprenden ventajosamente una trenza de Nitinol, la trenza puede en lugar de ello comprender un polímero –especialmente un polímero biodegradable de alta resistencia tal como el MX-2 (MAX-Preno), un monofilamento absorbible sintético (90/10 Glicólido/L-Láctido) y/o G-2 (Glicopreno), un monofilamento Similarly, while the balls advantageously comprise a Nitinol braid, the braid may instead comprise a polymer - especially a high strength biodegradable polymer such as MX-2 (MAX-Preno), a synthetic absorbable monofilament (90 / 10 Glycolide / L-Lactide) and / or G-2 (Glycoprene), a monofilament

absorbible sintético (Glicólido (PGA), ε-Caprolatona (PCL), un copolímero de Carbonato de Trimetileno (TMC)) que fija térmicamente su forma (por ejemplo, a 110 grados centígrados en una hora). synthetic absorbable (Glycolide (PGA), ε-Caprolatone (PCL), a copolymer of Trimethylene Carbonate (TMC)) that thermally sets its shape (for example, at 110 degrees Celsius in one hour).

La capacidad de colocación de los implantes expuestos en ciertos lugares neurovasculares (por ejemplo, aneurismas intracraneales distales) a menudo requiere que sean compresibles para pasar a través de un catéter dimensionado para navegar por los estrechos y tortuosos vasos del cerebro. Los catéteres neurovasculares normales apropiados para tal uso tienen unos diámetros de lumen de 0,021” (0,5 mm) y 0,027” (0,7 mm). Se pueden preferir los microcatéteres comercialmente disponibles para bolas de cantidades de alambre mayores de 0,027” (0,7 mm) ID (por ejemplo, Cordis Mass Transit Boston Scientific Renegade HI-FLO) o mayores (por ejemplo ID Concentric Merci Distal Access Catheter de 0,044” (1,1 mm)). Para dispositivos adaptados para responder a las indicaciones de PVO en las que cantidades de alambre mayores o diámetros de alambre mayores se emplean para fijar el anclaje, los implantes pueden requerir 5 y/o 6 catéteres de guía Fr para la colocación. The ability to place exposed implants in certain neurovascular sites (for example, distal intracranial aneurysms) often requires that they be compressible to pass through a sized catheter to navigate the narrow, tortuous vessels of the brain. Normal neurovascular catheters suitable for such use have lumen diameters of 0.021 "(0.5mm) and 0.027" (0.7mm). Commercially available microcatheters may be preferred for balls of wire quantities greater than 0.027 "(0.7 mm) ID (for example, Cordis Mass Transit Boston Scientific Renegade HI-FLO) or greater (for example Concentric Merci Distal Access Catheter ID of 0.044 "(1.1mm)). For devices adapted to respond to PVO indications in which larger amounts of wire or larger wire diameters are used to fix the anchor, the implants may require 5 and / or 6 Fr guide catheters for placement.

En alguna de las configuraciones descritas los dispositivos pueden comprender una trenza de Nitinol de alta densidad que está plegada/doblada hacia atrás sobre sí misma y fijada térmicamente para proporcionar un cuerpo abierto que tiene dos capas contiguas que forman una matriz incluso más densa para ocluir el flujo de sangre. La sección plegada hacia atrás (invertida o vuelta hacia fuera) puede estar cerrada para definir un extremo distal del dispositivo en el que puede colocarse un elemento radioopaco. En el lado opuesto del implante están sujetos unos filamentos de trenza en un buje que incluye al menos una banda exterior. In some of the described configurations the devices can comprise a high density Nitinol braid that is folded / folded back on itself and thermally fixed to provide an open body that has two contiguous layers that form an even denser matrix to occlude the blood flow The section folded back (inverted or turned outward) can be closed to define a distal end of the device in which a radiopaque element can be placed. On the opposite side of the implant braid filaments are attached in a bushing that includes at least one outer band.

Un puerto dentro del buje puede recibir un o unos componentes de un empujador opcional separable. Como alternativa, el implante puede ser desplegado a través de un catéter mediante el uso de un único empujador. Los filamentos de la trenza dentro del buje o los bujes pueden estar soldados entre sí y/o con la banda. Como alternativa, la trenza y el o los bujes pueden estar fijados mediante un adhesivo biocompatible. A port within the hub can receive one or a few components of an optional separable pusher. Alternatively, the implant can be deployed through a catheter by using a single pusher. The strands of the braid inside the bushing or bushings can be welded together and / or with the band. Alternatively, the braid and the bushing (s) may be fixed using a biocompatible adhesive.

En un estado relajado los implantes definen un volumen abierto, preferiblemente redondeado. En un catéter de colocación comprimen para formar un cuerpo sustancialmente cilíndrico. Cuando están desplegados en un lugar de tratamiento se expanden hasta hacer contacto con el tejido circundante y ocluyen el flujo en un espacio de tiempo clínicamente interesante. In a relaxed state, the implants define an open volume, preferably rounded. In a placement catheter they compress to form a substantially cylindrical body. When deployed at a treatment site, they expand to make contact with the surrounding tissue and occlude the flow in a clinically interesting period of time.

El uso de un empujador separable favorece el despliegue de un dispositivo (por ejemplo, en un aneurisma) y la comprobación del ajuste. Desplegado en un aneurisma para ocluir el aneurisma en su cuello, el dispositivo de implante adopta en gran medida la forma del aneurisma, con el buje proximal y el material de la trenza contiguo muycerca fuera del cuello. Para conseguir tal ajuste, los implantes están dispuestos en un intervalo de tamaños. Éstos pueden avanzar con unos aumentos de diámetro de 0,5 mm a 1 mm. Para el tratamiento del aneurisma en las bifurcaciones puede también ser deseable que la bola (al menos en su configuración colocada) adopte una forma de lágrima para ayudar en una función de tipo divisor/desviador del flujo descrita en Dieck y otros, antes mencionada. The use of a separable pusher favors the deployment of a device (for example, in an aneurysm) and the adjustment check. Deployed in an aneurysm to occlude the aneurysm in its neck, the implant device largely adopts the aneurysm shape, with the proximal bushing and the adjacent braid material very close outside the neck. To achieve such an adjustment, the implants are arranged in a range of sizes. These can advance with increases in diameter from 0.5 mm to 1 mm. For the treatment of the aneurysm in the bifurcations it may also be desirable that the ball (at least in its placed configuration) adopts a tear shape to assist in a flow-divider / diverter type function described in Dieck et al., Mentioned above.

No obstante, si el implante seleccionado no ajustase en la forma deseada, podría simplemente ser retirado al interior del catéter de colocación. Si se consiguiese el ajuste deseado (con el primer implante o con una sustitución) confirmado por visualización de imágenes médicas, el implante es liberado. However, if the selected implant does not fit the desired shape, it could simply be removed inside the placement catheter. If the desired setting is achieved (with the first implant or with a replacement) confirmed by viewing medical images, the implant is released.

Una junta de tipo GDC electrolíticamente liberable puede ser usada para mantener el implante fijado al empujador hasta su liberación. Los detalles con respecto a los sistemas de separación electrolítica adecuados pueden ser apreciados y aplicados al sistema actual descrito en el documento USPN 5.122.136 de Guglielmi y las solicitudes siguientes de él. Otro método de separación eléctricamente activada utiliza una unión por fibra o sutura fusible que conecta el implante con el empujador/guía de colocación. En tal sistema se puede configurar un núcleo polimérico con unas tiras conductoras arrolladas helicoidalmente sujetas al núcleo. Tras la aplicación de una tensión se envía una corriente suficiente a través de las cintas a un puente de alambre que las conecta. El calor generado a lo largo del puente, opcionalmente un alambre de Níquel Cromo, corta la sutura que está sujeta en o va contigua al puente con el fin de liberar el implante. Detalles adicionales de un sistema de separación de la sutura fundida están descritos en las aplicaciones provisionales incorporadas. An electrolytically releasable GDC type seal can be used to keep the implant attached to the pusher until it is released. Details regarding suitable electrolytic separation systems can be appreciated and applied to the current system described in Guglielmi document USPN 5,122,136 and the following requests thereto. Another electrically activated separation method uses a fiber bond or fusible suture that connects the implant with the pusher / positioning guide. In such a system a polymer core can be configured with helically wound conductive strips attached to the core. After applying a voltage, a sufficient current is sent through the tapes to a wire bridge that connects them. The heat generated along the bridge, optionally a Chrome Nickel wire, cuts the suture that is attached to or is adjacent to the bridge in order to release the implant. Additional details of a molten suture separation system are described in the interim applications incorporated.

Aun así, los sistemas de separación mecánicos pueden ser los más preferidos. Un aspecto de la presente descripción implica unos empujadores en los que al menos un miembro proporciona una interferencia mecánica en/con el puerto del buje del implante para de forma liberable bloquear el implante sobre el empujador. En un método un alambre o cinta que sale de una extensión del empujador con rosca a través del puerto produce tal interferencia hasta que es retirado. En otro ejemplo una pluralidad de alambres/cintas son recibidos a través del puerto. Uno o más (típicamente dos o tres) de estos alambres se extienden a través del cuerpo de un catéter empujador hasta una interfaz de una empuñadura proximal. Un alambre de “anclaje” final recibido a través del puerto puede también extenderse hasta la empuñadura. El alambre del anclaje incluye una cabeza dimensionada para salir del puerto del buje sólo después de que los alambres de “control” hayan sido eliminados de allí. La cabeza está preferiblemente formada por un láser o plasma térmico / de fusión. La empuñadura proporciona una interfaz de usuario para primero eliminar los alambres de control, y después (opcionalmente) también tirar del alambre de anclaje final. Even so, mechanical separation systems may be the most preferred. One aspect of the present description involves pushers in which at least one member provides mechanical interference in / with the port of the implant bushing so as to releasably block the implant on the pusher. In one method a wire or tape that exits an extension of the threaded pusher through the port produces such interference until it is removed. In another example a plurality of wires / tapes are received through the port. One or more (typically two or three) of these wires extend through the body of a pusher catheter to an interface of a proximal handle. A final "anchor" wire received through the port can also extend to the handle. The anchor wire includes a head sized to exit the bushing port only after the "control" wires have been removed there. The head is preferably formed by a laser or thermal / fusion plasma. The handle provides a user interface to first remove the control wires, and then (optionally) also pull the final anchor wire.

Para ayudar en la recaptura de un implante en caso de que no se libere, un perfil de recaptura liso con una forma de introducción / trompeta puede estar dispuesto entre el buje y el cuerpo principal del implante. En otro método pertinente en un implante de dos capas no está dispuesto tal perfil. Más bien solamente la parte exterior de la capa de la trenza está fijada dentro del buje, y la capa interior “flota”. De este modo solamente la capa exterior tiene que ser enderezada con relación al buje para recuperar la bola dentro del catéter/vaina, con la capa interior que corre a lo largo. To aid in the recapture of an implant in case it is not released, a smooth recapture profile with an introduction / trumpet form may be disposed between the bushing and the main body of the implant. In another relevant method in a two-layer implant such a profile is not arranged. Rather, only the outer part of the braid layer is fixed inside the bushing, and the inner layer "floats." In this way only the outer layer has to be straightened in relation to the bushing to recover the ball inside the catheter / sheath, with the inner layer running along it.

Con el fin de permitir tal acción la matriz de la trenza tiene que permanecer estable e interbloqueada. En consecuencia, cuando sea posible, se preferirá un modelo de trenza una sobre otra. Además, la trenza debería ser recortada contigua al buje, en donde la trenza fijada al buje es más densa. Así configurada, la trenza exterior sirve como una guía y es de tal densidad para evitar que los extremos sueltos de la capa interior sobresalgan a través de ella. En tanto que un implante de bola de tipo de capa flotante solamente se usaría típicamente para una indicación de aneurisma debido a la reducida resistencia radial, el perfil de recaptura puede ser usado bien en un implante para un aneurisma o bien para un uso en PVO. In order to allow such action the braid matrix has to remain stable and interlocked. Consequently, when possible, a braid model will be preferred over one another. In addition, the braid should be trimmed adjacent to the bushing, where the braid attached to the bushing is denser. Thus configured, the outer braid serves as a guide and is of such density to prevent the loose ends of the inner layer from protruding through it. While a floating layer type ball implant would typically only be used for an aneurysm indication due to reduced radial resistance, the recapture profile can be used either in an aneurysm implant or for PVO use.

Aparte de los elementos de recaptura, cuando se despliegan en un vaso para uso en la oclusión de un vaso principal el implante expuesto tiene una forma de “salchicha”. Para tales fines puede ser conveniente que la longitud comprimida de la bola se minimice con relación a su diámetro. Los extremos proximal y/o distal de la bola pueden ser aplanados o más planos (de modo que la bola tenga una forma más parecida a un “donut”) para este fin. Apart from the recapture elements, when they are deployed in a vessel for use in the occlusion of a main vessel, the exposed implant has a "sausage" shape. For such purposes it may be convenient that the compressed length of the ball be minimized relative to its diameter. The proximal and / or distal ends of the ball may be flattened or flatter (so that the ball has a shape more like a "donut") for this purpose.

El sobredimensionamiento del dispositivo con relación al vaso proporciona una fuerza radial adecuada para anclar su posición contra el flujo/presión de la sangre. Para generar más fuerza de anclaje dentro de un vaso para un implante especializado en PVO (es decir, de una longitud desplegada dada), la bola tiene que ser formada con un perfil de modo que tenga una sección recta elíptica. Para ofrecer un anclaje más mejorado del vaso se puede incorporar en la forma un cinturón cilíndrico. Los bordes formados concentrarán los esfuerzos en la pared del vaso en algunos casos para mejorar el anclaje. Aun así, el tamaño del perfil permite que el implante trabaje dentro de un amplio intervalo de tamaños de vasos. Ciertamente, un tamaño puede ajustarse en un amplio intervalo de diámetros de vasos (por ejemplo, una bola de 10 mm apropiada para vasos de 3-5 mm, etc). The oversizing of the device relative to the vessel provides adequate radial force to anchor its position against blood flow / pressure. To generate more anchoring force within a vessel for a specialized PVO implant (i.e., of a given deployed length), the ball has to be formed with a profile so that it has an elliptical straight section. To offer a more improved anchorage of the vessel, a cylindrical belt can be incorporated into the shape. The formed edges will concentrate the efforts on the vessel wall in some cases to improve anchoring. Even so, the profile size allows the implant to work within a wide range of vessel sizes. Certainly, a size can be adjusted over a wide range of vessel diameters (for example, a 10 mm ball suitable for 3-5 mm vessels, etc.).

En uno u otro tipo de implante (es decir, aneurisma o PVO) una construcción ventajosa implica plegar o doblar hacia atrás la trenza durante la fabricación para producir una matriz de dos capas. Se forma un doblez o pliegue central en la trenza, que se usa para definir un extremo del implante. In one or another type of implant (ie, aneurysm or PVO) an advantageous construction involves folding or folding back the braid during manufacturing to produce a two-layer matrix. A central fold or crease is formed in the braid, which is used to define one end of the implant.

El pliegue puede estar prefijado en la trenza o formado en la sujeción de la trenza para fijar su forma. En el caso anterior la curvatura está prefijada mediante la fijación térmica de la trenza cuando está confinada en una forma tubular muy ajustada (por ejemplo, por un ondulador o al menos parcialmente dentro de un hipotubo). En el último caso la trenza es ligada con una sutura en un punto, una forma se inserta en el extremo abierto del tubo de la trenza y la trenza es estirada, o colocada, sobre la forma con la sección plegada sometida a compresión. Cuando es calentada para fijar el perfil, la sutura arde y desaparece a medida que la fuerza de compresión fija el pliegue en un radio mínimo. The fold may be preset in the braid or formed in the braid fastener to fix its shape. In the previous case, the curvature is preset by the thermal fixation of the braid when it is confined in a very tight tubular shape (for example, by a corrugator or at least partially inside a hypotube). In the latter case the braid is tied with a suture at one point, a shape is inserted into the open end of the braid tube and the braid is stretched, or placed, over the shape with the folded section subjected to compression. When heated to fix the profile, the suture burns and disappears as the compression force sets the crease to a minimum radius.

El pliegue propiamente dicho se muestra útil en varios casos. En una variante de la invención, la sección plegada proporciona un extremo no traumático del implante. La sección plegada puede ser dejada abierta, o ligada cerrada por una sutura, un bucle de alambre (u otro material). Si no es radioopaca propiamente dicha, la ligadura puede también sujetar una banda marcadora (anudada, pegada u ondulada). Si se proporciona tal marcador puede ventajosamente estar suspendido contiguo al extremo superior/distal de la bola dentro del volumen interior. The fold itself is useful in several cases. In a variant of the invention, the folded section provides a non-traumatic end of the implant. The folded section can be left open, or linked closed by a suture, a loop of wire (or other material). If it is not radiopaque itself, the ligation can also hold a marker band (knotted, glued or wavy). If such a marker is provided, it can advantageously be suspended adjacent to the upper / distal end of the ball within the interior volume.

En uno u otro caso, tras la compresión hasta un perfil de colocación el cuerpo del implante básicamente pivota (más bien que se curva) en el pliegue, y de este modo se minimizan las fuerzas en el catéter/vaina. Esto mejora la capacidad de seguimiento del dispositivo así como la colocación y la capacidad de recapturarlo si se desea el tratamiento con un dispositivo de otro tamaño. In one case or another, after compression to a placement profile, the implant body basically pivots (rather than bends) in the fold, and thus the forces in the catheter / sheath are minimized. This improves the ability to track the device as well as the placement and the ability to recapture it if treatment with a device of another size is desired.

En un implante específico en PVO se puede sujetar una banda marcadora entre las capas de la trenza contiguas al pliegue central. La banda es capturada de forma segura y “oculta” sin mostrar bordes u otros elementos. Como tal, el extremo distal del dispositivo ofrece un perfil liso de colocación/seguimiento sin necesidad de por el contrario fijar la banda. In a specific PVO implant, a marker band can be attached between the braid layers adjacent to the central fold. The band is captured safely and "hidden" without showing edges or other elements. As such, the distal end of the device offers a smooth positioning / tracking profile without the need to fix the band.

Utilizado de cualquiera de tales formas (es decir, abierto, ligado o con una banda), en un extremo de la bola se evitan las juntas y otros elementos que aumentan el perfil de colocación. De este modo el pliegue ofrece unas ventajas constructivas (que incluyen la posibilidad de una fabricación mejorada) así como la reducción de las zonas de fallo en las que los extremos de la trenza de otro modo necesitarían ser asegurados. Además, el material laminado tubular doblado hacia atrás alcanza una excelente densidad a la vez que asegura una compresión uniforme y una capacidad de recuperación de la forma ya que las capas están bien apareadas. Así apareadas, se extienden/acortan en sustancialmente un grado igual cuando salen y vuelven a entrar en el catéter. Used in any of such ways (ie, open, bound or with a band), at one end of the ball joints and other elements that increase the placement profile are avoided. In this way the fold offers constructive advantages (which include the possibility of improved manufacturing) as well as the reduction of the areas of failure where the ends of the braid would otherwise need to be secured. In addition, the tubular laminated material folded back reaches an excellent density while ensuring uniform compression and a resilience of shape since the layers are well matched. Thus paired, they extend / shorten to a substantially equal degree when they exit and re-enter the catheter.

Una variante de la invención se aprovecha de las capas de trenzas apareadas, y simplemente elimina el pliegue por esmerilado o de otro modo recortándolo después de la fijación térmica (y, óptimamente, la fijación del buje de la trenza). Así preparado, el implante se hace más adaptable radialmente como puede ser deseable para el tratamiento A variant of the invention takes advantage of the paired braid layers, and simply removes the crease by grinding or otherwise trimming it after thermal fixation (and, optimally, fixing the braid bushing). Thus prepared, the implant becomes more radially adaptable as may be desirable for treatment.

del aneurisma. Y sin espacio adicional alguno ocupado por la curvatura en los filamentos la bola puede ser además comprimida para colocación a través de los microcatéteres más pequeños (para una densidad de trenza dada) para conseguir acceder a los lugares de tratamiento más distales. of aneurysm And without any additional space occupied by the curvature in the filaments the ball can also be compressed for placement through the smaller microcatheters (for a given braid density) to gain access to the most distal treatment sites.

Otra variante de la invención puede o puede no ser construida mediante un método de doblado hacia atrás. Para conseguir unas densidades de trenza mayores sin apilar capas adicionales que tengan que ajustar dentro del lumen del microcatéter, en cambio se pueden incorporar en el implante unas estructuras de “casquete” adicionales. Para su colocación, estos elementos se estrechan hacia abajo o se comprimen en serie. Sin embargo, tras la salida del microcatéter, recuperan una posición contigua al cuerpo principal del implante. Another variant of the invention may or may not be constructed by a backward bending method. To achieve higher braid densities without stacking additional layers that have to fit within the lumen of the microcatheter, however, additional "cap" structures can be incorporated into the implant. For placement, these elements are narrowed down or compressed in series. However, after the exit of the microcatheter, they recover a position adjacent to the main body of the implant.

El cuerpo de la bola y las partes de casquete del implante están típicamente construidas a partir de una sección continua de trenza. Las secciones intermedias del marcador pueden estar dispuestas entre los elementos. Un buje que incluye un puerto del sistema de colocación está dispuesto en el extremo proximal del dispositivo. The ball body and the cap parts of the implant are typically constructed from a continuous braid section. The intermediate sections of the marker can be arranged between the elements. A bushing that includes a port of the positioning system is disposed at the proximal end of the device.

Los casquetes proximales de trenza proporcionan unas capas de trenza adicionales al dispositivo en un extremo en el que la oclusión del flujo de sangre es crítica. El extremo proximal de una bola situada en un aneurisma hace contacto con la abertura y el cuello del aneurisma. Para conseguir una mayor oclusión del flujo los casquetes de la trenza pueden ser una trenza de capa única o doble. Se pueden situar uno o más casquetes de trenza en el extremo proximal de la bola (es decir, una bola de trenza puede tener hasta tres casquetes de trenza, y más si fuera posible). Proximal braid caps provide additional braid layers to the device at one end where blood flow occlusion is critical. The proximal end of a ball located in an aneurysm makes contact with the opening and neck of the aneurysm. To achieve greater flow occlusion the braid caps can be a single or double layer braid. One or more braid caps can be placed at the proximal end of the ball (that is, a braid ball can have up to three braid caps, and more if possible).

Los casquetes de trenza no funcionan, y no están adaptados a funcionar, como anclajes para el dispositivo. Un anclaje sujeta firmemente o comprueba el movimiento de un objeto unido a él. Para anclar algo hay que fijar o sujetar, o adherir firmemente un objeto. Los implantes de bolas no están anclados en el aneurisma o vaso principal mediante los casquetes de trenza. Más bien, los casquetes de trenza están diseñados para ser contiguos a la bola dentro de un aneurisma o para rellenar solamente la zona del cuello. En cualquier caso, los casquetes no se aplican sustancialmente en el tejido vascular contiguo a la bola. Sirven como elementos oclusivos que aumentan el potencial embólico de la bola. Braid caps do not work, and are not adapted to work, as anchors for the device. An anchor firmly holds or checks the movement of an object attached to it. To anchor something you have to fix or hold, or firmly adhere an object. Ball implants are not anchored in the aneurysm or main vessel by braid caps. Rather, braid caps are designed to be adjacent to the ball inside an aneurysm or to fill only the neck area. In any case, the caps are not substantially applied to the vascular tissue adjacent to the ball. They serve as occlusive elements that increase the embolic potential of the ball.

Como se ha mencionado, están dispuestos dos tipos de implantes de bola de trenza con casquete. Los casquetes adaptados a ajustarse solamente en el cuello del aneurisma son típicamente redondos (aunque pueden ser ovalados) y pueden ser ofrecidos en una variedad de tamaños para ajustar con diferentes tamaños de cuello precisamente cuando la parte de bola del implante es ofrecida en diversos tamaños. En otras palabras, a lo largo de una línea completa de implantes, se puede variar cada uno de los parámetros del tamaño del casquete y del tamaño de la bola. As mentioned, two types of braid ball implants with caps are arranged. Caps adapted to fit only on the aneurysm neck are typically round (although they can be oval) and can be offered in a variety of sizes to fit with different neck sizes precisely when the ball portion of the implant is offered in different sizes. In other words, along a complete line of implants, each of the parameters of the size of the cap and the size of the ball can be varied.

Los casquetes adaptados para ajustar en un aneurisma contiguo a la parte de bola del implante son mayores y con una forma para conformarse al cuerpo con forma de bola. Su colocación requiere comprimir la parte de bola del implante dentro del aneurisma y desplegar el casquete en él, o desplegar el casquete fuera del aneurisma y empujarlo hacia dentro del aneurisma en un estado desplegado. The caps adapted to fit in an aneurysm adjacent to the ball part of the implant are larger and with a shape to conform to the ball-shaped body. Its placement requires compressing the ball portion of the implant into the aneurysm and unfolding the cap on it, or deploying the cap outside the aneurysm and pushing it into the aneurysm in an unfolded state.

La colocación de los dispositivos con el o los casquetes o discos de relleno del cuello se realiza sustancialmente igual que las bolas sin tal o tales elementos con la excepción de que el catéter de colocación es retirado posteriormente para exponer el o los casquetes, o el catéter es estacionado fuera del cuello del aneurisma (en vez de en el cuello) y el implante es extrusionado de él. Por supuesto que alternativamente puede emplearse alguna combinación de tal actividad. The placement of the devices with the neck filling caps or discs is carried out substantially the same as the balls without such or such elements with the exception that the placement catheter is subsequently removed to expose the cap (s), or the catheter It is parked outside the neck of the aneurysm (instead of in the neck) and the implant is extruded from it. Of course, some combination of such activity can alternatively be used.

En cualquier caso, si se ha conseguido el ajuste deseado, el implante es liberado. De otro modo, se tira del implante al interior del catéter de colocación desde el buje proximal. Los uno o más casquetes se comprimen hasta conseguir el perfil lineal de la vaina de colocación/recuperación, seguido por la parte de la bola. In any case, if the desired setting has been achieved, the implant is released. Otherwise, the implant is pulled into the placement catheter from the proximal bushing. The one or more caps are compressed until the linear profile of the placement / recovery sheath is achieved, followed by the part of the ball.

En otra variante más de la invención se usa una bola de trenza en conjunción con una endoprótesis vascular. La bola puede ser unida a una endoprótesis vascular, colocada conjuntamente con ella. Alternativamente, se puede disponer un marco o caja en el extremo de una endoprótesis vascular en cuyo interior se coloca una bola de trenza después de que la endoprótesis vascular esté en su sitio. En cualquier caso, la bola y/o el marco pueden ser dimensionados para rellenar sustancialmente todo el aneurisma o solamente rellenar el cuello. En cualquier caso, la endoprótesis vascular servirá como un anclaje para impedir que la bola se vaya. La solución del marco más la bola ofrece ciertas ventajas en cuanto a la posibilidad de colocación gradual, en tanto que la endoprótesis vascular con la bola en la parte superior ofrece una solución sencilla que se puede conseguir en una única colocación. En cada ejemplo la endoprótesis vascular puede ser autoexpansible (por ejemplo, que comprende el Nitinol superelástico) o de pelota expansible (por ejemplo, que comprende acero inoxidable y montada en una pelota de tipo PTCA). A pesar de todo, el implante de bola de trenza empleado puede ser cualquiera de los descritos en el presente relleno o de los mencionados anteriormente. In yet another variant of the invention a braid ball is used in conjunction with a stent. The ball can be attached to a stent, placed in conjunction with it. Alternatively, a frame or box can be arranged at the end of a stent inside which a braid ball is placed after the stent is in place. In any case, the ball and / or the frame can be sized to substantially fill the entire aneurysm or just fill the neck. In any case, the stent will serve as an anchor to prevent the ball from leaving. The solution of the frame plus the ball offers certain advantages in terms of the possibility of gradual placement, while the stent with the ball at the top offers a simple solution that can be achieved in a single placement. In each example, the stent can be self-expanding (for example, comprising superelastic Nitinol) or expandable ball (for example, comprising stainless steel and mounted on a PTCA type ball). In spite of everything, the braid ball implant used can be any of those described in this filling or those mentioned above.

La presente invención incluye los dispositivos y conjuntos expuestos en los que están incluidos los métodos de uso y fabricación. Se han discutido antes varios aspectos de tal fabricación. Se presenta una discusión más detallada en conexión con las figuras que vienen más adelante. The present invention includes the exposed devices and assemblies in which the methods of use and manufacturing are included. Several aspects of such manufacturing have been discussed before. A more detailed discussion is presented in connection with the figures that come later.

El presente registro reivindica el beneficio de cada una de las Solicitudes de Patente de EEUU con Números de Serie 61/046594 y 61/046670 presentada el 21 de Abril de 2008; 61/083957 y 61/083961 presentada el 28 de Julio de 2008, y 61/145.097 presentada el 15 de Enero de 2009. This registration claims the benefit of each of the US Patent Applications with Serial Numbers 61/046594 and 61/046670 filed on April 21, 2008; 61/083957 and 61/083961 filed on July 28, 2008, and 61 / 145.097 filed on January 15, 2009.

BREVE DESCRIPCIÓN DE LAS FIGURAS BRIEF DESCRIPTION OF THE FIGURES

Las figuras aquí proporcionadas no están necesariamente dibujadas a escala, algunos componentes y elementos están ampliados para más claridad. De éstas: las Figuras 1A y 1B son vistas de la sección lateral que ilustran unas variantes del implante de bola de trenza en lugares de aneurisma de bifurcación y de pared lateral respectivamente, en las que una sección plegada en cada implante proporciona una interfaz de tejido no traumática; la Figura 2 es una vista ampliada del implante representado en la Figura 1B; las Figuras 3A-3B son vistas laterales en perspectiva de una bola de trenza de sección plegada en tamaños progresivamente mayores; las Figuras 4A y 4B son vistas de la sección lateral que ilustran unas variaciones del implante de bola de trenza de la aleta proximal desplegadas dentro de los lugares del aneurisma de bifurcación; la Figura 5A es una vista lateral de una versión de la endoprótesis vascular anclada de un implante de bola de trenza; la Figura 5B es una vista lateral de una endoprótesis vascular con una caja para la recepción de un implante de bola de trenza; la Figura 6 es una vista lateral que ilustra un implante de bola de trenza de sección plegada en una aplicación en PVO; la Figura 7 es una vista lateral de la sección del implante de la Figura 6; las Figuras 8A y 8B son unas vistas laterales de la sección de un implante mostrado en las fases de fabricación; la Figura 9 es una vista lateral de la sección de un implante en el que la sección plegada va a ser utilizada en un lado proximal del dispositivo; las Figuras 10A-10D son unas vistas laterales que ilustran las fases de fabricación de un implante de bola de trenza de sección plegada; las Figuras 11A y 11B son unas vistas desde un extremo que ilustran de forma diagramática una técnica para presentar el perfil del pliegue del implante; las Figuras 12A y 12B son unas vistas laterales de la sección que ilustran implantes de bola de trenza de sección plegada con las herramientas asociadas para fijar su forma; las Figuras 13A y 13B son vistas parciales de la sección lateral que ilustran métodos de adherencia alternativos de trenza/banda; la Figura 14 es una vista parcial de la sección lateral que ilustra un método de pegado del buje; la Figura 15 es una vista lateral parcial que muestra un método de recorte del buje; la Figura 16 es una vista lateral de la sección que ilustra otra variante del implante de bola de trenza de sección plegada; las Figuras 17A-17D son vistas laterales que ilustran las fases de fabricación de la realización de la Figura 16; la Figura 18 es una vista lateral de una variante del sistema de colocación apropiado para uso en la presente invención; la Figura 19A es una vista parcial de la sección lateral de un extremo distal de otra variante del sistema de colocación apropiado para uso en la presente invención; la Figura 19B es una vista desde el extremo desde dentro del implante del sistema mostrado en la Figura 19A; las Figuras 20A-20F son vistas parciales en perspectiva de la separación del implante con un sistema construido de acuerdo con el método mostrado en las Figuras 19A y 10B; y la Figura 21 es una vista en perspectiva que proporciona un resumen de un sistema de tratamiento de acuerdo con la presente invención. The figures provided here are not necessarily drawn to scale, some components and elements are enlarged for clarity. Of these: Figures 1A and 1B are views of the lateral section illustrating variants of the braid ball implant in locations of bifurcation and lateral wall aneurysm respectively, in which a folded section in each implant provides a tissue interface nontraumatic; Figure 2 is an enlarged view of the implant depicted in Figure 1B; Figures 3A-3B are perspective side views of a braid ball of folded section in progressively larger sizes; Figures 4A and 4B are views of the side section illustrating variations of the braid ball implant of the proximal fin deployed within the locations of the bifurcation aneurysm; Figure 5A is a side view of a version of the anchored stent of a braid ball implant; Figure 5B is a side view of a stent with a box for receiving a braid ball implant; Figure 6 is a side view illustrating a braid ball implant of folded section in a PVO application; Figure 7 is a side view of the implant section of Figure 6; Figures 8A and 8B are side views of the section of an implant shown in the manufacturing phases; Figure 9 is a side view of the section of an implant in which the folded section is to be used on a proximal side of the device; Figures 10A-10D are side views illustrating the manufacturing phases of a braid ball implant of folded section; Figures 11A and 11B are views from one end that diagrammatically illustrate a technique for presenting the profile of the implant fold; Figures 12A and 12B are side views of the section illustrating folded section braid ball implants with associated tools to fix their shape; Figures 13A and 13B are partial views of the side section illustrating alternative braid / band adhesion methods; Figure 14 is a partial view of the side section illustrating a method of gluing the bushing; Figure 15 is a partial side view showing a method of bushing trimming; Figure 16 is a side view of the section illustrating another variant of the folded section braid ball implant; Figures 17A-17D are side views illustrating the manufacturing phases of the embodiment of Figure 16; Figure 18 is a side view of a variant of the positioning system suitable for use in the present invention; Figure 19A is a partial view of the side section of a distal end of another variant of the positioning system suitable for use in the present invention; Figure 19B is a view from the end from within the implant of the system shown in Figure 19A; Figures 20A-20F are partial perspective views of the implant separation with a system constructed in accordance with the method shown in Figures 19A and 10B; and Figure 21 is a perspective view that provides a summary of a treatment system according to the present invention.

Se contemplan variantes de la invención a partir de las realizaciones representadas. En consecuencia, la representación de aspectos y elementos de la invención en las figuras no se considera que limite el alcance de la invención. Variants of the invention are contemplated from the embodiments represented. Consequently, the representation of aspects and elements of the invention in the figures is not considered to limit the scope of the invention.

DESCRIPCIÓN DETALLADA DETAILED DESCRIPTION

A continuación se describen diversas realizaciones a modo de ejemplo de la invención. Se hace referencia a estos ejemplos en un sentido no limitativo. Se proporcionan para ilustrar los aspectos más ampliamente aplicables de la presente invención. Se pueden realizar diversos cambios en la invención descrita y se pueden sustituir términos equivalentes sin apartarse del verdadero espíritu y alcance de la invención. Además, se pueden realizar muchas modificaciones para adaptarse a una determinada situación, material, composición del material, proceso, acción o acciones o paso o pasos del proceso hacia el objetivo u objetivos, espíritu o alcance de la presente invención. Todas estas modificaciones se tienen como fin estar dentro del alcance de las reivindicaciones aquí hechas. Various exemplary embodiments of the invention are described below. Reference is made to these examples in a non-limiting sense. They are provided to illustrate the most widely applicable aspects of the present invention. Various changes can be made to the described invention and equivalent terms can be substituted without departing from the true spirit and scope of the invention. In addition, many modifications can be made to adapt to a given situation, material, composition of the material, process, action or actions or step or steps of the process towards the objective or objectives, spirit or scope of the present invention. All these modifications are intended to be within the scope of the claims made herein.

Volviendo a la Figura 1A, se muestra un primer implante 20 de acuerdo con la presente invención. Está formado a partir de un material tubular de trenza que comprende un material elástico tal como el Nitinol que define un volumen abierto (generalmente redondo, esférico, ovular, en forma de corazón, etc) en un estado no comprimido/constreñido. Returning to Figure 1A, a first implant 20 according to the present invention is shown. It is formed from a tubular braid material comprising an elastic material such as Nitinol that defines an open volume (generally round, spherical, ovular, heart-shaped, etc.) in an uncompressed / constricted state.

El implante 20 se fija dentro de una bolsa 2 del aneurisma en una bifurcación vascular 4. Se coloca mediante un acceso a través del vaso principal 8 (por ejemplo, la arteria basilar), preferiblemente a través de un microcatéter disponible comercialmente (no mostrado) con un sistema de colocación como se detalla más adelante. The implant 20 is fixed inside a bag 2 of the aneurysm in a vascular bifurcation 4. It is placed through an access through the main vessel 8 (for example, the basilar artery), preferably through a commercially available microcatheter (not shown) with a placement system as detailed below.

El tamaño del implante puede ser seleccionado para rellenar y extenderse de algún modo fuera del cuello 10 del aneurisma de modo que el extremo proximal 22 del dispositivo ayude a dirigir el flujo de sangre a lo largo de la superficie de la trenza a partir de la que está construido hasta los vasos secundarios 8. Un extremo distal de la bola tiene una forma de caperuza y contiguo a un pliegue 24 en la trenza, lo que da lugar a una construcción en dos capas 26, 28 (capas interna y externa respectivamente) al menos en donde es impactado por el flujo en el cuello 10 del aneurisma. Como se muestra, una o más vueltas de la espiral 30 (por ejemplo, alambre de Pt) o una banda (no mostrada) pueden proporcionar un elemento radioopaco para marcar el lugar del implante. The size of the implant can be selected to fill and somehow extend out of the neck 10 of the aneurysm so that the proximal end 22 of the device helps direct blood flow along the surface of the braid from which it is constructed to the secondary vessels 8. A distal end of the ball has a cap shape and adjacent to a fold 24 in the braid, which results in a two-layer construction 26, 28 (inner and outer layers respectively) at less where it is impacted by the flow in the neck 10 of the aneurysm. As shown, one or more turns of the spiral 30 (for example, Pt wire) or a band (not shown) can provide a radiopaque element to mark the implant site.

El pliegue 24 en la trenza se fija en un radio más ajustado en el implante 40 mostrado en la Figura 1B. Aquí, el implante 40 es recibido dentro de un aneurisma 12 de una pared lateral fuera de un vaso 14. Un buje 42 del implante está enfrente de la sangre procedente y dirigida a lo largo de la línea de acceso y colocación vascular. The fold 24 in the braid is fixed in a more tight radius in the implant 40 shown in Figure 1B. Here, the implant 40 is received inside an aneurysm 12 of a side wall outside a vessel 14. A hub 42 of the implant is in front of the blood coming and directed along the access line and vascular placement.

Como se ve más fácilmente en la Figura 2, el implante 40 incluye una ligadura 44 que cierra una abertura 46 definida por el pliegue. Un marcador radioopaco 48 (por ejemplo Pt) está sujeto por la ligadura. Tal marcador no interfiere con la compresión del implante para su colocación. La visibilidad radiográfica del extremo proximal de la bola puede conseguirse debido a la densidad de la trenza que viene conjuntamente, sola, o se puede añadir una banda radioopaca 50 (por ejemplo Pt). As seen more easily in Figure 2, the implant 40 includes a ligature 44 that closes an opening 46 defined by the fold. A radiopaque marker 48 (for example Pt) is attached by ligation. Such a marker does not interfere with the compression of the implant for placement. The radiographic visibility of the proximal end of the ball can be achieved due to the density of the braid that comes together, alone, or a radiopaque band 50 (for example Pt) can be added.

La ligadura 44 puede comprender cualquier material biocompatible que incluya Acero Inoxidable, Titanio, Nitinol (posiblemente un alambre que es martensítico a temperatura del cuerpo –comúnmente denominado como “alambre de músculo”), sutura, etc. Una ventaja de utilizar alambre es que puede ser retorcido simplemente para fijar su posición, junto con el marcador. En cualquier caso, el filamento de ligadura debería ser delgado (por ejemplo, aproximadamente 0,0015 pulgadas (0,4 mm) de diámetro o menos) si se desea un pliegue de radio mínimo. Ligation 44 may comprise any biocompatible material that includes Stainless Steel, Titanium, Nitinol (possibly a wire that is martensitic at body temperature - commonly referred to as "muscle wire"), suture, etc. An advantage of using wire is that it can be twisted simply to fix its position, along with the marker. In any case, the ligation filament should be thin (for example, approximately 0.0015 inches (0.4 mm) in diameter or less) if a minimum radius fold is desired.

Otro elemento notable del implante 40 se refiere al buje 42 contiguo a la zona. Específicamente, un perfil de recaptura 52 ensanchado o con forma de trompeta se fija en la trenza para ayudar en la recaptura del dispositivo en el interior del catéter de colocación a través del cual se avanza el dispositivo. Un puerto de acceso 54 está dispuesto dentro del buje. Este puerto acepta una interfaz del sistema de colocación. La construcción del sistema de colocación así como otros detalles opcionales del implante se proporcionan más adelante. Another notable element of the implant 40 refers to the hub 42 adjacent to the area. Specifically, a widened or trumpet-shaped recapture profile 52 is fixed in the braid to aid in the recapture of the device inside the placement catheter through which the device is advanced. An access port 54 is disposed within the bushing. This port accepts a placement system interface. The construction of the placement system as well as other optional details of the implant are provided below.

Por supuesto, la Figura 2 muestra una bola en un estado no constreñido. Cuando está fijada dentro de un aneurisma, el implante más bien se adaptará a su forma (por ejemplo, como se muestra en la Figura 1A). Generalmente, el implante estará en cierto modo sobredimensionado para ejercer alguna pequeña carga sobre la pared del aneurisma a fin de ayudar a mantener una posición estable de la bola. No obstante, la bola puede ser deliberadamente subdimensionada, especialmente en una aplicación de pared lateral (por ejemplo, como se muestra en la Figura 1B) en caso de que se desee que cualquier elemento del buje sea capaz de girar con la bola para ser arrastrada con el flujo de sangre. Of course, Figure 2 shows a ball in an unconstrained state. When fixed within an aneurysm, the implant will rather adapt to its shape (for example, as shown in Figure 1A). Generally, the implant will be somewhat oversized to exert a small load on the aneurysm wall to help maintain a stable position of the ball. However, the ball can be deliberately undersized, especially in a side wall application (for example, as shown in Figure 1B) in case it is desired that any element of the bushing be able to rotate with the ball to be dragged With the flow of blood.

Dependiendo del ajuste deseado, el implante seleccionado por el médico puede girar hacia fuera para tener exactamente el tamaño apropiado tras la colocación debido a la variabilidad de la morfología del aneurisma y/o a las limitaciones de la formación de imágenes médicas. Es entonces cuando el perfil de recaptura es más útil facilitando la recuperación del implante. El primer implante puede ser desechado en favor de un segundo con un tamaño más apropiado. Las Figuras 3A-3C ilustran unos implantes 60, 62 y 64 en una gradación de tamaños. Naturalmente, el intervalo de dimensionamiento puede ser variado. Igualmente, la forma puede ser variada. Depending on the desired setting, the implant selected by the doctor may rotate outward to have exactly the appropriate size after placement due to the variability of the aneurysm morphology and / or the limitations of medical imaging. That is when the recapture profile is most useful in facilitating implant recovery. The first implant can be discarded in favor of a second with a more appropriate size. Figures 3A-3C illustrate implants 60, 62 and 64 in a gradation of sizes. Naturally, the sizing interval can be varied. Similarly, the shape can be varied.

En los tres ejemplos proporcionados es importante que se mantenga un tamaño de poros fijo hacia el centro de la bola. Generalmente será deseable minimizar el tamaño general de los poros. Sin embargo, la densidad de la trenza que puede ser conseguida en el trenzado de un tubo dado o el material laminado de la trenza está limitada por su diámetro y tamaño del alambre. En consecuencia, cada una de las tres bolas mostradas está hecha de una trenza que incorpora un número diferente de alambres o “extremos”. Por ejemplo, el primer implante 62 puede ser producido a partir de un material de 72 extremos doblado hacia atrás trenzado sobre un mandril de 6 mm de diámetro, el segundo implante 64 hecho de una trenza de 96 extremos doblada hacia atrás en un mandril de 8 mm, y el tercer implante 64 hecho de una trenza de 144 extremos doblada hacia atrás hecha en un mandril de 10 mm. Como alternativa, los implantes mayores (es decir, aquéllos de aproximadamente 10 mm de diámetro) pueden también estar hechos de una trenza de 96 extremos con el fin de mantener un menor perfil de cruce. Específicamente, se puede conseguir un perfil de cruce del catéter de 0,027 pulgadas (0,7 mm) cuando se usa una trenza de 96 extremos hecha de un cable con un diámetro de 0,001 pulgadas (0,025 mm). Igualmente, en el extremo menor del intervalo (por ejemplo, alrededor de un diámetro de 5 mm) se puede seleccionar en cambio una trenza de 64 extremos para conseguir unos perfiles de cruce de 0,021 pulgadas (0,5 mm). In the three examples provided it is important that a fixed pore size be maintained towards the center of the ball. It will generally be desirable to minimize the overall pore size. However, the density of the braid that can be achieved in the braid of a given tube or the laminated material of the braid is limited by its diameter and wire size. Consequently, each of the three balls shown is made of a braid that incorporates a different number of wires or "ends." For example, the first implant 62 can be produced from a 72-end material folded back braided on a 6 mm diameter mandrel, the second implant 64 made of a 96-end braid folded back on a mandrel of 8 mm, and the third implant 64 made of a 144-end braid bent backward made on a 10 mm mandrel. Alternatively, larger implants (that is, those approximately 10 mm in diameter) may also be made of a 96-end braid in order to maintain a lower crossing profile. Specifically, a catheter cross profile of 0.027 inches (0.7 mm) can be achieved when using a 96-end braid made of a cable with a diameter of 0.001 inches (0.025 mm). Similarly, at the lower end of the range (for example, around a diameter of 5 mm), a braid of 64 ends can be selected instead to achieve cross profiles of 0.021 inches (0.5 mm).

En cualquier caso, los filamentos de la trenza se muestran por pares dentro de este implante –uno de cada capa 26, In any case, the braid filaments are shown in pairs within this implant - one of each layer 26,

28. Mientras que la organización de la trenza es a menudo más aleatoria, la construcción de capa doble/dual –de promedio- da lugar a una mayor densidad que podría ser conseguida con un implante de una sola capa debido a las limitaciones en la densidad de la trenza para un diámetro de principio dado de la trenza. 28. While braid organization is often more random, double / dual layer construction - on average - results in a higher density that could be achieved with a single layer implant due to density limitations of the braid for a given beginning diameter of the braid.

Los implantes 70, 72 mostrados en las Figuras 4A y 4B, respectivamente, pueden también tener una construcción de capa doble. En cuyo caso, compartirían su configuración distal con los implantes previos 20/40/60. Como se muestra, son unos dispositivos de una sola capa en los que el extremo distal adopta la forma de un buje de inserción The implants 70, 72 shown in Figures 4A and 4B, respectively, may also have a double layer construction. In which case, they would share their distal configuration with the previous implants 20/40/60. As shown, they are single-layer devices in which the distal end takes the form of an insert bushing.

74. 74.

En uno u otro caso los implantes incluyen unas configuraciones de extremo proximal único. Además de una bola o parte bulbosa 80, cada implante incluye una aleta 76, 78 prevista para mejorar su potencial de interrupción del flujo de la sangre. La aleta 76 incluida en el implante 70 está prevista para un uso intraaneurismático. Para colocarla como se ha mostrado, la bola o la parte bulbosa es primero colocada en el interior de la bolsa 2 del aneurisma. A continuación, esa parte del dispositivo es comprimida mientras todavía está montada en el empujador 100 para In either case, the implants include single proximal end configurations. In addition to a bulbous ball or part 80, each implant includes a fin 76, 78 intended to improve its potential for interruption of blood flow. The flap 76 included in the implant 70 is intended for intraaneurysmal use. To place it as shown, the ball or bulbous part is first placed inside the bag 2 of the aneurysm. Next, that part of the device is compressed while it is still mounted on the pusher 100 to

desplegar la sección de aleta en ella. Después de conseguida la colocación final como se muestra en la Figura 4A, a continuación se liberan el o los miembros de bloqueo del empujador recibidos dentro del buje 42. Finalmente, el empujador es retirado al interior del catéter de colocación 110. Para ayudar en el método de colocación se pueden disponer uno o más elementos radioopacos (tal como una banda 50 en el extremo proximal de la sección 80 de la bola) de modo que el despliegue pueda ser visualizado en cada etapa. unfold the fin section on it. After the final placement is achieved as shown in Figure 4A, the pusher blocking member (s) received within the hub 42 are then released. Finally, the pusher is removed into the placement catheter 110. To assist in the method of placement one or more radiopaque elements (such as a band 50 at the proximal end of section 80 of the ball) can be arranged so that the deployment can be visualized at each stage.

El implante en la Figura 4B no requiere tal complicación en la colocación. Debido a que la aleta 78 tiene un tamaño seleccionado solamente para rellenar el cuello del aneurisma, puede ser colocada en línea recta. Además, los elementos radioopacos intermedios pueden ser convenientes para confirmar el ajuste y/o despliegue apropiados. The implant in Figure 4B does not require such a complication in placement. Because the fin 78 has a size selected only to fill the aneurysm neck, it can be placed in a straight line. In addition, intermediate radiopaque elements may be convenient for confirming the appropriate adjustment and / or deployment.

Como se ha representado, la variante de bola y disco del implante mostrado en la Figura 4B solamente puede ser aplicable a aneurismas de cuello pequeño en comparación con la variante de tipo “bellota” de la Figura 4A. Generalmente, el tamaño del disco no será significativamente mayor que el del diámetro del vaso principal/troncal 6 y o el de la zona de bifurcación 4. De otro modo, el conjunto de vasos interferirá con el despliegue. De este modo, el disco puede estar limitado de aproximadamente 2,5 a aproximadamente 5 mm de diámetro. As shown, the implant ball and disc variant shown in Figure 4B can only be applied to small neck aneurysms compared to the "acorn" type variant of Figure 4A. Generally, the size of the disk will not be significantly larger than that of the diameter of the main / trunk vessel 6 and that of the bifurcation zone 4. Otherwise, the set of vessels will interfere with the deployment. Thus, the disk can be limited from about 2.5 to about 5 mm in diameter.

En tanto que entendido mejor en el contexto de los pasos de fabricación del implante que se exponen más adelante, la aleta 78 puede ser formada mediante una simple arandela o placa sobre la cual la trenza se fija térmicamente. De otro modo, el útil de conformación puede ser curvo o abombado de modo que la aleta 78 siga mejor el contorno del cuerpo principal del implante. While better understood in the context of the manufacturing steps of the implant set forth below, the fin 78 may be formed by a simple washer or plate on which the braid is thermally fixed. Otherwise, the shaping tool may be curved or domed so that the fin 78 better follows the contour of the main body of the implant.

La variante de la aleta 76 en la Figura 4A típicamente estará formada por una forma cóncava/convexa de un modo similar. El tamaño de esta aleta puede variar. Como se muestra, su tamaño exterior tiene prácticamente el mismo diámetro de la parte 80 de bola del dispositivo. Puede ser menor y/o cubrir una menor extensión del lado proximal del implante 70. Generalmente, la aleta 70 cubrirá al menos aproximadamente un tercio y tanto como la mitad del cuerpo 80. De este modo, se asegura mejor la adecuada cubrición del cuello cuando se emplea para tratar aneurismas de cuello ancho. The variant of the flap 76 in Figure 4A will typically be formed by a concave / convex shape in a similar manner. The size of this fin may vary. As shown, its outer size has practically the same diameter of the ball portion 80 of the device. It may be smaller and / or cover a smaller extension of the proximal side of the implant 70. Generally, the fin 70 will cover at least about one third and as much as half of the body 80. In this way, adequate neck covering is best ensured when It is used to treat wide neck aneurysms.

La Figura 5A es una vista lateral de una versión de una endoprótesis vascular anclada de un implante de bola de trenza. La endoprótesis vascular 120 está dimensionada para ser anclada en el vaso principal en el tratamiento de un aneurisma terminal. De este modo, la parte 122 de la bola puede ser dimensionada solamente para rellenar el cuello del aneurisma en lugar de todo su volumen. Tal método puede ser especialmente útil para aneurismas de formas menos regulares. El dispositivo en la Figura 5B se usa de una forma similar, excepto que un implante de bola de trenza se introduce y está sujeto por un marco o caja 124, después se coloca en su sitio la sección de la endoprótesis vascular. Figure 5A is a side view of a version of an anchored vascular stent of a braid ball implant. The stent 120 is sized to be anchored in the main vessel in the treatment of a terminal aneurysm. Thus, part 122 of the ball can only be sized to fill the neck of the aneurysm instead of its entire volume. Such a method can be especially useful for aneurysms in less regular ways. The device in Figure 5B is used in a similar manner, except that a braid ball implant is inserted and is held by a frame or box 124, then the section of the stent is placed in place.

El marco puede comprender una pluralidad de alambres individuales 126 fijados a un buje 128 de la endoprótesis vascular en un extremo próximo y a otro buje o plato 130 en el extremo distal. En otra variante, los alambres que forman el marco están cortados a partir del mismo tubo que el de las celdas de la endoprótesis vascular y cualquier buje incluido. Pueden terminar en un extremo distal dentro de un buje, ser recalcados dentro de una banda radioopaca, soldados conjuntamente, fijados con adhesivo, o unidos por cualquier otro medio. En cualquier caso, están típicamente (aunque no necesariamente) unidos para formar un marco cerrado. También, se contempla un marco abierto –especialmente uno en el que los alambres enganchan hacia atrás (es decir, proximalmente) para ayudar a “agarrar” la bola cuando está colocada. The frame may comprise a plurality of individual wires 126 fixed to a hub 128 of the stent at a proximal end and to another hub or plate 130 at the distal end. In another variant, the wires that form the frame are cut from the same tube as that of the stent cells and any bushing included. They can end at a distal end inside a bushing, be stressed inside a radiopaque band, welded together, fixed with adhesive, or joined by any other means. In any case, they are typically (though not necessarily) linked to form a closed frame. Also, an open frame is contemplated - especially one in which the wires hook back (that is, proximally) to help "grab" the ball when it is placed.

Estos dispositivos (es decir, los ilustrados en las Figuras 5A y 5B) son colocados mediante técnicas normales, excepto que se pueden incorporar unos elementos “antisalto”/recuperación en la sección de la endoprótesis vascular. A pesar de todo, al menos una fila de celdas 132 de la endoprótesis vascular está dispuesta en la endoprótesis vascular para efectuar un nivel mínimo de anclaje; no obstante, se pueden emplear no menos de cinco These devices (that is, those illustrated in Figures 5A and 5B) are placed by normal techniques, except that "anti-skip" / recovery elements can be incorporated into the stent section. Nevertheless, at least one row of cells 132 of the stent is arranged in the stent to effect a minimum level of anchorage; however, no less than five can be used

o más con o sin cualesquiera elementos especiales antisalto/control de colocación. or more with or without any special anti-skip / placement control elements.

En tanto que las endoprótesis vasculares ventajosamente incluyen tres extensiones de soporte 134 para la bola o la caja de la bola, se pueden emplear más o menos. Sin embargo, el uso de tres ofrece la estructura estable mínima disponible. Y en donde se juntan funcionan muy parecido a una junta universal para ayudar a que la bola/marco montada en el extremo haga con éxito de interfaz con el aneurisma que ha de tratarse. While vascular stents advantageously include three support extensions 134 for the ball or ball housing, they can be used more or less. However, the use of three offers the minimum stable structure available. And where they come together they work very similar to a universal joint to help the ball / frame mounted at the end successfully interface with the aneurysm to be treated.

La Figura 6 ilustra un uso completamente diferente de los implantes expuestos. Es decir, un implante 140 es desplegado en un vaso (al contrario que el vaso contiguo dentro de un aneurisma) para ocluir el flujo. Como se ha mencionado antes, para uso en PVO el extremo distal de la bola puede incluir un nudo o boquilla 142. En realidad, tal elemento es ventajoso en una construcción ilustrada en la Figura 7. Figure 6 illustrates a completely different use of the exposed implants. That is, an implant 140 is deployed in a vessel (unlike the adjacent vessel within an aneurysm) to occlude the flow. As mentioned before, for use in PVO the distal end of the ball may include a knot or nozzle 142. In fact, such an element is advantageous in a construction illustrated in Figure 7.

En esta vista de la sección lateral la matriz de la trenza se muestra invertida (o vuelta hacia fuera) en el pliegue 24. Una banda 144 está fijada entre las capas interior y exterior de la trenza. La banda cierra el extremo y sirve como marcador (especialmente cuando comprende Pt). Se puede usar un compuesto adhesivo 146 (por ejemplo, LOCTITE 331 o 4014) para rellenar cualquier lumen residual dentro de la abertura del pliegue. Como con los otros implantes (incluidos los de las Figuras 4A y 4B), el implante puede incluir una sección 52 del perfil de recaptura en su extremo proximal, contiguo al buje 42. Igualmente, puede incluir un puerto 54 del buje. In this view of the side section the braid matrix is shown inverted (or turned outward) in the fold 24. A band 144 is fixed between the inner and outer layers of the braid. The band closes the end and serves as a marker (especially when it comprises Pt). An adhesive compound 146 (for example, LOCTITE 331 or 4014) can be used to fill in any residual lumen within the crease opening. As with the other implants (including those in Figures 4A and 4B), the implant may include a section 52 of the recapture profile at its proximal end, adjacent to the bushing 42. Similarly, it may include a bushing port 54.

De otro modo, ambos extremos del implante pueden ser cerrados/enchufados con un adhesivo o de otro modo. Sin un puerto de acceso del sistema de colocación el implante puede ser colocado mediante un simple empujador (al contrario que totalmente recuperable y/o reposicionable). Así configurado, de cualquier modo no se requiere un buje proximal. En realidad, la trenza puede simplemente ser recortada y fijada en su perfil para juntarse y/o ser asegurado su perfil mediante soldadura, adhesivo o de otro modo en el extremo proximal. Otherwise, both ends of the implant can be closed / plugged in with an adhesive or otherwise. Without an access port of the positioning system, the implant can be placed by means of a simple pusher (as opposed to fully recoverable and / or repositionable). Thus configured, a proximal bushing is not required anyway. In reality, the braid can simply be trimmed and fixed on its profile to join and / or its profile secured by welding, adhesive or otherwise at the proximal end.

Otro aspecto opcional de la invención está ilustrado en las Figuras 8A y 8B. Es decir, se forma primero un implante 140 de capa plegada sin tomar medidas para minimizar el radio de curvatura en el pliegue 24 de la trenza. Mientras todavía puede usarse, puede en cambio ser conveniente recortar la capa plegada para producir un implante modificado 140’ como se muestra en la Figura 8B. Al hacer esto se elimina volumen, y también en ciertos casos se cambian las propiedades de colocación de los implantes como se desee. El implante se hace más adaptable radialmente y capaz de ajustar un intervalo más amplio de tamaños de aneurismas debido a que los extremos 142 de la trenza pueden pasar uno entre otro más bien que apoyarse en el fondo. De este modo el mismo implante 140’ puede rellenar un volumen menor sin necesariamente extenderse desde el cuello del aneurisma como está indicado con línea de puntos en la Figura 8B. Another optional aspect of the invention is illustrated in Figures 8A and 8B. That is, a folded layer implant 140 is first formed without taking measures to minimize the radius of curvature in the fold 24 of the braid. While it can still be used, it may instead be convenient to trim the folded layer to produce a modified 140 ’implant as shown in Figure 8B. By doing this, volume is eliminated, and also in certain cases the implant placement properties are changed as desired. The implant becomes more radially adaptable and capable of adjusting a wider range of aneurysm sizes because the ends 142 of the braid can pass between each other rather than resting on the bottom. In this way, the same implant 140 'can fill a smaller volume without necessarily extending from the neck of the aneurysm as indicated by dotted lines in Figure 8B.

En cualquier caso, debido a que la técnica de construcción original que utiliza un tubo de trenza y lo repliega para producir dos capas, las capas (ahora separadas) están bien apareadas para previsiblemente expandirse y contraerse. Por otra parte, una vez eliminada cualquier curvatura que limita el perfil (por ejemplo, por corte, esmerilado, etc) las capas pueden ser conectadas de nuevo si no se desea el elemento de ajustabilidad antes descrito. Se puede usar localmente una capa 144 de revestimiento de uretano u otro adhesivo (que ventajosamente incluya un polvo radioopaco de Bario o de Tantalio) para llevar a cabo tal acción sin producir un aumento en el perfil de colocación. In any case, because the original construction technique that uses a braid tube and folds it back to produce two layers, the layers (now separated) are well paired to foreseeably expand and contract. On the other hand, once any curvature that limits the profile (for example, by cutting, grinding, etc.) has been removed, the layers can be reconnected if the adjustment element described above is not desired. A layer 144 of urethane or other adhesive coating (which advantageously includes a radiopaque powder of Barium or Tantalum) can be used locally to carry out such an action without increasing the placement profile.

Además, el mantenimiento del pliegue en un implante ofrece numerosas ventajas en otras circunstancias – especialmente cuando está formado de tal modo que minimiza el radio/perfil de curvatura del alambre. Es decir, los implantes que incluyen el pliegue pueden ofrecer una mejor integridad del tamaño y de la fuerza radial en circunstancias en las que se desee, eliminar cualesquiera fibras sueltas en un extremo del implante sin un posterior procesamiento (tal como por la aplicación de un polímero), proporcionar una bolsa para un marcador y/o una ligadura para suspender un marcador, etc. In addition, the maintenance of the fold in an implant offers numerous advantages in other circumstances - especially when it is formed in such a way that it minimizes the radius / curvature profile of the wire. That is to say, the implants that include the fold can offer a better integrity of the size and radial force in circumstances in which it is desired, to eliminate any loose fibers at one end of the implant without further processing (such as by the application of a polymer), provide a bag for a marker and / or a ligature to suspend a marker, etc.

Por otra parte, se ha de reconocer que el extremo plegado del implante no estará necesariamente fijado en el extremo distal del dispositivo. Más bien, la sección plegada 24 puede utilizarse en un extremo próximo como se muestra en la Figura 9. Y la abertura 46 formada por la sección plegada (cuando esté sujeta por un anillo, banda o ligadura 150) proporciona una interfaz del sistema de colocación 110. El extremo opuesto del implante puede tener un buje intercalado (por ejemplo, como está ilustrado en las Figuras 4A y 4B) o terminar en unos extremos recortados 142 muy iguales a los mostrados en la Figura 8B (con o sin un polímero incorporado) o ser configurados de otro modo. On the other hand, it should be recognized that the folded end of the implant will not necessarily be fixed at the distal end of the device. Rather, the folded section 24 can be used at a proximal end as shown in Figure 9. And the opening 46 formed by the folded section (when held by a ring, band or ligature 150) provides an interface of the positioning system. 110. The opposite end of the implant may have an intercalated bushing (for example, as illustrated in Figures 4A and 4B) or terminate at trimmed ends 142 very similar to those shown in Figure 8B (with or without a polymer incorporated) or be configured differently.

En cualquier caso las Figuras 10A-10D ilustran un método para construir un implante de sección plegada en el que el perfil del pliegue se ha minimizado. Como apreciarán los expertos en la técnica, los elementos del método se pueden aplicar a las diversas configuraciones del implante aquí discutidas. In any case, Figures 10A-10D illustrate a method for constructing a folded section implant in which the fold profile has been minimized. As those skilled in the art will appreciate, the elements of the method can be applied to the various implant configurations discussed herein.

En estas figuras la Figura 10A muestra una sección de trenza 200 ligada mediante una sutura 202 sobre un mandril In these figures, Figure 10A shows a section of braid 200 linked by a suture 202 on a mandrel

204. La ligadura está desplazada de donde la trenza es cortada de modo que, cuando la trenza está invertida como se muestra en la Figura 10B, la capa exterior 28 se extiende pasada la capa interior 26. Se desarrolla un pliegue suelto 210 y la trenza rodea la forma de perfilado 212 del implante. 204. The ligature is displaced from where the braid is cut so that, when the braid is inverted as shown in Figure 10B, the outer layer 28 extends past the inner layer 26. A loose fold 210 and the braid develop surrounds the profiling shape 212 of the implant.

En la Figura 10C la trenza es estirada y fijada por un arrollamiento 214 (típicamente un alambre de Pt o de Acero Inoxidable) alrededor de la forma 212 de la bola. Las formas de compresión 216, 218 también se muestran (sujetas por unas piezas de fijación, como está indicado por flechas). La forma 216 del pliegue lateral comprime el pliegue hasta un perfil mínimo durante la fijación térmica (por ejemplo, para una trenza de Nitinol a 550º C durante 5 minutos). En este proceso la ligadura natural 202 (si está hecha de sutura) desaparece quemándose y se elimina cualquier impedimento para conseguir un radio de curvatura cero o casi cero en el pliegue. La forma opuesta 218 puede definir una sección de rebordes agudos (para cuando ese extremo de la bola vaya a ser recortado y usado como el extremo distal, en una bola de “capa flotante” como se describe más adelante, etc) o formar un perfil de recaptura en la trenza. In Figure 10C the braid is stretched and fixed by a winding 214 (typically a Pt or Stainless Steel wire) around the shape 212 of the ball. Compression shapes 216, 218 are also shown (fastened by fixing pieces, as indicated by arrows). The shape 216 of the lateral fold compresses the fold to a minimum profile during thermal fixation (for example, for a Nitinol braid at 550 ° C for 5 minutes). In this process, natural ligation 202 (if made of suture) disappears by burning and any impediment to achieve a zero or near zero radius of curvature in the fold is eliminated. Opposite shape 218 may define a section of sharp ridges (for when that end of the ball is to be trimmed and used as the distal end, in a "floating layer" ball as described below, etc.) or form a profile of recapture in the braid.

Después de tal fijación de la forma, un dispositivo de realización 220 está preparado una vez que la forma interna es finalmente retirada como está ilustrado en la Figura 10D. Durante este proceso los extremos de la trenza son obligados a abrirse y típicamente pierden la integridad/aplicación de la trenza. De modo que tal acción no afecta negativamente a la integridad del implante, una “cola” 222 incorporada en la realización 220 sería suficientemente larga (es decir, a menudo aproximadamente 2 cm o más) para impedir cualquier daño debido a los extremos deshilados de la trenza que impactan en el cuerpo 224 previsto del implante. After such form fixation, an embodiment device 220 is prepared once the internal shape is finally removed as illustrated in Figure 10D. During this process the ends of the braid are forced to open and typically lose the integrity / application of the braid. So that such an action does not adversely affect the integrity of the implant, a "tail" 222 incorporated in the embodiment 220 would be long enough (ie, often about 2 cm or more) to prevent any damage due to the frayed ends of the braid that impact on the intended body 224 of the implant.

Si el implante se forma a partir de una trenza que incluye una capa de óxido la realización es a continuación grabada y después pasivizada. No obstante, si el alambre pregrabado se emplea en trenzar y para cualquier conformado por If the implant is formed from a braid that includes an oxide layer the embodiment is then recorded and then passivated. However, if the prerecorded wire is used in braiding and for any conformed by

calor realizado en una cuba con sal, horno en vacío, o mediante otro equipo para minimizar la formación de óxido, larealización puede simplemente ser sometida a una pasivización mediante Ácido Nítrico. heat made in a bowl with salt, oven in vacuum, or by other equipment to minimize the formation of rust, the realization can simply be subjected to a passivation by nitric acid.

Incluso en un proceso intermedio adicional se hace por pasos. La Figura 10E ilustra una manera en la que una banda 50 puede ser añadida para la formación de un buje. Específicamente, después de ligar la capa exterior 28 con una espiral 226 la banda puede ser roscada a lo largo de esta sección. Sin la capa interior debajo, la sección ligada 228 se ajusta dentro de la banda 50 de modo que la banda puede ser dimensionada para ajustarse sin holgura alrededor de ambas capas de trenza (y de un mandril opcional 230 –cuya utilidad se discute más adelante) cuando se avanza hasta un punto contiguo al cuerpo 224 del implante. Even in an additional intermediate process it is done in steps. Figure 10E illustrates a way in which a band 50 can be added for bushing formation. Specifically, after linking the outer layer 28 with a spiral 226 the band can be threaded along this section. Without the inner layer underneath, the bonded section 228 fits inside the band 50 so that the band can be sized to fit snugly around both braid layers (and an optional mandrel 230 - whose utility is discussed below) when advancing to a point adjacent to the body 224 of the implant.

Como un método alternativo a la conformación por compresión, en las Figuras 11A y 11B se presenta el pliegue durante la realización del perfilado para conseguir unas curvaturas de radio mínimo en el alambre de la trenza. Estas figuras ilustran una técnica para prefijar la forma del pliegue del implante. En la Figura 11A las cuñas 240 de un dispositivo ondulador (por ejemplo, disponible a través de Machine Solutions, Inc y otros) reciben la trenza 200 que está doblada hacia atrás para definir una pluralidad de curvaturas. Un mandril 242 está ventajosamente fijado dentro de la trenza. El mandril limita la compresión del tubo de la trenza, que requiere que los radios de curvatura se ajusten sin holgura cuando la abertura 224 formada por las cuñas está cerrada como se indica en la Figura 11B. La forma del pliegue se fija por calor y/o una combinación de tensión y calor. El calor puede ser aplicado por un soplete oxiacetilénico, dentro de un horno o, ventajosamente, haciendo pasar una corriente a través del mandril. En otro método se emplea un plato o pinza portapiezas multielemento de una forma similar a las cuñas del ondulador antes ilustradas. As an alternative method to compression forming, in Figures 11A and 11B the fold is presented during profiling to achieve minimum radius curvatures in the braid wire. These figures illustrate a technique for prefixing the shape of the implant fold. In Figure 11A the wedges 240 of an undulating device (for example, available through Machine Solutions, Inc and others) receive the braid 200 that is bent back to define a plurality of curvatures. A mandrel 242 is advantageously fixed within the braid. The mandrel limits the compression of the braid tube, which requires that the radii of curvature fit snugly when the opening 224 formed by the wedges is closed as indicated in Figure 11B. The shape of the fold is fixed by heat and / or a combination of tension and heat. The heat can be applied by an oxyacetylene torch, inside an oven or, advantageously, by passing a current through the mandrel. In another method, a multi-element plate holder or clamp is used in a manner similar to the wedges of the inverter illustrated above.

Así formado, el implante general puede ser conformado ampliamente como se ha descrito en conexión con las Figuras 10A-10D sin el uso de la ligadura por sutura o compresión de 216. En lugar de ello, se puede emplear una ligadura permanente mediante un alambre fino que permanece a lo largo de todo el proceso para cerrar el extremo plegado de la bola. Esta ligadura puede instalarse simplemente invirtiendo hacia atrás la trenza plegada para exponer las curvaturas. Como alternativa, puede ser tratado a través y alrededor de los pliegues de la curvatura con una aguja y ligado. Thus formed, the general implant can be broadly shaped as described in connection with Figures 10A-10D without the use of suture or compression ligation of 216. Instead, a permanent ligation using a fine wire can be employed. which remains throughout the entire process to close the folded end of the ball. This ligature can be installed simply by reversing the folded braid back to expose the curvatures. Alternatively, it can be treated through and around the folds of the curvature with a needle and tied.

El pretratamiento del pliegue o el conformado por compresión de él durante la fijación térmica del volumen del implante es ventajoso especialmente en aquellos casos en los que la zona contigua al pliegue va a adoptar la forma de una caperuza. No obstante, cuando se puede aceptar un botón en el diseño del dispositivo dado su uso previsto (por ejemplo, en PVO) las Figuras 12A y 12B ilustran otro método. Específicamente, un hipotubo 250 (u otra forma perfilada que incluye una bolsa) se coloca sobre la trenza en donde la trenza está atrapada entre una banda 50 y/o la banda y el mandril 204, como se muestra. Además, como se muestra en la Figura 12B, un segundo hipotubo 252 (o superficie con forma de bolsa) puede hacer contacto con el punto de inflexión 254 para además estrechar la trenza para la fijación precisa de la forma. The pretreatment of the fold or the compression forming thereof during thermal fixation of the implant volume is advantageous especially in those cases in which the area adjacent to the fold is going to take the form of a cap. However, when a button can be accepted in the design of the device given its intended use (for example, in PVO), Figures 12A and 12B illustrate another method. Specifically, a hypotube 250 (or other profiled shape that includes a bag) is placed on the braid where the braid is caught between a band 50 and / or the band and the mandrel 204, as shown. In addition, as shown in Figure 12B, a second hypotube 252 (or bag-shaped surface) can make contact with the inflection point 254 to further narrow the braid for precise shape fixation.

En cuanto a la fijación de la forma restante del implante o de su realización 220, la Figura 12A ilustra el uso de una forma 256 perfilada de trompeta proximal para fijar un perfil de recaptura liso. En la Figura 12B la forma proximal 258 fija un radio muy ajustado o agudo. Tal forma puede ser conveniente para conseguir una mayor fuerza radial en el implante debido a un mayor esfuerzo de curvatura local. Regarding the fixation of the remaining form of the implant or its embodiment 220, Figure 12A illustrates the use of a profiled form 256 of the proximal trumpet to fix a smooth recapture profile. In Figure 12B, the proximal shape 258 sets a very tight or sharp radius. Such a shape may be convenient to achieve greater radial force in the implant due to a greater effort of local curvature.

El implante mostrado en la Figura 12B trata de conseguir un mejor anclaje que el de la Figura 12A debido a la otra lengüeta digna de mención ilustrada en los dibujos. Es decir, la forma 260 de la banda cilíndrica fijada en el implante a lo largo de la forma del dispositivo, en otros casos ovular, produce unos bordes 262 que interactúan con el tejido vascular con un esfuerzo local incrementado para mejorar el anclaje. The implant shown in Figure 12B tries to achieve a better anchorage than that of Figure 12A due to the other noteworthy tongue illustrated in the drawings. That is, the shape 260 of the cylindrical band fixed in the implant along the shape of the device, in other cases ovular, produces edges 262 that interact with the vascular tissue with an increased local effort to improve the anchorage.

Ambos implantes comparten también una relación de aspecto aplanado/reducido con relación a los implantes de bola esférica previamente representados. Tal relación de aspecto tiene en cuenta un mayor sobredimensionamiento para anclar los implantes autoexpansibles en el vaso para una longitud resultante del dispositivo. Este hecho es ventajoso dado que la longitud focal de oclusión es a menudo importante en el tratamiento de defectos neurovasculares con el fin de bloquear involuntariamente los vasos contiguos del perforador / secundarios en aplicaciones en PVO. Both implants also share a flattened / reduced aspect ratio relative to the spherical ball implants previously shown. Such aspect ratio takes into account a larger oversize to anchor the self-expanding implants in the vessel for a resulting length of the device. This fact is advantageous since the focal length of occlusion is often important in the treatment of neurovascular defects in order to unintentionally block adjacent perforator / secondary vessels in PVO applications.

Cualquiera que sea la forma del implante, cuando se incluye un buje para asegurar los filamentos de la trenza, se debe hacer frente a ciertos problemas de adherencia. El buje tiene que ser sujetado de forma segura a la trenza y puede ser necesario minimizar la longitud del elemento. Las Figuras 13A y 13B son vistas parcialmente seccionadas lateralmente que ilustran unos métodos alternativos de adherencia de la trenza/banda. En la Figura 13A, la banda 50 se fija pasada una línea de corte de la trenza. La pequeña cola resultante 270 proporciona una superficie a través de la cual se puede aplicar un pegamento 272. Una vez endurecido (por ejemplo, por aplicación de UV) el adhesivo es arrastrado en la trenza y forma un borde 274 sobre el cual la banda no puede pasar. Si no se usa un pegamento, entonces la trenza puede ser mezclada con un láser para formar igualmente un elemento de interferencia de la banda. Tal aplicación de láser puede soldar la trenza a una banda interna 276 si se emplea una. El láser puede ser aplicado en una dirección radial alrededor de la trenza, o axialmente a través de la cara recortada de la trenza. Whatever the shape of the implant, when a bushing is included to secure the braid filaments, certain adhesion problems must be addressed. The bushing has to be securely attached to the braid and it may be necessary to minimize the length of the element. Figures 13A and 13B are partially laterally sectioned views illustrating alternative methods of adhesion of the braid / band. In Figure 13A, the band 50 is fixed past a cut line of the braid. The resulting small glue 270 provides a surface through which a glue 272 can be applied. Once hardened (for example, by UV application) the adhesive is dragged into the braid and forms an edge 274 on which the web does not You can pass. If a glue is not used, then the braid can be mixed with a laser to also form an interference element of the band. Such a laser application can weld the braid to an inner band 276 if one is used. The laser can be applied in a radial direction around the braid, or axially through the cropped face of the braid.

Especialmente cuando se utiliza una energía de láser se puede emplear un método alternativo ilustrado en la Figura 13B. Aquí, aplicando una energía de láser dirigida axialmente a través del borde de la o las bandas y de la cara de la trenza se pueden soldar conjuntamente todas ellas. Incluso si son así soldadas, la cara resultante puede ser sellada con un adhesivo polimérico 272. Especially when using a laser energy an alternative method illustrated in Figure 13B can be used. Here, by applying an axially directed laser energy through the edge of the band (s) and the braid face all of them can be welded together. Even if so welded, the resulting face can be sealed with a 272 polymeric adhesive.

La Figura 14 ilustra además otro método de fijación del buje. Aquí, la difusión depende de la penetración del pegamento/adhesivo a través de la trenza por debajo de la banda para formar una unión. Se aplica una perla de pegamento 280 a un segmento de trenza expuesto 200 contiguo a la banda 50. Un mandril 230 (por ejemplo, recubierto de PTFE) no adherente puede estar situado dentro de la trenza para definir de forma precisa un lumen dentro de la trenza impregnada de pegamento. El lumen ventajosamente funciona como un puerto del sistema de colocación. Una vez que ha endurecido el adhesivo y se ha retirado el mandril, se ha conseguido una estructura de pared compuesta exactamente dimensionada. Figure 14 further illustrates another method of bushing fixing. Here, diffusion depends on the penetration of the glue / adhesive through the braid below the band to form a joint. A glue bead 280 is applied to an exposed braid segment 200 adjacent to the band 50. A non-adherent mandrel 230 (for example, PTFE coated) may be located within the braid to precisely define a lumen within the braid impregnated with glue. The lumen advantageously functions as a port of the placement system. Once the adhesive has hardened and the mandrel has been removed, an exactly sized composite wall structure has been achieved.

El adhesivo puede aplicarse uniformemente alrededor de la trenza girando el conjunto como se ha indicado. También se pueden utilizar otros métodos. En uno de ellos se puede incluir una pluralidad de ventanas de acceso opcionales 282 en la banda para recibir y extender el adhesivo. El adhesivo es también opcionalmente extendido alejándose de la trenza 200 por una cartulina o una almohadilla de papel absorbente 284 (o retirado por otros medios) de modo que no haya un exceso de adhesivo que se extiende/fluye utilizado para asegurar la cubrición del lumen de la trenza y/o la adhesión de la banda 50 no interfiera con la acción de autoexpansión del cuerpo 224 del implante. The adhesive can be applied evenly around the braid by rotating the assembly as indicated. Other methods can also be used. In one of them, a plurality of optional access windows 282 can be included in the web to receive and extend the adhesive. The adhesive is also optionally extended away from the braid 200 by a cardboard or absorbent paper pad 284 (or removed by other means) so that there is not an excess of extending / flowing adhesive used to ensure the lumen coverage of the braid and / or the adhesion of the band 50 does not interfere with the self-expanding action of the implant body 224.

El uso de una banda interna 276 es también opcional. En tanto que ocupa el espacio que conserva el lumen de la trenza y el pegamento solamente, la inclusión de una banda interna en el conjunto 42 del buje puede a veces ser conveniente para la interfaz del sistema de separación. The use of an internal band 276 is also optional. As long as it occupies the space that retains the lumen of the braid and the glue only, the inclusion of an internal band in the bushing assembly 42 may sometimes be convenient for the interface of the separation system.

El uso de un hipotubo adjunto 286 también es opcional. Sin embargo, este tubo ofrece un agarre o empuñadura en los que comprimir para un posterior recorte. Especialmente para tal uso, puede ser conveniente un tubo con pared ancha (por ejemplo, de aproximadamente 0,005” (0,13 mm) o mayor) debido a la estabilidad que pueda ofrecer. Como con la banda que se convierte en parte del implante, el hipotubo 286 puede incluir una o más ventanas de acceso 282 para la aplicación del adhesivo. The use of an attached hypotube 286 is also optional. However, this tube offers a grip or grip on which to compress for later trimming. Especially for such use, a wide-walled tube (for example, approximately 0.005 "(0.13 mm) or greater) may be convenient due to the stability it may offer. As with the band that becomes part of the implant, the hypotube 286 may include one or more access windows 282 for the application of the adhesive.

Para recortar una realización 220 del implante (sin embargo, está perfilado), la Figura 15 ilustra un método que se coordina bien con el método de adherencia del buje ilustrado en la Figura 14. El hipotubo adjunto específicamente es capturado en un útil 290 montado en una deslizadera 292. El ajuste lateral puede ser dispuesto con el fin de alinear una hoja de sierra 294 (típicamente una rueda recubierta de diamante de 0,004-0,010 pulgadas (0,1 – 0,25 mm)) con un espacio intermedio 296 situado entre la banda y el agarre 286 del hipotubo. Una vez alineado (la línea de corte puede estar en el espacio intermedio, o la banda propiamente dicha puede ser cortada) el implante es recortado. Para ayudar en el manejo, el implante puede estar al menos constreñido en una vaina 298, como se muestra. Un corte/recorte de precisión tiene en cuenta una banda (recortada o instalada inicialmente) tan pequeña como de aproximadamente 0,010 pulgadas (0,25 mm) de altura. Un tamaño más conservador (por ejemplo, aproximadamente 0,020 pulgadas (0,5 mm) de altura) puede, no obstante, ser conveniente para asegurar la captura de la trenza y la robustez del sistema de separación. To trim an embodiment 220 of the implant (however, it is profiled), Figure 15 illustrates a method that coordinates well with the method of adhesion of the bushing illustrated in Figure 14. The attached hypotube is specifically captured in a tool 290 mounted on a slide 292. The lateral adjustment may be arranged in order to align a saw blade 294 (typically a diamond coated wheel of 0.004-0.010 inches (0.1-0.25 mm)) with an intermediate space 296 located between the band and grip 286 of the hypotube. Once aligned (the cutting line can be in the intermediate space, or the band itself can be cut) the implant is trimmed. To aid in handling, the implant may be at least constrained in a sheath 298, as shown. Precision cutting / trimming takes into account a band (trimmed or initially installed) as small as approximately 0.010 inches (0.25 mm) high. A more conservative size (for example, approximately 0.020 inches (0.5 mm) in height) may, however, be convenient to ensure braid capture and robustness of the separation system.

Después de hecho el corte, la longitud del buje puede ser reducida más puliendo su cara. Después de la retirada del mandril (también el corte en el procedimiento de recorte) y de la limpieza en un baño ultrasónico, la cara del buje puede ser sellada con un adhesivo. After the cut is made, the length of the bushing can be reduced further by polishing its face. After removal of the mandrel (also the cut in the trimming procedure) and cleaning in an ultrasonic bath, the face of the bushing can be sealed with an adhesive.

En la Figura 16 se ilustra otra variante 300 del implante producida mediante el uso de cualquiera de las técnicas de punzonado de cavidades. En las Figuras 17A-17D se presentan unos pasos adicionales únicos para esta fabricación. Another variant 300 of the implant produced by using any of the cavity punching techniques is illustrated in Figure 16. Figures 17A-17D present a few additional steps unique to this manufacturing.

El implante difiere de los discutidos antes en que incluye una capa de trenza que no está asegurada en cada extremo del dispositivo. Más bien, la capa interna 26 “flota”. Su presencia aumenta la densidad del implante, pero sus fibras contiguas al buje 42 no están obligadas a curvarse cuando la bola es comprimida en una vaina para su colocación y/o recaptura. Por lo tanto, se requiere una fuerza relativamente menor para la recaptura, incluso cuando la trenza está curvada aproximadamente 90 grados después de salir del buje (es decir, sin el extremo próximo del cuerpo 224 del implante que incluye un perfil de recaptura en el diseño). The implant differs from those discussed above in that it includes a braid layer that is not secured at each end of the device. Rather, the inner layer 26 "floats." Its presence increases the density of the implant, but its fibers adjacent to the hub 42 are not required to bend when the ball is compressed in a sheath for placement and / or recapture. Therefore, a relatively smaller force is required for recapture, even when the braid is curved approximately 90 degrees after exiting the bushing (i.e., without the proximal end of the implant body 224 which includes a recapture profile in the design ).

Para producir una bola con los extremos 302 interiores de la trenza próximos al buje en donde la densidad de la trenza exterior es la más alta y la más capaz para impedir que cada uno de los filamentos de la capa interior asome a través de la matriz de la trenza se lleva a cabo un elegante conjunto de pasos de fabricación. Específicamente, después de comenzar con una realización 220 del implante como se muestra en la Figura 17A, la capa exterior se tira de la trenza o se empuja afuera del cuerpo previsto 224 del implante como se muestra en la Figura 17B. La capa interior de la trenza es recortada como se muestra en la Figura 17C. Se pueden emplear cortadores de alambre, tijeras u otros medios. Finalmente, la capa exterior es devuelta a su posición original como se muestra en la Figura 17D y el dispositivo de implante es posteriormente procesado. To produce a ball with the inner ends 302 of the braid near the bushing where the density of the outer braid is the highest and most capable to prevent each of the filaments of the inner layer from peeking through the matrix of The braid is carried out an elegant set of manufacturing steps. Specifically, after starting with an embodiment 220 of the implant as shown in Figure 17A, the outer layer is pulled from the braid or pushed out of the intended body 224 of the implant as shown in Figure 17B. The inner layer of the braid is trimmed as shown in Figure 17C. Wire cutters, scissors or other means can be used. Finally, the outer layer is returned to its original position as shown in Figure 17D and the implant device is subsequently processed.

Tal proceso posterior puede incluir la aplicación de una banda / punzonado, el recorte y/o ligado de la abertura del pliegue cerrada. No obstante, tal ligadura puede ser ventajosamente realizada antes de restaurar la posición de la trenza exterior en tanto que el pliegue 24 está expuesto según la Figura 17B/17C. Such a subsequent process may include the application of a band / punching, trimming and / or binding of the closed fold opening. However, such ligation can be advantageously performed before restoring the position of the outer braid while the fold 24 is exposed according to Figure 17B / 17C.

Cualesquiera que sean las técnicas empleadas en su construcción, los implantes son ventajosamente montados en un empujador separable. El sistema de colocación 310 en la Figura 18 incluye un buje 312 del hipotubo con unas ventanas 314 cortadas. La ventana 312 contigua al buje de la bola es crítica, la otra simplemente ventajosa. Un elemento 316 del núcleo (ventajosamente una cinta de Nitinol) sale de la ventana proximal 312 o corte y vuelve a entrar en la segunda 314. Un reborde/paragolpes 316 unido al hipotubo hace contacto en un extremo próximo del buje 50 para empujar el implante 40. Alternativamente, se puede disponer un manguito exterior (no mostrado) que se extiende a lo largo de la longitud del hipotubo hasta una protección 318 y/o buje 320 del sistema de colocación. Para permitir la retirada del implante en el catéter de colocación (no mostrado), el miembro 316 del núcleo se aplica en la superficie interior del lumen del buje (oculto) para retener el implante. Whatever the techniques used in its construction, the implants are advantageously mounted on a separable pusher. The positioning system 310 in Figure 18 includes a hub 312 of the hypotube with cut windows 314. The window 312 adjacent to the ball hub is critical, the other simply advantageous. An element 316 of the core (advantageously a Nitinol tape) leaves the proximal window 312 or cut and re-enters the second 314. A flange / bumper 316 attached to the hypotube makes contact at a proximal end of the bushing 50 to push the implant 40. Alternatively, an outer sleeve (not shown) can be arranged that extends along the length of the hypotube to a protection 318 and / or bushing 320 of the positioning system. To allow removal of the implant in the placement catheter (not shown), the core member 316 is applied to the inner surface of the bushing lumen (hidden) to retain the implant.

Para permitir la liberación, el miembro del núcleo es extraído al interior del hipotubo 310 que limpia cada una de las ventanas 312, 314 tirando del agarre 322. En este punto el hipotubo puede salir del puerto 54 del buje extrayendo el empujador. To allow release, the core member is removed inside the hypotube 310 which cleans each of the windows 312, 314 by pulling on the grip 322. At this point the hypotube can exit port 54 of the bushing by removing the pusher.

Otro sistema de colocación 330 separable está ilustrado en las Figuras 19A y 19B. Es un diseño totalmente coaxial en el que se tira de los alambres de control 332 para liberar la interferencia de una cabeza 334 montada en un alambre de anclaje 336 que de otro modo es incapaz de pasar a través de un puerto del buje o lumen 54. Debido a que se tira directamente de los alambres y solamente la posición de la cabeza del alambre de anclaje asegura la interferencia (claramente ilustrada en la Figura 19B) se requiere un esfuerzo mínimo. También es útil un recubrimiento de EPTFE sobre al menos los alambres de control. Another separable positioning system 330 is illustrated in Figures 19A and 19B. It is a fully coaxial design in which control wires 332 are pulled to release interference from a head 334 mounted on an anchor wire 336 that is otherwise unable to pass through a bushing port or lumen 54. Because the wires are pulled directly and only the position of the anchor wire head ensures interference (clearly illustrated in Figure 19B), minimal effort is required. An EPTFE coating on at least the control wires is also useful.

Los alambres de control 332 pueden extenderse hasta o pasada la cabeza 334 del alambre de control (el anterior caso ilustrado en la Figura 19A). Otra opción es limitar la longitud del alambre de control a la de cualquier banda interior 276 o a la dimensión total de la altura del buje 42 (como está ilustrado en la Figura 19B). Obsérvese también: la Figura 19A muestra un espacio entre un manguito empujador 338 y el buje 50 del implante. Esta representación es solamente con fines ilustrativos. The control wires 332 can extend to or past the head 334 of the control wire (the previous case illustrated in Figure 19A). Another option is to limit the length of the control wire to that of any inner band 276 or to the total dimension of bushing height 42 (as illustrated in Figure 19B). Note also: Figure 19A shows a gap between a pusher sleeve 338 and the hub 50 of the implant. This representation is for illustrative purposes only.

En cualquier caso, cada lumen del manguito empujador 340 y el lumen/puerto 52 del buje del implante se dimensionan preferiblemente de modo que los alambres (los alambres de control 332 y el alambre de anclaje 336) son recibidos en una disposición de empaquetamiento cerrado. De esta manera el implante y el manguito empujador sirven como una guía que elimina las dificultades de carga asociadas con los alambres que llegan a estar trenzados In any case, each lumen of the pusher sleeve 340 and the lumen / port 52 of the implant bushing are preferably sized so that the wires (the control wires 332 and the anchor wire 336) are received in a closed packing arrangement. In this way the implant and the pusher sleeve serve as a guide that eliminates the loading difficulties associated with the wires that become braided.

o entrelazados. También para cargar el sistema, el alambre de anclaje está típicamente tensionado hasta un grado muy ligero (antes de simplemente pegarlo en una empuñadura o usar un muelle de derivación incorporado en el diseño de la empuñadura) para asegurar que cualquier espacio entre el implante y el empujador esté cerrado y permanezca cerrado durante su uso. or intertwined. Also to load the system, the anchor wire is typically tensioned to a very light degree (before simply sticking it in a handle or using a bypass spring incorporated in the design of the handle) to ensure that any space between the implant and the pusher is closed and remains closed during use.

Las Figuras 20A-20F ilustran una variante del sistema de colocación 330 en uso. El extremo distal del sistema de separación se muestra con la parte 42 del buje de un implante. La Figura 20A muestra el enclavamiento del empujador aplicado. Las Figuras 20B-20D ilustran la retirada secuencial de los alambres de control 332. El alambre de anclaje 336 puede también ser individualmente retirado como se muestra en la Figura 20E. No obstante, en cambio puede ser retirado con el manguito 338 del sistema de separación. En realidad, puede ser adherido al manguito. Además, hay que reconocer que no es necesario tirar de los alambres de control de uno en uno. Pueden ser accionados conjuntamente. En cualquier caso, la separación del implante completo está ilustrada en la Figura 20F. Figures 20A-20F illustrate a variant of the installation system 330 in use. The distal end of the separation system is shown with part 42 of the implant bushing. Figure 20A shows the interlocking of the applied pusher. Figures 20B-20D illustrate the sequential removal of control wires 332. The anchor wire 336 can also be individually removed as shown in Figure 20E. However, it can instead be removed with sleeve 338 of the separation system. Actually, it can be attached to the sleeve. In addition, it must be recognized that it is not necessary to pull the control wires one at a time. They can be operated together. In any case, the separation of the complete implant is illustrated in Figure 20F.

Finalmente, la Figura 21 presenta una visión general de un sistema de tratamiento 340 que incluye un implante 342 y la empuñadura 342. Uno o ambos pueden estar construidos de acuerdo con las enseñanzas aquí expuestas. La empuñadura 342 mostrada incluye tres perillas de mando. Dos perillas de mando 344 están conectadas a los alambres de control (ocultos a la vista), y la tercera perilla de mando 346 a un alambre de anclaje (oculto a la vista). Un casquete de bloqueo separable 348 puede estar incluido en el diseño de la empuñadura así como una sección 350 de carcasa de protección. El eje 338 del catéter/empujador puede comprender una simple extrusión (por ejemplo, PTFE, FEP, PEEK, etc) o puede ser construido mediante el uso de técnicas convencionales de construcción de catéteres e incluir un revestimiento, un soporte de la trenza y una envoltura exterior (no mostrada). Una vaina de carga 352 está típicamente dispuesta sobre el eje del empujador. Ventajosamente, la vaina de carga es divisible como se muestra en el modelo. Finally, Figure 21 presents an overview of a treatment system 340 that includes an implant 342 and the handle 342. One or both may be constructed in accordance with the teachings set forth herein. The handle 342 shown includes three knobs. Two control knobs 344 are connected to the control wires (hidden from view), and the third control knob 346 to an anchor wire (hidden from view). A detachable locking cap 348 may be included in the handle design as well as a protective housing section 350. The axis 338 of the catheter / pusher may comprise a simple extrusion (for example, PTFE, FEP, PEEK, etc.) or can be constructed by using conventional catheter construction techniques and include a liner, a braid support and a outer wrap (not shown). A loading sheath 352 is typically disposed on the axis of the pusher. Advantageously, the loading sheath is divisible as shown in the model.

Después de retirar el empaquetado estéril (no mostrado) el implante es empujado al interior de la vaina de carga After removing the sterile packaging (not shown) the implant is pushed into the loading sheath

350. La vaina de carga es recibida dentro del buje del catéter a fin de ser usada para la colocación del implante, y el implante es avanzado dentro del catéter. A continuación, el implante puede ser avanzado hasta y desplegado en un lugar de tratamiento. O puede ser recuperado para intercambiarlo por un implante de otro tamaño, o bien reposicionado si se desea antes de finalizar la separación, como está ilustrado en las Figuras 20A-20F. 350. The loading sheath is received inside the catheter bushing in order to be used for implant placement, and the implant is advanced into the catheter. Then, the implant can be advanced to and deployed in a treatment site. Or it can be recovered to exchange it for an implant of another size, or repositioned if desired before finalizing the separation, as illustrated in Figures 20A-20F.

Los métodos expuestos pueden incluir cada una de las actividades médicas asociadas con el posicionamiento y liberación del implante. De este modo, la metodología implícita al posicionamiento y despliegue de un dispositivo de implante forma parte de la descripción. Tal metodología puede incluir la colocación y el implante dentro de un aneurisma en el cerebro, o en un vaso principal señalado como objetivo para una oclusión, u otras aplicaciones. En algunos métodos se consideran las diversas acciones de introducción del implante en un aneurisma o vaso principal. The exposed methods may include each of the medical activities associated with the positioning and release of the implant. Thus, the methodology implicit to the positioning and deployment of an implant device is part of the description. Such a methodology may include placement and implantation within an aneurysm in the brain, or in a main vessel indicated as an objective for an occlusion, or other applications. In some methods the various actions of introducing the implant into an aneurysm or main vessel are considered.

Más particularmente, varios métodos de acuerdo con la presente descripción implican la forma en la que el sistema de colocación funciona para alcanzar un lugar de tratamiento, por ejemplo. Otros métodos se refieren a la forma en la que el sistema está preparado para colocar un implante, por ejemplo uniendo la bola de la trenza al sistema de colocación. Cualquier método aquí expuesto puede ser realizado en cualquier orden de los sucesos relatados que sea lógicamente posible, así como en el orden de sucesos relatados o con ligeras modificaciones de los sucesos o en el orden de los sucesos. More particularly, several methods according to the present description imply the way in which the placement system works to reach a treatment site, for example. Other methods refer to the way in which the system is prepared to place an implant, for example by attaching the braid ball to the placement system. Any method set forth herein may be performed in any order of the reported events that is logically possible, as well as in the order of related events or with slight modifications of the events or in the order of the events.

También, se ha contemplado que cualquier elemento opcional de las variantes de la invención descritas puede ser expuesto y reivindicado independientemente, o en combinación con uno o más de los elementos aquí descritos. La referencia a un elemento singular incluye la posibilidad de que haya una pluralidad de los mismos elementos presentes. Más específicamente, como se ha usado aquí y en las reivindicaciones anejas, las formas singulares “a”, “uno”, “dicho”, y “el” incluyen referencias plurales a menos que se manifieste específicamente de otro modo. En otras palabras, el uso de los artículos considera “al menos uno” del elemento expuesto en la descripción anterior así como las reivindicaciones posteriores. Se ha observado posteriormente que se puede redactar un borrador de las reivindicaciones en el que se excluya cualquier elemento opcional. De este modo, esta exposición tiene como fin servir de base antecedente para el uso de una terminología exclusiva tal como “únicamente”, “solamente” y similares en conexión con la recitación de los elementos de la reivindicación, o el uso de una limitación “negativa”. Also, it has been contemplated that any optional element of the variants of the invention described can be exposed and claimed independently, or in combination with one or more of the elements described herein. The reference to a singular element includes the possibility of a plurality of the same elements present. More specifically, as used herein and in the appended claims, the singular forms "a," "one," "said," and "the" include plural references unless specifically stated otherwise. In other words, the use of the articles considers "at least one" of the element set forth in the previous description as well as the subsequent claims. It has subsequently been observed that a draft of the claims can be drafted in which any optional element is excluded. Thus, this exhibition is intended to serve as a background for the use of an exclusive terminology such as "only", "only" and the like in connection with the recitation of the elements of the claim, or the use of a limitation " negative".

Sin el uso de tal terminología exclusiva, el término “que comprende” en las reivindicaciones considera la inclusión de cualquier elemento adicional independientemente de si un número dado de elementos están enumerados en la reivindicación o la adición de un elemento podría ser considerada como que transforma la naturaleza de un elemento expuesto en las reivindicaciones. Excepto que se haya definido específicamente aquí, todos los términos técnicos y científicos aquí usados se dan en un sentido lo más ampliamente entendido a la vez que se mantiene la validez de la reivindicación. Without the use of such exclusive terminology, the term "comprising" in the claims considers the inclusion of any additional element regardless of whether a given number of elements are listed in the claim or the addition of an element could be considered as transforming the nature of an element set forth in the claims. Except as specifically defined herein, all the technical and scientific terms used herein are given in a sense as widely understood as the validity of the claim is maintained.

El alcance de la presente invención no está limitado a los ejemplos expuestos y/o a la especificación expuesta, sino más bien solamente por el alcance de lo expuesto en la reivindicación. Más bien, debería reconocerse que la “invención” incluye las muchas variantes explícita o implícitamente aquí descritas que incluyen las variantes que serían obvias para aquéllos con una especialización ordinaria en la técnica después de leer la presente especificación. Además, no se pretende que cualquier sección de esta especificación (por ejemplo, la descripción detallada, el resumen, el campo de la invención) tenga un especial significado en la descripción de la invención con respecto a otra de las reivindicaciones. Aunque la anterior invención ha sido descrita en detalle con fines de claridad de entendimiento, se ha considerado que ciertas modificaciones pueden ser realizadas dentro del alcance de las reivindicaciones. The scope of the present invention is not limited to the examples set forth and / or to the specification set forth, but rather only by the scope set forth in the claim. Rather, it should be recognized that the "invention" includes the many variants explicitly or implicitly described herein that include variants that would be obvious to those with an ordinary specialization in the art after reading the present specification. Furthermore, it is not intended that any section of this specification (for example, the detailed description, the summary, the field of the invention) has a special meaning in the description of the invention with respect to another of the claims. Although the foregoing invention has been described in detail for purposes of clarity of understanding, it has been considered that certain modifications may be made within the scope of the claims.

Claims (5)

REIVINDICACIONES 1. Un sistema (330) separable de empujador de implantes que comprende: un implante (10, 40, 60, 62, 64, 70, 72, 140, 300, 342) que incluye una sección de puerto proximal (276); un manguito empujador alargado (338); y 1. A detachable implant pusher system (330) comprising: an implant (10, 40, 60, 62, 64, 70, 72, 140, 300, 342) that includes a proximal port section (276); an elongated pusher sleeve (338); Y 5 una pluralidad de miembros alargados (332, 336) recibidos dentro de una luz del manguito empujador, que sale en 5 a plurality of elongate members (332, 336) received within a light of the pusher sleeve, which exits at unos extremos proximal y distal, y los miembros alargados son recibidos a través del puerto de implante, en donde el manguito es bloqueado al implante hasta que al menos un miembro alargado sea llevado al interior del manguito; proximal and distal ends, and elongated members are received through the implant port, where the sleeve is blocked to the implant until at least one elongated member is taken inside the sleeve; caracterizado porque uno de los miembros alargados (336) incluye un extremo del terminal ampliado situado fuera 10 de la sección del puerto; y en donde el otro miembro alargado (332) incluye un extremo ampliado. characterized in that one of the elongate members (336) includes an end of the extended terminal located outside 10 of the port section; and wherein the other elongated member (332) includes an enlarged end.
2.2.
El sistema de la reivindicación 1, en donde el extremo ampliado tiene una forma seleccionada entre las formas de bola y cilindro.  The system of claim 1, wherein the enlarged end has a shape selected from the ball and cylinder shapes.
3.3.
El sistema de la reivindicación 1, en donde tres miembros alargados son recibidos dentro del puerto.  The system of claim 1, wherein three elongated members are received within the port.
15 4. El sistema de la reivindicación 1, en donde los miembros alargados son recibidos dentro del lumen del manguito en una configuración de empaquetamiento cerrado. The system of claim 1, wherein the elongate members are received within the lumen of the sleeve in a closed packing configuration.
5.5.
El sistema de la reivindicación 1, en donde el miembro alargado es conectado a un accionador de empuñadura.  The system of claim 1, wherein the elongate member is connected to a handle actuator.
6. 6.
El sistema de la reivindicación 1, en donde la pluralidad de miembros alargados proporciona una interferencia mecánica en el puerto. The system of claim 1, wherein the plurality of elongated members provides mechanical interference in the port.
ES11173659.1T 2008-04-21 2009-04-21 Embolic braid ball devices and placement systems Active ES2436590T3 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US4667008P 2008-04-21 2008-04-21
US4659408P 2008-04-21 2008-04-21
US46670P 2008-04-21
US46594P 2008-04-21
US8396108P 2008-07-28 2008-07-28
US8395708P 2008-07-28 2008-07-28
US83961P 2008-07-28
US83957P 2008-07-28
US14509709P 2009-01-15 2009-01-15
US145097P 2009-01-15

Publications (1)

Publication Number Publication Date
ES2436590T3 true ES2436590T3 (en) 2014-01-03

Family

ID=41009998

Family Applications (4)

Application Number Title Priority Date Filing Date
ES12150959.0T Active ES2675394T3 (en) 2008-04-21 2009-04-21 Embolic braid ball devices and placement systems
ES11173659.1T Active ES2436590T3 (en) 2008-04-21 2009-04-21 Embolic braid ball devices and placement systems
ES11184201.9T Active ES2438519T3 (en) 2008-04-21 2009-04-21 Embolic braid ball devices and placement systems
ES11173658T Active ES2430117T3 (en) 2008-04-21 2009-04-21 Embolic braid ball devices and placement systems

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES12150959.0T Active ES2675394T3 (en) 2008-04-21 2009-04-21 Embolic braid ball devices and placement systems

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES11184201.9T Active ES2438519T3 (en) 2008-04-21 2009-04-21 Embolic braid ball devices and placement systems
ES11173658T Active ES2430117T3 (en) 2008-04-21 2009-04-21 Embolic braid ball devices and placement systems

Country Status (14)

Country Link
US (12) US8142456B2 (en)
EP (9) EP2387959B1 (en)
JP (1) JP5610542B2 (en)
CN (3) CN102014769B (en)
AT (1) ATE533414T1 (en)
AU (1) AU2009239424B9 (en)
CA (1) CA2722037C (en)
DK (1) DK2265193T3 (en)
EA (1) EA201071225A1 (en)
ES (4) ES2675394T3 (en)
IL (1) IL208659A0 (en)
SG (1) SG189809A1 (en)
WO (1) WO2009132045A2 (en)
ZA (1) ZA201007444B (en)

Families Citing this family (245)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569066B2 (en) 1997-07-10 2009-08-04 Boston Scientific Scimed, Inc. Methods and devices for the treatment of aneurysms
US6632241B1 (en) 2000-03-22 2003-10-14 Endovascular Technologies, Inc. Self-expanding, pseudo-braided intravascular device
US20030195553A1 (en) 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US20070225749A1 (en) 2006-02-03 2007-09-27 Martin Brian B Methods and devices for restoring blood flow within blocked vasculature
EP2015683B1 (en) 2006-04-17 2015-12-09 Covidien LP System for mechanically positioning intravascular implants
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
ES2426348T3 (en) * 2007-04-16 2013-10-22 Occlutech Holding Ag Occlusion instrument to close a heart apron and method to produce the same
US10064635B2 (en) 2007-04-17 2018-09-04 Covidien Lp Articulating retrieval devices
US8512352B2 (en) 2007-04-17 2013-08-20 Lazarus Effect, Inc. Complex wire formed devices
US11202646B2 (en) 2007-04-17 2021-12-21 Covidien Lp Articulating retrieval devices
US10076346B2 (en) 2007-04-17 2018-09-18 Covidien Lp Complex wire formed devices
EP2157937B1 (en) 2007-06-04 2017-03-22 Sequent Medical, Inc. Devices for treatment of vascular defects
US9034007B2 (en) 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US8968382B2 (en) 2007-12-11 2015-03-03 Cornell University Method and apparatus for restricting flow through an opening in the side wall
EP2231037B1 (en) 2007-12-26 2015-08-12 Lazarus Effect, Inc. Retrieval systems
WO2009132045A2 (en) 2008-04-21 2009-10-29 Nfocus Neuromedical, Inc. Braid-ball embolic devices and delivery systems
CN102083493A (en) 2008-05-01 2011-06-01 安纽克罗斯有限责任公司 Aneurysm occlusion device
US20210401440A1 (en) * 2008-05-01 2021-12-30 Aneuclose Llc Janjua Aneurysm Net with a Stiff Proximal Portion and a Flexible Distal Portion
US11583289B2 (en) 2008-05-01 2023-02-21 Aneuclose Llc Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation
US11471163B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies
US11471164B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant
US11357511B2 (en) * 2008-05-01 2022-06-14 Aneuclose Llc Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US11944316B2 (en) * 2008-05-01 2024-04-02 Aneuclose Llc Janjua aneurysm net and other intrasacular aneurysm occlusion devices
US11464518B2 (en) 2008-05-01 2022-10-11 Aneuclose Llc Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms
US20160374690A9 (en) * 2010-10-21 2016-12-29 Robert A. Connor Devices and Methods for Occluding a Cerebral Aneurysm
US11484322B2 (en) 2018-01-03 2022-11-01 Aneuclose Llc Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
WO2009135166A2 (en) 2008-05-02 2009-11-05 Sequent Medical Inc. Filamentary devices for treatment of vascular defects
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
CN102137626A (en) 2008-07-22 2011-07-27 微治疗公司 Vascular remodeling device
US20100191168A1 (en) 2009-01-29 2010-07-29 Trustees Of Tufts College Endovascular cerebrospinal fluid shunt
EP2403583B1 (en) 2009-03-06 2016-10-19 Lazarus Effect, Inc. Retrieval systems
ES2728418T3 (en) * 2009-06-15 2019-10-24 Perflow Medical Ltd Apparatus to allow blood flow through an occluded vessel
BR112012010758A2 (en) * 2009-11-05 2019-09-24 Sequent Medical Inc multilayer filament devices for treatment of vascular defects
US20110202085A1 (en) * 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
US9814562B2 (en) 2009-11-09 2017-11-14 Covidien Lp Interference-relief type delivery detachment systems
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8801748B2 (en) 2010-01-22 2014-08-12 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
WO2011094638A1 (en) * 2010-01-28 2011-08-04 Micro Therapeutics, Inc. Vascular remodeling device
WO2011094634A1 (en) * 2010-01-28 2011-08-04 Micro Therapeutics, Inc. Vascular remodeling device
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
WO2012002944A1 (en) 2010-06-29 2012-01-05 Artventive Medical Group, Inc. Reducing flow through a tubular structure
WO2012009675A2 (en) 2010-07-15 2012-01-19 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US8974512B2 (en) * 2010-09-10 2015-03-10 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
WO2012078678A1 (en) 2010-12-06 2012-06-14 Tyco Healthcare Group Lp Vascular remodeling device
CA2822311C (en) * 2011-01-17 2021-10-19 Novita Therapeutics, Llc Detachable metal balloon delivery device and method
DE102011010754A1 (en) * 2011-02-09 2012-08-09 Alaxo GmbH Stent to the rails of a nasal passage
JP5868432B2 (en) 2011-02-11 2016-02-24 コヴィディエン リミテッド パートナーシップ Two-stage deployed aneurysm embolization device
WO2012112749A2 (en) * 2011-02-18 2012-08-23 Sequent Medical, Inc. Blood flow disruption devices and methods for the treatment of vascular defects
US20120245674A1 (en) 2011-03-25 2012-09-27 Tyco Healthcare Group Lp Vascular remodeling device
EP2693981A4 (en) 2011-04-01 2015-07-01 Univ Cornell Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US20120283768A1 (en) * 2011-05-05 2012-11-08 Sequent Medical Inc. Method and apparatus for the treatment of large and giant vascular defects
WO2012154782A1 (en) 2011-05-11 2012-11-15 Tyco Healthcare Group Lp Vascular remodeling device
SG10201500492VA (en) 2011-05-23 2015-03-30 Lazarus Effect Inc Retrieval systems and methods for use thereof
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
DE102011102955B4 (en) * 2011-05-31 2018-05-03 Acandis Gmbh & Co. Kg Medical implant for arranging a hollow body, in particular an aneurysm, and method for producing a medical implant
EP2713961B1 (en) 2011-06-03 2016-09-28 Covidien LP Embolic implant
US20120330341A1 (en) 2011-06-22 2012-12-27 Becking Frank P Folded-Flat Aneurysm Embolization Devices
US9364637B2 (en) * 2011-09-06 2016-06-14 Medtronic, Inc. Transcatheter balloon-assisted mitral valve navigation device and method
WO2013049448A1 (en) 2011-09-29 2013-04-04 Covidien Lp Vascular remodeling device
US8945171B2 (en) 2011-09-29 2015-02-03 Covidien Lp Delivery system for implantable devices
US8795313B2 (en) 2011-09-29 2014-08-05 Covidien Lp Device detachment systems with indicators
US9072620B2 (en) * 2011-11-04 2015-07-07 Covidien Lp Protuberant aneurysm bridging device deployment method
US8771341B2 (en) 2011-11-04 2014-07-08 Reverse Medical Corporation Protuberant aneurysm bridging device and method of use
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
CN104039246A (en) * 2012-01-06 2014-09-10 因赛普特斯医学有限责任公司 Expandable occlusion devices and methods of use
KR102189536B1 (en) * 2012-01-17 2020-12-14 아르티오 메디컬 인크. Expandable body device and method of use
AU2013211873B2 (en) * 2012-01-26 2018-04-26 Endoshape, Inc. Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control
CN104185490B (en) * 2012-01-31 2017-10-20 波士顿科学西美德公司 Guiding extension conduit
US9113890B2 (en) * 2012-02-06 2015-08-25 Aga Medical Corporation Devices and methods for occluding vascular abnormalities
CA2867130C (en) * 2012-03-15 2019-02-12 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US9186267B2 (en) 2012-10-31 2015-11-17 Covidien Lp Wing bifurcation reconstruction device
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
KR102309795B1 (en) * 2012-11-13 2021-10-08 코비디엔 엘피 Occlusive devices
CN103006286B (en) * 2012-12-18 2015-07-08 邹旭华 Developable sealed type woven body implantation material and conveying device
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US10561509B2 (en) 2013-03-13 2020-02-18 DePuy Synthes Products, Inc. Braided stent with expansion ring and method of delivery
US20140277467A1 (en) 2013-03-14 2014-09-18 Spinal Stabilization Technologies, Llc Prosthetic Spinal Disk Nucleus
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
WO2014150288A2 (en) 2013-03-15 2014-09-25 Insera Therapeutics, Inc. Vascular treatment devices and methods
US10076336B2 (en) 2013-03-15 2018-09-18 Covidien Lp Delivery and detachment mechanisms for vascular implants
CN105142546B (en) 2013-03-15 2018-11-13 柯惠有限合伙公司 Occlude implant infrastructure
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
WO2014144980A1 (en) 2013-03-15 2014-09-18 Covidien Lp Occlusive device
US8715315B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment systems
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
EP3007648B1 (en) 2013-06-14 2019-11-13 Avantec Vascular Corporation Inferior vena cava filter and retrieval systems
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US11291452B2 (en) * 2013-06-26 2022-04-05 W. L. Gore & Associates, Inc. Medical device deployment system
US20150018860A1 (en) 2013-07-12 2015-01-15 Inceptus Medical, Llc Methods and apparatus for treating small vessel thromboembolisms
WO2017142874A2 (en) 2016-02-16 2017-08-24 Insera Therapeutics, Inc. Aspiration devices and anchored flow diverting devices
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9955976B2 (en) * 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
EP2839949B1 (en) 2013-08-23 2016-10-12 W.L. Gore & Associates GmbH Process for the production of a structured film
US9662120B2 (en) 2013-08-23 2017-05-30 Cook Medical Technologies Llc Detachable treatment device delivery system utilizing compression at attachment zone
CN106456182B (en) 2013-12-20 2021-04-09 泰尔茂株式会社 Vascular occlusion device
US10045786B2 (en) * 2013-12-20 2018-08-14 Microvention, Inc. Expansile member
EP3094365B1 (en) 2014-01-15 2021-12-08 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9737696B2 (en) * 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9724101B2 (en) * 2014-01-22 2017-08-08 Bandula Wijay Lumen occluding device, delivery catheter and method
WO2015120155A1 (en) * 2014-02-06 2015-08-13 Boston Scientific Scimed, Inc. Occlusion device detachable by inflation of a balloon
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US9629635B2 (en) * 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
US9694201B2 (en) 2014-04-24 2017-07-04 Covidien Lp Method of use of an embolic implant for radio-ablative treatment
WO2015166013A1 (en) * 2014-04-30 2015-11-05 Cerus Endovascular Limited Occlusion device
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
US9918718B2 (en) 2014-08-08 2018-03-20 DePuy Synthes Products, Inc. Embolic coil delivery system with retractable mechanical release mechanism
US9808256B2 (en) 2014-08-08 2017-11-07 Covidien Lp Electrolytic detachment elements for implant delivery systems
US9814466B2 (en) 2014-08-08 2017-11-14 Covidien Lp Electrolytic and mechanical detachment for implant delivery systems
JP2017511203A (en) * 2014-08-14 2017-04-20 シークエント メディカル インコーポレイテッド Filament device for the treatment of vascular defects
US10206796B2 (en) 2014-08-27 2019-02-19 DePuy Synthes Products, Inc. Multi-strand implant with enhanced radiopacity
CN107148293B (en) 2014-10-31 2020-08-11 西瑞维斯克有限责任公司 Methods and systems for treating hydrocephalus
US10314714B2 (en) * 2014-11-04 2019-06-11 Spinal Stabilization Technologies Llc Percutaneous implantable nuclear prosthesis
EP3215069B1 (en) 2014-11-04 2023-03-08 Spinal Stabilization Technologies LLC Percutaneous implantable nuclear prosthesis
JP6601501B2 (en) 2014-11-04 2019-11-13 ニプロ株式会社 Catheter device internally provided with a longitudinal inflation element for compressing cancellous bone
CN112220585B (en) 2014-12-12 2024-03-08 阿万泰血管公司 Inferior vena cava filter retrieval system with interposed support member
CN107249513B (en) * 2014-12-12 2020-11-03 阿万泰血管公司 Forming improvements for inferior vena cava filters and recovery systems
US10278804B2 (en) 2014-12-12 2019-05-07 Avantec Vascular Corporation IVC filter retrieval systems with releasable capture feature
JP6913702B2 (en) * 2014-12-12 2021-08-04 アバンテック バスキュラー コーポレイション Molding improvements for inferior vena cava filters and recovery systems
US10925611B2 (en) 2015-01-20 2021-02-23 Neurogami Medical, Inc. Packaging for surgical implant
US11484319B2 (en) 2015-01-20 2022-11-01 Neurogami Medical, Inc. Delivery system for micrograft for treating intracranial aneurysms
US10736730B2 (en) 2015-01-20 2020-08-11 Neurogami Medical, Inc. Vascular implant
US9999413B2 (en) 2015-01-20 2018-06-19 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US10857012B2 (en) 2015-01-20 2020-12-08 Neurogami Medical, Inc. Vascular implant
EP3256200A1 (en) 2015-02-11 2017-12-20 Covidien LP Expandable tip medical devices and methods
CN107530523B (en) 2015-02-25 2021-03-19 盖乐西医疗公司 System for treating aneurysm
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
US9717503B2 (en) 2015-05-11 2017-08-01 Covidien Lp Electrolytic detachment for implant delivery systems
US20160331377A1 (en) 2015-05-11 2016-11-17 Covidien Lp Electrolytic detachment with flush system for implant delivery
US10575967B2 (en) 2015-09-01 2020-03-03 Spinal Stabilization Technologies Llc Implantable nuclear prosthesis
EP3346947A4 (en) * 2015-09-10 2019-07-24 Ikonano Venture Partners, LLC Polymeric electrospun embolization device and methods of use
US10314593B2 (en) 2015-09-23 2019-06-11 Covidien Lp Occlusive devices
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US10272230B2 (en) 2015-10-30 2019-04-30 Cerevasc, Llc Systems and methods for treating hydrocephalus
WO2017097862A2 (en) 2015-12-07 2017-06-15 Cerus Endovascular Limited Occlusion device
EP3456272B1 (en) 2016-02-10 2022-10-05 Microvention, Inc. Devices for vascular occlusion
EP3782576A1 (en) 2016-03-11 2021-02-24 Cerus Endovascular Limited Occlusion device
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
US10555738B2 (en) 2016-05-18 2020-02-11 Microvention, Inc. Embolic containment
CN109688945B (en) 2016-05-18 2022-06-24 微仙美国有限公司 Embolism stopper
CN109561896B (en) 2016-05-26 2022-06-07 纳米结构公司 Systems and methods for embolic occlusion of neurovascular aneurysms
EP3463166A1 (en) 2016-06-03 2019-04-10 SOMATEX Medical Technologies GmbH Marking device and implantation system
US10470773B2 (en) 2016-06-10 2019-11-12 Terumo Corporation Vessel occluder
US20170367710A1 (en) * 2016-06-24 2017-12-28 Cook Medical Technologies Llc Double sided occlusive device
US10420563B2 (en) 2016-07-08 2019-09-24 Neurogami Medical, Inc. Delivery system insertable through body lumen
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10076428B2 (en) 2016-08-25 2018-09-18 DePuy Synthes Products, Inc. Expansion ring for a braided stent
CA3034356A1 (en) * 2016-09-14 2018-03-22 Medinol Ltd. Aneurysm closure device
WO2018053314A1 (en) 2016-09-16 2018-03-22 Greg Mirigian Occlusive implants with fiber-based release structures
US10292851B2 (en) 2016-09-30 2019-05-21 DePuy Synthes Products, Inc. Self-expanding device delivery apparatus with dual function bump
JP7062303B2 (en) 2016-10-14 2022-05-06 インセプタス メディカル, エルエルシー Braiding machine and usage
CN110072588B (en) 2016-10-18 2022-06-07 波士顿科学国际有限公司 Guide extension catheter
WO2018097891A1 (en) 2016-11-23 2018-05-31 Hologic, Inc. Biopsy site marker
CN110167482A (en) 2016-12-22 2019-08-23 阿万泰血管公司 The systems, devices and methods for being used to fetch system with tether
AU2018224126A1 (en) 2017-02-23 2019-09-12 DePuy Synthes Products, Inc. Aneurysm device and delivery system
EP3554391A4 (en) 2017-02-24 2020-09-16 Inceptus Medical LLC Vascular occlusion devices and methods
US10709464B2 (en) 2017-05-12 2020-07-14 Covidien Lp Retrieval of material from vessel lumens
US11129630B2 (en) 2017-05-12 2021-09-28 Covidien Lp Retrieval of material from vessel lumens
US11298145B2 (en) 2017-05-12 2022-04-12 Covidien Lp Retrieval of material from vessel lumens
US11191555B2 (en) 2017-05-12 2021-12-07 Covidien Lp Retrieval of material from vessel lumens
US10722257B2 (en) 2017-05-12 2020-07-28 Covidien Lp Retrieval of material from vessel lumens
US10945746B2 (en) 2017-06-12 2021-03-16 Covidien Lp Tools for sheathing treatment devices and associated systems and methods
US10478322B2 (en) 2017-06-19 2019-11-19 Covidien Lp Retractor device for transforming a retrieval device from a deployed position to a delivery position
US10575864B2 (en) 2017-06-22 2020-03-03 Covidien Lp Securing element for resheathing an intravascular device and associated systems and methods
EP3422226A1 (en) * 2017-06-29 2019-01-02 Koninklijke Philips N.V. Device and method for predicting an unfolded state of a foldable implant in cardiovascular tissue
US11191927B2 (en) 2017-07-31 2021-12-07 Boston Scientific Scimed, Inc. Dilator with engagement region
CN111315305B (en) 2017-08-15 2023-09-22 波士顿科学国际有限公司 Plugging medical instrument system
ES2929060T3 (en) 2017-08-17 2022-11-24 Arissa Medical Inc flow attenuation device
CN111278367B (en) 2017-08-21 2024-02-09 Cerus血管内设备有限公司 Occlusion device
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10874402B2 (en) 2017-10-10 2020-12-29 Boston Scientific Scimed, Inc. Detachable RF energized occlusive device
EP3695037B1 (en) 2017-10-14 2024-03-27 Inceptus Medical, LLC Braiding machine and methods of use
WO2019116792A1 (en) * 2017-12-15 2019-06-20 東レ株式会社 Woven fabric and method for manufacturing same
US10806462B2 (en) 2017-12-21 2020-10-20 DePuy Synthes Products, Inc. Implantable medical device detachment system with split tube and cylindrical coupling
US11185335B2 (en) 2018-01-19 2021-11-30 Galaxy Therapeutics Inc. System for and method of treating aneurysms
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
CN111936063A (en) 2018-01-31 2020-11-13 纳米结构公司 Vascular occlusion device using thin film nitinol foil
JP7034307B2 (en) 2018-02-01 2022-03-11 ボストン サイエンティフィック サイムド,インコーポレイテッド Medical device release system
US11284902B2 (en) 2018-02-01 2022-03-29 Boston Scientific Scimed, Inc. Method of making a vascular occlusion device
EP3762083A1 (en) 2018-03-08 2021-01-13 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11058430B2 (en) * 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
CN112584799A (en) 2018-06-29 2021-03-30 阿万泰血管公司 Systems and methods for implants and deployment devices
AU2019204522A1 (en) 2018-07-30 2020-02-13 DePuy Synthes Products, Inc. Systems and methods of manufacturing and using an expansion ring
US10456280B1 (en) 2018-08-06 2019-10-29 DePuy Synthes Products, Inc. Systems and methods of using a braided implant
US10278848B1 (en) 2018-08-06 2019-05-07 DePuy Synthes Products, Inc. Stent delivery with expansion assisting delivery wire
US11051825B2 (en) 2018-08-08 2021-07-06 DePuy Synthes Products, Inc. Delivery system for embolic braid
US11744710B2 (en) 2018-09-04 2023-09-05 Spinal Stabilization Technologies Llc Implantable nuclear prosthesis, kits, and related methods
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11076861B2 (en) 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11564692B2 (en) 2018-11-01 2023-01-31 Terumo Corporation Occlusion systems
US11147562B2 (en) 2018-12-12 2021-10-19 DePuy Synthes Products, Inc. Systems and methods for embolic implant detachment
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
WO2020131975A2 (en) 2018-12-17 2020-06-25 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11272939B2 (en) 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
WO2020139544A2 (en) * 2018-12-27 2020-07-02 Stryker Corporation Shape adaptable multi-layered intra-saccular flow reduction device and methods of manufacturing same
US11039944B2 (en) 2018-12-27 2021-06-22 DePuy Synthes Products, Inc. Braided stent system with one or more expansion rings
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
JP7469323B2 (en) 2019-03-15 2024-04-16 マイクロベンション インコーポレイテッド Filamentous Devices for the Treatment of Vascular Disorders - Patent application
US11317921B2 (en) 2019-03-15 2022-05-03 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
WO2020190630A1 (en) 2019-03-15 2020-09-24 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US10653425B1 (en) 2019-05-21 2020-05-19 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US10856880B1 (en) 2019-05-25 2020-12-08 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11253265B2 (en) 2019-06-18 2022-02-22 DePuy Synthes Products, Inc. Pull wire detachment for intravascular devices
US11426174B2 (en) 2019-10-03 2022-08-30 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant mechanical release
US11207494B2 (en) 2019-07-03 2021-12-28 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant distal portion
US11672946B2 (en) 2019-09-24 2023-06-13 Boston Scientific Scimed, Inc. Protection and actuation mechanism for controlled release of implantable embolic devices
US11826863B2 (en) * 2019-11-04 2023-11-28 Covidien Lp Systems and methods for treating aneurysms
US11376013B2 (en) 2019-11-18 2022-07-05 DePuy Synthes Products, Inc. Implant delivery system with braid cup formation
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
US11457922B2 (en) 2020-01-22 2022-10-04 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant distal portion
US11432822B2 (en) 2020-02-14 2022-09-06 DePuy Synthes Products, Inc. Intravascular implant deployment system
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11951026B2 (en) 2020-06-30 2024-04-09 DePuy Synthes Products, Inc. Implantable medical device detachment system with flexible braid section
WO2022138383A1 (en) * 2020-12-23 2022-06-30 株式会社カネカ Embolization device
US20220296788A1 (en) 2021-03-16 2022-09-22 Covidien Lp Injectable biopolymer compositions and associated systems and methods
CN113057694B (en) * 2021-03-29 2022-05-13 聚辉医疗科技(深圳)有限公司 Plugging device and manufacturing method thereof
CN113619088B (en) * 2021-07-07 2023-08-04 岳阳高澜节能装备制造有限公司 Pipe bending mold core straightening device, pipe bending system and pipe bending process
US11937824B2 (en) 2021-12-30 2024-03-26 DePuy Synthes Products, Inc. Implant detachment systems with a modified pull wire
US11844490B2 (en) 2021-12-30 2023-12-19 DePuy Synthes Products, Inc. Suture linkage for inhibiting premature embolic implant deployment
US11957356B2 (en) 2022-02-24 2024-04-16 NV MEDTECH, Inc. Methods and apparatus for stent assisted aneurysm coiling
US11937825B2 (en) 2022-03-02 2024-03-26 DePuy Synthes Products, Inc. Hook wire for preventing premature embolic implant detachment
US11937826B2 (en) 2022-03-14 2024-03-26 DePuy Synthes Products, Inc. Proximal link wire for preventing premature implant detachment
KR20230146275A (en) * 2022-04-12 2023-10-19 한스바이오메드 주식회사 Blood flow restricting device with multi-layer structures and composite materials
US20240032932A1 (en) 2022-07-29 2024-02-01 Covidien Lp Devices, systems, and methods for treating aneurysms
US20240032933A1 (en) 2022-07-30 2024-02-01 Covidien Lp Devices, systems, and methods for treating aneurysms

Family Cites Families (636)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US102003A (en) * 1870-04-19 Improvement in gates
US3108593A (en) 1961-03-13 1963-10-29 Jacob A Glassman Surgical extractor
DE1283434B (en) 1963-06-25 1968-11-21 Dr Jacob A Glassmann Instrument for introducing into natural body canals and for capturing and bringing out foreign bodies in them
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
SE445884B (en) * 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
FR2556210B1 (en) 1983-12-08 1988-04-15 Barra Jean Aubert VENOUS PROSTHESIS AND PROCESS FOR PRODUCING THE SAME
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US5749920A (en) 1983-12-09 1998-05-12 Endovascular Technologies, Inc. Multicapsule intraluminal grafting system and method
US4659408A (en) 1984-05-29 1987-04-21 American Can Company Multi-layer sheet structure, method of making same and containers made therefrom
DE3418429A1 (en) 1984-05-18 1985-11-21 Bayer Ag, 5090 Leverkusen METHOD FOR THE PRODUCTION OF SOLID POLYISOCYANATES OF RETARDED REACTIVITY, POLYMER COVERED, FINE-PARTICLE POLYISOCYANATES AND THE USE THEREOF
DK151404C (en) 1984-05-23 1988-07-18 Cook Europ Aps William FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD
DE3786721D1 (en) 1986-02-24 1993-09-02 Fischell Robert DEVICE FOR DETECTING BLOOD VESSELS AND SYSTEM FOR ITS INTRODUCTION.
SE453258B (en) 1986-04-21 1988-01-25 Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
WO1988000813A1 (en) 1986-08-05 1988-02-11 St. Jude Medical, Inc. Braided polyester vascular prosthesis and method
FR2624747A1 (en) * 1987-12-18 1989-06-23 Delsanti Gerard REMOVABLE ENDO-ARTERIAL DEVICES FOR REPAIRING ARTERIAL WALL DECOLLEMENTS
US4921484A (en) 1988-07-25 1990-05-01 Cordis Corporation Mesh balloon catheter device
US5480382A (en) * 1989-01-09 1996-01-02 Pilot Cardiovascular Systems, Inc. Steerable medical device
US5728129A (en) * 1989-02-17 1998-03-17 American Biomed, Inc. Distal atherectomy catheter
EP0408245B1 (en) 1989-07-13 1994-03-02 American Medical Systems, Inc. Stent placement instrument
IE73670B1 (en) * 1989-10-02 1997-07-02 Medtronic Inc Articulated stent
US5545208A (en) * 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5122136A (en) 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5354295A (en) 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
USRE42625E1 (en) 1990-03-13 2011-08-16 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US6083220A (en) * 1990-03-13 2000-07-04 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5221261A (en) 1990-04-12 1993-06-22 Schneider (Usa) Inc. Radially expandable fixation member
US5158548A (en) 1990-04-25 1992-10-27 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5405379A (en) * 1990-07-26 1995-04-11 Lane; Rodney J. Self expanding vascular endoprosthesis for aneurysms
US5222971A (en) 1990-10-09 1993-06-29 Scimed Life Systems, Inc. Temporary stent and methods for use and manufacture
US5749895A (en) 1991-02-13 1998-05-12 Fusion Medical Technologies, Inc. Method for bonding or fusion of biological tissue and material
USRE38653E1 (en) 1991-03-08 2004-11-16 Kabushikikaisha Igaki Iryo Sekkei Luminal stent, holding structure therefor and device for attaching luminal stent
USRE38711E1 (en) * 1991-03-08 2005-03-15 Kabushikikaisha Igaki Iryo Sekkei Luminal stent, holding structure therefor and device for attaching luminal stent
US5766151A (en) * 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
US5232648A (en) 1991-07-19 1993-08-03 United States Surgical Corporation Bioabsorbable melt spun fiber based on glycolide-containing copolymer
US5304194A (en) * 1991-10-02 1994-04-19 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
JP2602625B2 (en) * 1991-12-12 1997-04-23 ターゲット セラピューティクス,インコーポレイテッド Removable pusher with occlusal connection-vaso-occlusive coil assembly
US5282806A (en) * 1992-08-21 1994-02-01 Habley Medical Technology Corporation Endoscopic surgical instrument having a removable, rotatable, end effector assembly
US5326350A (en) 1992-05-11 1994-07-05 Li Shu Tung Soft tissue closure systems
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5527338A (en) 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
US5350397A (en) * 1992-11-13 1994-09-27 Target Therapeutics, Inc. Axially detachable embolic coil assembly
CA2123983C (en) 1992-09-22 1996-07-30 Thomas J. Palermo Detachable embolic coil assembly
US5250071A (en) * 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5382260A (en) * 1992-10-30 1995-01-17 Interventional Therapeutics Corp. Embolization device and apparatus including an introducer cartridge and method for delivering the same
EP0596145B1 (en) 1992-10-31 1996-05-08 Schneider (Europe) Ag Disposition for implanting a self-expanding endoprothesis
US5490859A (en) * 1992-11-13 1996-02-13 Scimed Life Systems, Inc. Expandable intravascular occlusion material removal devices and methods of use
US5284488A (en) 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
WO1994021170A1 (en) 1993-03-16 1994-09-29 Ep Technologies, Inc. Flexible circuit assemblies employing ribbon cable
US5476495A (en) * 1993-03-16 1995-12-19 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5334210A (en) * 1993-04-09 1994-08-02 Cook Incorporated Vascular occlusion assembly
US5545209A (en) 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5499985A (en) * 1993-11-24 1996-03-19 Orthopaedic Innovations, Inc. Detachable coupling system for surgical instruments
RU2089131C1 (en) 1993-12-28 1997-09-10 Сергей Апполонович Пульнев Stent-expander
FR2714815B1 (en) 1994-01-10 1996-03-08 Microfil Ind Sa Elastic prosthesis to widen a duct, in particular a blood vessel.
US5549635A (en) 1994-01-24 1996-08-27 Solar, Rita & Gaterud, Ltd. Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore
US20030032963A1 (en) * 2001-10-24 2003-02-13 Kyphon Inc. Devices and methods using an expandable body with internal restraint for compressing cancellous bone
WO1995023623A1 (en) * 1994-03-04 1995-09-08 Mentor Corporation Self-sealing injection sites and method of manufacture
US5417708A (en) * 1994-03-09 1995-05-23 Cook Incorporated Intravascular treatment system and percutaneous release mechanism therefor
US5634942A (en) 1994-04-21 1997-06-03 B. Braun Celsa Assembly comprising a blood filter for temporary or definitive use and a device for implanting it
US6001092A (en) 1994-06-24 1999-12-14 Target Therapeutics, Inc. Complex coils having fibered centers
JPH10504738A (en) 1994-07-08 1998-05-12 マイクロベナ コーポレイション Medical device forming method and vascular embolization device
US6123715A (en) 1994-07-08 2000-09-26 Amplatz; Curtis Method of forming medical devices; intravascular occlusion devices
US5725552A (en) * 1994-07-08 1998-03-10 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US5846261A (en) * 1994-07-08 1998-12-08 Aga Medical Corp. Percutaneous catheter directed occlusion devices
US5702419A (en) 1994-09-21 1997-12-30 Wake Forest University Expandable, intraluminal stents
US5690671A (en) 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5879366A (en) * 1996-12-20 1999-03-09 W.L. Gore & Associates, Inc. Self-expanding defect closure device and method of making and using
US5814062A (en) 1994-12-22 1998-09-29 Target Therapeutics, Inc. Implant delivery assembly with expandable coupling/decoupling mechanism
DE69624525T2 (en) 1995-03-30 2003-03-20 Boston Scient Ltd System for implanting liquid spirals with a secondary structure
BE1009278A3 (en) * 1995-04-12 1997-01-07 Corvita Europ Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as.
DE69626108T2 (en) 1995-04-14 2003-11-20 Boston Scient Ltd STENTING DEVICE WITH ROLLING MEMBRANE
US8790363B2 (en) 1995-04-20 2014-07-29 DePuy Synthes Products, LLC Three dimensional, low friction vasoocclusive coil, and method of manufacture
US5645558A (en) 1995-04-20 1997-07-08 Medical University Of South Carolina Anatomically shaped vasoocclusive device and method of making the same
US5911731A (en) 1995-04-20 1999-06-15 Target Therapeutics, Inc. Anatomically shaped vasoocclusive devices
US6994689B1 (en) * 1995-06-05 2006-02-07 Medtronic Vascular, Inc. Occlusion of a vessel
US5624461A (en) * 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
NO962336L (en) 1995-06-06 1996-12-09 Target Therapeutics Inc Vaso-occlusive spiral
US5713907A (en) 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
US5758562A (en) 1995-10-11 1998-06-02 Schneider (Usa) Inc. Process for manufacturing braided composite prosthesis
US6689162B1 (en) 1995-10-11 2004-02-10 Boston Scientific Scimed, Inc. Braided composite prosthesis
GB9522332D0 (en) 1995-11-01 1996-01-03 Biocompatibles Ltd Braided stent
EP0775470B1 (en) 1995-11-14 1999-03-24 Schneider (Europe) GmbH Stent delivery device
WO1997025919A1 (en) * 1996-01-19 1997-07-24 Ep Technologies, Inc. Systems and methods for heating and ablating tissue using multifunctional electrode structures
US6168622B1 (en) * 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
JP2000504594A (en) * 1996-02-02 2000-04-18 トランスバスキュラー インコーポレイテッド Method and apparatus for blocking flow in a blood vessel
US5733294A (en) 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
JP3804690B2 (en) * 1996-03-11 2006-08-02 鹿島塩ビモノマー株式会社 Heat recovery method and heat recovery apparatus in thermal decomposition process of 1,2-dichloroethane
US5853422A (en) * 1996-03-22 1998-12-29 Scimed Life Systems, Inc. Apparatus and method for closing a septal defect
AR001590A1 (en) * 1996-04-10 1997-11-26 Jorge Alberto Baccaro Abnormal vascular communications occluder device and applicator cartridge of said device
US5792154A (en) 1996-04-10 1998-08-11 Target Therapeutics, Inc. Soft-ended fibered micro vaso-occlusive devices
US5718159A (en) 1996-04-30 1998-02-17 Schneider (Usa) Inc. Process for manufacturing three-dimensional braided covered stent
US6440088B1 (en) 1996-05-24 2002-08-27 Precision Vascular Systems, Inc. Hybrid catheter guide wire apparatus and method
US6666883B1 (en) 1996-06-06 2003-12-23 Jacques Seguin Endoprosthesis for vascular bifurcation
US6190402B1 (en) 1996-06-21 2001-02-20 Musc Foundation For Research Development Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
US6077295A (en) 1996-07-15 2000-06-20 Advanced Cardiovascular Systems, Inc. Self-expanding stent delivery system
US6096034A (en) 1996-07-26 2000-08-01 Target Therapeutics, Inc. Aneurysm closure device assembly
US5980514A (en) * 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
US5823198A (en) 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5968069A (en) 1996-08-23 1999-10-19 Scimed Life Systems, Inc. Stent delivery system having stent securement apparatus
US5964797A (en) 1996-08-30 1999-10-12 Target Therapeutics, Inc. Electrolytically deployable braided vaso-occlusion device
US5941249A (en) 1996-09-05 1999-08-24 Maynard; Ronald S. Distributed activator for a two-dimensional shape memory alloy
US5968068A (en) 1996-09-12 1999-10-19 Baxter International Inc. Endovascular delivery system
JP2001500987A (en) 1996-09-23 2001-01-23 ピーエスシー・スキャニング・インコーポレイテッド Dithering mechanism for barcode scanner
US5895391A (en) * 1996-09-27 1999-04-20 Target Therapeutics, Inc. Ball lock joint and introducer for vaso-occlusive member
US5957974A (en) 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
JP3523765B2 (en) 1997-01-24 2004-04-26 テルモ株式会社 Living organ dilator
US6096073A (en) 1997-02-25 2000-08-01 Scimed Life Systems, Inc. Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel
US5830230A (en) 1997-03-07 1998-11-03 Micro Therapeutics, Inc. Method of intracranial vascular embolotherapy using self anchoring coils
US5980554A (en) * 1997-05-05 1999-11-09 Micro Therapeutics, Inc. Wire frame partial flow obstruction for aneurysm treatment
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US5928260A (en) 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US7569066B2 (en) 1997-07-10 2009-08-04 Boston Scientific Scimed, Inc. Methods and devices for the treatment of aneurysms
GB9715241D0 (en) 1997-07-18 1997-09-24 Jeffree Martin A Device for treating aneurysms
AU8599898A (en) 1997-08-04 1999-02-22 Boston Scientific Corporation Occlusion system for aneurysm repair
US6063070A (en) 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
EP1003422B1 (en) * 1997-08-05 2006-06-14 Boston Scientific Limited Detachable aneurysm neck bridge
US5916235A (en) 1997-08-13 1999-06-29 The Regents Of The University Of California Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities
US6086577A (en) 1997-08-13 2000-07-11 Scimed Life Systems, Inc. Detachable aneurysm neck bridge (III)
US6322576B1 (en) 1997-08-29 2001-11-27 Target Therapeutics, Inc. Stable coil designs
US5984929A (en) * 1997-08-29 1999-11-16 Target Therapeutics, Inc. Fast detaching electronically isolated implant
US6860893B2 (en) * 1997-08-29 2005-03-01 Boston Scientific Scimed, Inc. Stable coil designs
US6066149A (en) 1997-09-30 2000-05-23 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
US6511468B1 (en) * 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US5908435A (en) 1997-10-23 1999-06-01 Samuels; Shaun L. W. Expandable lumen device and method of use
CA2309055C (en) 1997-11-07 2004-08-03 Salviac Limited An embolic protection device
EP1039864B1 (en) * 1997-11-14 2006-12-27 Boston Scientific Limited Multi-sheath delivery catheter
US6443972B1 (en) 1997-11-19 2002-09-03 Cordis Europa N.V. Vascular filter
US6159165A (en) 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US6036720A (en) 1997-12-15 2000-03-14 Target Therapeutics, Inc. Sheet metal aneurysm neck bridge
US6022374A (en) 1997-12-16 2000-02-08 Cardiovasc, Inc. Expandable stent having radiopaque marker and method
US5976169A (en) 1997-12-16 1999-11-02 Cardiovasc, Inc. Stent with silver coating and method
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
FR2772592B1 (en) * 1997-12-19 2000-04-07 Braun Celsa Sa ASSEMBLY FOR THE PLACEMENT OF AN IMPLANT IN AN INTERNAL CONDUIT OF A BODY
US6203547B1 (en) * 1997-12-19 2001-03-20 Target Therapeutics, Inc. Vaso-occlusion apparatus having a manipulable mechanical detachment joint and a method for using the apparatus
US7070607B2 (en) 1998-01-27 2006-07-04 The Regents Of The University Of California Bioabsorbable polymeric implants and a method of using the same to create occlusions
US20070093889A1 (en) 1999-01-27 2007-04-26 Wu Benjamin M Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy
US5873907A (en) * 1998-01-27 1999-02-23 Endotex Interventional Systems, Inc. Electrolytic stent delivery system and methods of use
US5944738A (en) 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
EP1054635B1 (en) * 1998-02-10 2010-01-06 Artemis Medical, Inc. Occlusion, anchoring, tensioning or flow direction apparatus
US6676696B1 (en) * 1998-02-12 2004-01-13 Thomas R. Marotta Endovascular prosthesis
DE69929036T2 (en) * 1998-02-12 2006-08-31 Thomas R. North Vancouver Marotta ENDOVASCULAR PROSTHESIS
US6022369A (en) * 1998-02-13 2000-02-08 Precision Vascular Systems, Inc. Wire device with detachable end
US5925060A (en) * 1998-03-13 1999-07-20 B. Braun Celsa Covered self-expanding vascular occlusion device
EP1071491A4 (en) 1998-03-30 2004-10-20 Univ Virginia Flow arrest, double balloon technique for occluding aneurysms or blood vessels
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6168615B1 (en) 1998-05-04 2001-01-02 Micrus Corporation Method and apparatus for occlusion and reinforcement of aneurysms
EP1083836B1 (en) * 1998-06-01 2010-10-13 Kyphon SÀRL Expandable preformed structures for deployment in interior body regions
JP4741728B2 (en) 1998-06-04 2011-08-10 ニューヨーク・ユニバーシティ Intravascular thin film device and stroke treatment
US6139564A (en) 1998-06-16 2000-10-31 Target Therapeutics Inc. Minimally occlusive flow disruptor stent for bridging aneurysm necks
US5935148A (en) 1998-06-24 1999-08-10 Target Therapeutics, Inc. Detachable, varying flexibility, aneurysm neck bridge
US6165193A (en) 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6093199A (en) 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
US6478773B1 (en) * 1998-12-21 2002-11-12 Micrus Corporation Apparatus for deployment of micro-coil using a catheter
DE69936869T2 (en) 1998-09-04 2008-05-15 Boston Scientific Ltd., St. Michael REMOVABLE SYSTEM FOR CLOSING AN ANEURYSMAS NECK
US7410482B2 (en) 1998-09-04 2008-08-12 Boston Scientific-Scimed, Inc. Detachable aneurysm neck bridge
US7713282B2 (en) 1998-11-06 2010-05-11 Atritech, Inc. Detachable atrial appendage occlusion balloon
US6544278B1 (en) 1998-11-06 2003-04-08 Scimed Life Systems, Inc. Rolling membrane stent delivery system
US7128073B1 (en) 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
US6152144A (en) 1998-11-06 2000-11-28 Appriva Medical, Inc. Method and device for left atrial appendage occlusion
US7044134B2 (en) 1999-11-08 2006-05-16 Ev3 Sunnyvale, Inc Method of implanting a device in the left atrial appendage
US6059813A (en) 1998-11-06 2000-05-09 Scimed Life Systems, Inc. Rolling membrane stent delivery system
US6723112B2 (en) 1998-11-10 2004-04-20 Scimed Life Systems, Inc. Bioactive three loop coil
US6569179B2 (en) 1998-11-10 2003-05-27 Scimed Life Systems, Inc. Bioactive three loop coil
US6325820B1 (en) 1998-11-16 2001-12-04 Endotex Interventional Systems, Inc. Coiled-sheet stent-graft with exo-skeleton
US6591472B1 (en) 1998-12-08 2003-07-15 Medtronic, Inc. Multiple segment catheter and method of fabrication
US6409750B1 (en) 1999-02-01 2002-06-25 Board Of Regents, The University Of Texas System Woven bifurcated and trifurcated stents and methods for making the same
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6695876B1 (en) * 1999-02-12 2004-02-24 Thomas R. Marotta Endovascular prosthesis
US6368338B1 (en) 1999-03-05 2002-04-09 Board Of Regents, The University Of Texas Occlusion method and apparatus
US6613074B1 (en) 1999-03-10 2003-09-02 Cordis Corporation Endovascular aneurysm embolization device
US6428558B1 (en) 1999-03-10 2002-08-06 Cordis Corporation Aneurysm embolization device
US6682505B2 (en) * 1999-03-12 2004-01-27 Arteria Medical Science, Inc. Catheter for removing emboli from saphenous vein grafts and native coronary arteries
US6709465B2 (en) 1999-03-18 2004-03-23 Fossa Medical, Inc. Radially expanding ureteral device
US6258099B1 (en) 1999-03-31 2001-07-10 Scimed Life Systems, Inc. Stent security balloon/balloon catheter
US6716445B2 (en) 1999-04-12 2004-04-06 Cornell Research Foundation, Inc. Hydrogel entrapping therapeutic agent and stent with coating comprising this
WO2000067814A1 (en) 1999-05-07 2000-11-16 Salviac Limited Biostability of polymeric structures
US6585756B1 (en) 1999-05-14 2003-07-01 Ernst P. Strecker Implantable lumen prosthesis
US6375676B1 (en) 1999-05-17 2002-04-23 Advanced Cardiovascular Systems, Inc. Self-expanding stent with enhanced delivery precision and stent delivery system
CA2371780C (en) 1999-05-20 2009-10-06 Boston Scientific Limited Stent delivery system with nested stabilizer and method of loading and using same
US20020169473A1 (en) 1999-06-02 2002-11-14 Concentric Medical, Inc. Devices and methods for treating vascular malformations
DE60037025T2 (en) 1999-06-02 2008-09-11 Microtransform, Inc., Hillsborough INTRAKORPORAL CLOSURE DEVICE
US6375668B1 (en) 1999-06-02 2002-04-23 Hanson S. Gifford Devices and methods for treating vascular malformations
US6280412B1 (en) 1999-06-17 2001-08-28 Scimed Life Systems, Inc. Stent securement by balloon modification
US6309367B1 (en) 1999-07-23 2001-10-30 Neurovasx, Inc. Aneurysm shield
US6371980B1 (en) 1999-08-30 2002-04-16 Cardiovasc, Inc. Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method
US6159531A (en) 1999-08-30 2000-12-12 Cardiovasc, Inc. Coating having biological activity and medical implant having surface carrying the same and method
US6602261B2 (en) 1999-10-04 2003-08-05 Microvention, Inc. Filamentous embolic device with expansile elements
US6238403B1 (en) 1999-10-04 2001-05-29 Microvention, Inc. Filamentous embolic device with expansible elements
US6364895B1 (en) * 1999-10-07 2002-04-02 Prodesco, Inc. Intraluminal filter
US6652555B1 (en) 1999-10-27 2003-11-25 Atritech, Inc. Barrier device for covering the ostium of left atrial appendage
US6689150B1 (en) 1999-10-27 2004-02-10 Atritech, Inc. Filter apparatus for ostium of left atrial appendage
US6551303B1 (en) 1999-10-27 2003-04-22 Atritech, Inc. Barrier device for ostium of left atrial appendage
US6994092B2 (en) * 1999-11-08 2006-02-07 Ev3 Sunnyvale, Inc. Device for containing embolic material in the LAA having a plurality of tissue retention structures
US7004977B2 (en) 1999-11-24 2006-02-28 A Enterprises, Inc. Soft tissue substitute and method of soft tissue reformation
US6331184B1 (en) 1999-12-10 2001-12-18 Scimed Life Systems, Inc. Detachable covering for an implantable medical device
US6790218B2 (en) * 1999-12-23 2004-09-14 Swaminathan Jayaraman Occlusive coil manufacture and delivery
US6312458B1 (en) 2000-01-19 2001-11-06 Scimed Life Systems, Inc. Tubular structure/stent/stent securement member
US6350270B1 (en) 2000-01-24 2002-02-26 Scimed Life Systems, Inc. Aneurysm liner
US20020043456A1 (en) 2000-02-29 2002-04-18 Ho Ken K. Bimorphic, compositionally-graded, sputter-deposited, thin film shape memory device
US6391037B1 (en) * 2000-03-02 2002-05-21 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6346117B1 (en) * 2000-03-02 2002-02-12 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6632241B1 (en) 2000-03-22 2003-10-14 Endovascular Technologies, Inc. Self-expanding, pseudo-braided intravascular device
US20030114918A1 (en) 2000-04-28 2003-06-19 Garrison Michi E. Stent graft assembly and method
US6451050B1 (en) 2000-04-28 2002-09-17 Cardiovasc, Inc. Stent graft and method
US6530934B1 (en) * 2000-06-06 2003-03-11 Sarcos Lc Embolic device composed of a linear sequence of miniature beads
AU2001275376A1 (en) 2000-06-08 2001-12-17 John J Frantzen Radially expandable stent featuring covering tip primarily for bifurcated arteryaneurysms
WO2002000139A1 (en) 2000-06-23 2002-01-03 Frantzen John J Radially expandable aneurysm treatment stent
US8298257B2 (en) * 2000-06-29 2012-10-30 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7153323B1 (en) 2000-06-30 2006-12-26 Boston Scientific Scimed, Inc. Aneurysm liner with multi-segment extender
US6855154B2 (en) 2000-08-11 2005-02-15 University Of Louisville Research Foundation, Inc. Endovascular aneurysm treatment device and method
US6969401B1 (en) 2000-08-18 2005-11-29 Marotta Thomas R Endovascular prosthesis
JP2004508140A (en) 2000-09-11 2004-03-18 クロージャー メディカル コーポレイション Bronchial obstruction method and device
US6723108B1 (en) 2000-09-18 2004-04-20 Cordis Neurovascular, Inc Foam matrix embolization device
US6605101B1 (en) 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6635069B1 (en) 2000-10-18 2003-10-21 Scimed Life Systems, Inc. Non-overlapping spherical three-dimensional coil
US6589265B1 (en) * 2000-10-31 2003-07-08 Endovascular Technologies, Inc. Intrasaccular embolic device
US8192484B2 (en) 2000-12-12 2012-06-05 Cardiatis S.A. Stent for blood flow improvement
BE1013757A6 (en) 2000-12-12 2002-07-02 Frid Noureddine Luminal endoprosthesis MODULAR.
US6852330B2 (en) 2000-12-21 2005-02-08 Depuy Mitek, Inc. Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US6547804B2 (en) 2000-12-27 2003-04-15 Scimed Life Systems, Inc. Selectively permeable highly distensible occlusion balloon
US6699274B2 (en) 2001-01-22 2004-03-02 Scimed Life Systems, Inc. Stent delivery system and method of manufacturing same
US6494884B2 (en) 2001-02-09 2002-12-17 Concentric Medical, Inc. Methods and devices for delivering occlusion elements
JP4673987B2 (en) 2001-02-27 2011-04-20 株式会社トップ Stent and stent member
US6579302B2 (en) 2001-03-06 2003-06-17 Cordis Corporation Total occlusion guidewire device
JP2005508201A (en) 2001-03-08 2005-03-31 アトリテック, インコーポレイテッド Atrial filter implant
US7018402B2 (en) 2001-03-09 2006-03-28 Georgia Tech Research Corporation Intravascular device and method for axially stretching blood vessels
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
US6855153B2 (en) 2001-05-01 2005-02-15 Vahid Saadat Embolic balloon
WO2002089863A1 (en) 2001-05-04 2002-11-14 Concentric Medical Bioactive polymer vaso-occlusive device
EP1392175A2 (en) 2001-05-04 2004-03-03 Concentric Medical Hydrogel filament vaso-occlusive device
EP1392182A1 (en) 2001-05-04 2004-03-03 Concentric Medical Hydrogel vaso-occlusive device
WO2002089865A2 (en) 2001-05-04 2002-11-14 Concentric Medical Coated combination vaso-occlusive device
US6814739B2 (en) * 2001-05-18 2004-11-09 U.S. Endoscopy Group, Inc. Retrieval device
CA2449055C (en) 2001-05-29 2010-03-02 Microvention, Inc. Method of manufacturing expansile filamentous embolization devices
AU2002318349A1 (en) 2001-06-11 2002-12-23 Ev3 Inc. A method of training nitinol wire
US6692510B2 (en) 2001-06-14 2004-02-17 Cordis Neurovascular, Inc. Aneurysm embolization device and deployment system
US6454780B1 (en) 2001-06-21 2002-09-24 Scimed Life Systems, Inc. Aneurysm neck obstruction device
US6599307B1 (en) 2001-06-29 2003-07-29 Advanced Cardiovascular Systems, Inc. Filter device for embolic protection systems
US20030100945A1 (en) 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
US6602452B2 (en) * 2001-07-18 2003-08-05 Mcghan Medical Corporation Rotational molding of medical articles
US7011671B2 (en) * 2001-07-18 2006-03-14 Atritech, Inc. Cardiac implant device tether system and method
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US20030028209A1 (en) 2001-07-31 2003-02-06 Clifford Teoh Expandable body cavity liner device
FR2828091B1 (en) * 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
US7687053B2 (en) 2001-08-20 2010-03-30 Boston Scientific Scimed, Inc. Embolic compositions with non-cyanoacrylate rheology modifying agents
WO2003017872A1 (en) 2001-08-23 2003-03-06 Scimed Life Systems Inc Rotating stent delivery system for side branch access and protection and method of using same.
US7485088B2 (en) * 2001-09-05 2009-02-03 Chase Medical L.P. Method and device for percutaneous surgical ventricular repair
US6802851B2 (en) 2001-09-20 2004-10-12 Gordia Neurovascular, Inc. Stent aneurysm embolization method using collapsible member and embolic coils
US6811560B2 (en) 2001-09-20 2004-11-02 Cordis Neurovascular, Inc. Stent aneurysm embolization method and device
US20030093111A1 (en) 2001-10-26 2003-05-15 Concentric Medical Device for vaso-occlusion and interventional therapy
JP2003190175A (en) * 2001-11-15 2003-07-08 Cordis Neurovascular Inc Aneurysm neck cover for sealing aneurysm
JP4429589B2 (en) 2001-11-15 2010-03-10 コーディス・ニューロバスキュラー・インコーポレイテッド Aneurysm embolization device using an occluding member
US20060292206A1 (en) 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US7294146B2 (en) * 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US20030113478A1 (en) 2001-12-12 2003-06-19 Dang Mai Huong Surface coating method and coated device
CA2470824A1 (en) 2001-12-21 2003-08-28 Cardiovasc, Inc. Composite stent with polymeric covering and bioactive coating
US6723116B2 (en) 2002-01-14 2004-04-20 Syde A. Taheri Exclusion of ascending/descending aorta and/or aortic arch aneurysm
US6989024B2 (en) 2002-02-28 2006-01-24 Counter Clockwise, Inc. Guidewire loaded stent for delivery through a catheter
US6908784B1 (en) 2002-03-06 2005-06-21 Micron Technology, Inc. Method for fabricating encapsulated semiconductor components
US6773448B2 (en) 2002-03-08 2004-08-10 Ev3 Inc. Distal protection devices having controllable wire motion
US20030176884A1 (en) 2002-03-12 2003-09-18 Marwane Berrada Everted filter device
US7695488B2 (en) 2002-03-27 2010-04-13 Boston Scientific Scimed, Inc. Expandable body cavity liner device
US6932833B1 (en) 2002-04-01 2005-08-23 Bobby W. Presley Method and barrier for limiting fluid movement through a tissue rent
US20030195609A1 (en) * 2002-04-10 2003-10-16 Scimed Life Systems, Inc. Hybrid stent
US20030195553A1 (en) 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US20080086196A1 (en) 2002-06-05 2008-04-10 Dfine,Inc. Polymer matrix devices for treatment of vascular malformations
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US6887258B2 (en) * 2002-06-26 2005-05-03 Advanced Cardiovascular Systems, Inc. Embolic filtering devices for bifurcated vessels
US7166122B2 (en) * 2002-06-27 2007-01-23 Boston Scientific Scimed, Inc. Anchor assemblies in stretch-resistant vaso-occlusive coils
US6698877B2 (en) * 2002-06-28 2004-03-02 Kimberly-Clark Worldwide, Inc. Offset printing apparatus for applying a substance
US20040172056A1 (en) 2002-07-12 2004-09-02 Guterman Lee R. Bifurcated aneurysm buttress arrangement
US6746890B2 (en) 2002-07-17 2004-06-08 Tini Alloy Company Three dimensional thin film devices and methods of fabrication
JP2004049585A (en) 2002-07-22 2004-02-19 Piolax Medical Device:Kk Stent type therapeutic instrument
US20040015224A1 (en) 2002-07-22 2004-01-22 Armstrong Joseph R. Endoluminal expansion system
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US7608058B2 (en) * 2002-07-23 2009-10-27 Micrus Corporation Stretch resistant therapeutic device
US20040034386A1 (en) * 2002-08-19 2004-02-19 Michael Fulton Aneurysm stent
US6991617B2 (en) 2002-08-21 2006-01-31 Hektner Thomas R Vascular treatment method and device
US20040044391A1 (en) 2002-08-29 2004-03-04 Stephen Porter Device for closure of a vascular defect and method of treating the same
US8075585B2 (en) 2002-08-29 2011-12-13 Stryker Corporation Device and method for treatment of a vascular defect
US7063679B2 (en) * 2002-09-20 2006-06-20 Flowmedica, Inc. Intra-aortic renal delivery catheter
US7331973B2 (en) * 2002-09-30 2008-02-19 Avdanced Cardiovascular Systems, Inc. Guide wire with embolic filtering attachment
US7481821B2 (en) 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US20040111112A1 (en) 2002-11-20 2004-06-10 Hoffmann Gerard Von Method and apparatus for retaining embolic material
FR2847155B1 (en) 2002-11-20 2005-08-05 Younes Boudjemline METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY
WO2004050137A2 (en) 2002-11-29 2004-06-17 Mindguard Ltd. Braided intraluminal device for stroke prevention
US20040115164A1 (en) 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
US7169177B2 (en) * 2003-01-15 2007-01-30 Boston Scientific Scimed, Inc. Bifurcated stent
US8377035B2 (en) 2003-01-17 2013-02-19 Boston Scientific Scimed, Inc. Unbalanced reinforcement members for medical device
US20040143286A1 (en) 2003-01-17 2004-07-22 Johnson Eric G. Catheter with disruptable guidewire channel
DE10362223B4 (en) * 2003-01-21 2010-02-04 pfm Produkte für die Medizin AG Basic coil shape
US20040153119A1 (en) 2003-01-30 2004-08-05 Kusleika Richard S. Embolic filters with a distal loop or no loop
US7744583B2 (en) 2003-02-03 2010-06-29 Boston Scientific Scimed Systems and methods of de-endothelialization
US7943810B2 (en) 2003-02-04 2011-05-17 Buckman Robert F Method and apparatus for hemostasis
US20040193141A1 (en) 2003-02-14 2004-09-30 Leopold Eric W. Intravascular flow modifier and reinforcement device and deployment system for same
US7314480B2 (en) 2003-02-27 2008-01-01 Boston Scientific Scimed, Inc. Rotating balloon expandable sheath bifurcation delivery
US20040193246A1 (en) 2003-03-25 2004-09-30 Microvention, Inc. Methods and apparatus for treating aneurysms and other vascular defects
US20040193178A1 (en) 2003-03-26 2004-09-30 Cardiomind, Inc. Multiple joint implant delivery systems for sequentially-controlled implant deployment
US20040215229A1 (en) 2003-04-22 2004-10-28 Medtronic Ave, Inc. Stent delivery system and method
US7597704B2 (en) 2003-04-28 2009-10-06 Atritech, Inc. Left atrial appendage occlusion device with active expansion
US8784466B2 (en) 2003-05-23 2014-07-22 Kabushikikaisha Igaki Iryo Sekkei Stent delivery system
US7569626B2 (en) 2003-06-05 2009-08-04 Dfine, Inc. Polymer composites for biomedical applications and methods of making
US7470282B2 (en) 2003-06-30 2008-12-30 Boston Scientific Scimed, Inc. Stent grip and system for use therewith
ES2428967T3 (en) * 2003-07-14 2013-11-12 W.L. Gore & Associates, Inc. Oval foramen tubular permeable closure device (FOP) with retention system
US20050021023A1 (en) * 2003-07-23 2005-01-27 Scimed Life Systems, Inc. System and method for electrically determining position and detachment of an implantable device
DE10335649A1 (en) 2003-07-30 2005-02-24 Jotec Gmbh Braid stent for implantation in a blood vessel
JP2007020590A (en) 2003-08-19 2007-02-01 Institute Of Physical & Chemical Research Material for aneurysm curing
BRPI0413867A (en) 2003-08-26 2006-10-24 Alza Corp device and method for intradermal cell implantation
US20050060017A1 (en) * 2003-09-15 2005-03-17 Fischell Robert E. Means and method for the treatment of cerebral aneurysms
US20070135907A1 (en) 2003-10-02 2007-06-14 The Regents Of The University Of California Stent with expandable foam
US7232461B2 (en) 2003-10-29 2007-06-19 Cordis Neurovascular, Inc. Neck covering device for an aneurysm
US20050107867A1 (en) 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
US20050107823A1 (en) 2003-11-19 2005-05-19 Leone Jim E. Anchored stent and occlusive device for treatment of aneurysms
WO2005051176A2 (en) 2003-11-25 2005-06-09 Boston Scientific Limited Hemostatic pressure plug
US20080109057A1 (en) 2003-12-10 2008-05-08 Calabria Marie F Multiple point detacher system
US7763011B2 (en) 2003-12-22 2010-07-27 Boston Scientific Scimed, Inc. Variable density braid stent
US8012210B2 (en) 2004-01-16 2011-09-06 Warsaw Orthopedic, Inc. Implant frames for use with settable materials and related methods of use
US8211140B2 (en) 2004-01-22 2012-07-03 Rex Medical, L.P. Vein filter
US20110208233A1 (en) 2004-01-22 2011-08-25 Mcguckin Jr James F Device for preventing clot migration from left atrial appendage
DE102004004115B4 (en) 2004-01-28 2016-08-18 Leica Microsystems Cms Gmbh Microscope system and method for shading correction of the existing optics in the microscope system
US20050222605A1 (en) 2004-03-16 2005-10-06 Secant Medical, Llc Occluding coil delivery device and method
US8747453B2 (en) * 2008-02-18 2014-06-10 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US8777974B2 (en) * 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US20050228434A1 (en) 2004-03-19 2005-10-13 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US8398670B2 (en) 2004-03-19 2013-03-19 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US8313505B2 (en) 2004-03-19 2012-11-20 Aga Medical Corporation Device for occluding vascular defects
US8915952B2 (en) 2004-03-31 2014-12-23 Merlin Md Pte Ltd. Method for treating aneurysms
US8500751B2 (en) 2004-03-31 2013-08-06 Merlin Md Pte Ltd Medical device
ES2529352T3 (en) 2004-04-08 2015-02-19 Aga Medical Corporation Flange occlusion devices
US7704246B2 (en) 2004-04-30 2010-04-27 Connor Christopher S Shielded intraocular probe for improved illumination or therapeutic application of light
WO2005110240A1 (en) 2004-05-07 2005-11-24 Nmt Medical, Inc. Catching mechanisms for tubular septal occluder
ATE490736T1 (en) * 2004-05-21 2010-12-15 Micro Therapeutics Inc METAL COILS COVERED WITH BIOLOGICAL OR BIODEGRADABLE OR SYNTHETIC POLYMERS OR FIBERS FOR EMBOLIZING A BODY CAVITY
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
JP2008502378A (en) 2004-05-25 2008-01-31 チェストナット メディカル テクノロジーズ インコーポレイテッド Flexible vascular closure device
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US20050267510A1 (en) 2004-05-26 2005-12-01 Nasser Razack Device for the endovascular treatment of intracranial aneurysms
BE1016067A3 (en) 2004-06-03 2006-02-07 Frid Noureddine Luminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT.
WO2005123171A2 (en) 2004-06-09 2005-12-29 Stout Medical Group Lp Three-dimensional coils for treatment of vascular aneurysms
US7699056B2 (en) 2004-06-10 2010-04-20 Conceptus, Inc. Medical devices and methods of making and using such devices
US20050278023A1 (en) 2004-06-10 2005-12-15 Zwirkoski Paul A Method and apparatus for filling a cavity
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20050288766A1 (en) 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US20060025801A1 (en) * 2004-07-30 2006-02-02 Robert Lulo Embolic device deployment system with filament release
US20060025802A1 (en) * 2004-07-30 2006-02-02 Sowers William W Embolic coil delivery system with U-shaped fiber release mechanism
US7226460B2 (en) * 2004-08-02 2007-06-05 Karl Storz Endovision, Inc. Surgical instrument attachment system
US7393358B2 (en) 2004-08-17 2008-07-01 Boston Scientific Scimed, Inc. Stent delivery system
DE102004040868A1 (en) 2004-08-23 2006-03-09 Miloslavski, Elina Device for removing thrombi
CA2595809A1 (en) 2004-08-31 2006-03-09 Cook Incorporated Device for treating an aneurysm
US8357180B2 (en) 2004-09-17 2013-01-22 Codman & Shurtleff, Inc. Thin film metallic device for plugging aneurysms or vessels
USRE46662E1 (en) 2004-09-17 2018-01-09 DePuy Synthes Products, Inc. Vascular occlusion device with an embolic mesh ribbon
EP2468349B1 (en) 2004-09-17 2019-03-06 Codman & Shurtleff, Inc. Thin film metallic devices for plugging aneurysms or vessels
EP1804719A2 (en) * 2004-09-22 2007-07-11 Lee R. Guterman Cranial aneurysm treatment arrangement
US7635383B2 (en) 2004-09-28 2009-12-22 Boston Scientific Scimed, Inc. Rotating stent delivery system for side branch access and protection and method of using same
US8142454B2 (en) 2004-09-29 2012-03-27 The Regents Of The University Of California, San Francisco Apparatus and method for magnetic alteration of anatomical features
US8535345B2 (en) * 2004-10-07 2013-09-17 DePuy Synthes Products, LLC Vasoocclusive coil with biplex windings to improve mechanical properties
US20060106421A1 (en) 2004-11-16 2006-05-18 Clifford Teoh Expansible neck bridge
US20060116714A1 (en) * 2004-11-26 2006-06-01 Ivan Sepetka Coupling and release devices and methods for their assembly and use
US20060116709A1 (en) 2004-11-26 2006-06-01 Ivan Sepetka Aneurysm treatment devices and methods
US20090297582A1 (en) 2004-11-26 2009-12-03 Biomerix Corporation Vascular occlusion devices and methods
US8771294B2 (en) 2004-11-26 2014-07-08 Biomerix Corporation Aneurysm treatment devices and methods
US20060116713A1 (en) 2004-11-26 2006-06-01 Ivan Sepetka Aneurysm treatment devices and methods
US20060122548A1 (en) 2004-12-06 2006-06-08 Leonard Abrams Devices and methods of treatment of wounds and burns and related impaired blood circulation problems
US7608089B2 (en) * 2004-12-22 2009-10-27 Boston Scientific Scimed, Inc. Vaso-occlusive device having pivotable coupling
US20060155323A1 (en) 2005-01-07 2006-07-13 Porter Stephen C Intra-aneurysm devices
US7306623B2 (en) 2005-01-13 2007-12-11 Medtronic Vascular, Inc. Branch vessel graft design and deployment method
US20060167494A1 (en) 2005-01-21 2006-07-27 Loubert Suddaby Aneurysm repair method and apparatus
EP1855600B1 (en) 2005-02-04 2011-06-29 Zuli Holdings, Ltd. A device for the treatment of an aneurysm
US20060190070A1 (en) 2005-02-23 2006-08-24 Dieck Martin S Rail stent and methods of use
US20060206140A1 (en) 2005-02-24 2006-09-14 Samuel Shaolian Adjustable embolic aneurysm coil
US20060200234A1 (en) 2005-03-03 2006-09-07 Hines Richard A Endovascular aneurysm treatment device and delivery system
US7632296B2 (en) 2005-03-03 2009-12-15 Boston Scientific Scimed, Inc. Rolling membrane with hydraulic recapture means for self expanding stent
EP1859406A2 (en) 2005-03-07 2007-11-28 Koninklijke Philips Electronics N.V. Apparatus and method for correlating first and second 3d images of tubular object
US20060206198A1 (en) 2005-03-12 2006-09-14 Churchwell Stacey D Aneurysm treatment devices and methods
US20060206199A1 (en) 2005-03-12 2006-09-14 Churchwell Stacey D Aneurysm treatment devices
DE102005013547B4 (en) 2005-03-23 2009-02-05 Admedes Schuessler Gmbh Aneurysm stent and process for its preparation
US7402168B2 (en) 2005-04-11 2008-07-22 Xtent, Inc. Custom-length stent delivery system with independently operable expansion elements
US20060264905A1 (en) 2005-05-02 2006-11-23 Pulsar Vascular, Inc. Improved Catheters
WO2006119422A2 (en) 2005-05-02 2006-11-09 Pulsar Vascular, Incorporated Improved catheters
US20060264907A1 (en) 2005-05-02 2006-11-23 Pulsar Vascular, Inc. Catheters having stiffening mechanisms
EP1885259B1 (en) * 2005-05-11 2016-08-17 Mayo Foundation For Medical Education And Research Apparatus for internal surgical procedures
WO2006127005A1 (en) 2005-05-25 2006-11-30 Chestnut Medical Technologies, Inc. System and method for delivering and deploying and occluding device within a vessel
US20060276826A1 (en) * 2005-06-02 2006-12-07 Vladimir Mitelberg Stretch resistant embolic coil delivery system with mechanical release mechanism
US7708754B2 (en) * 2005-06-02 2010-05-04 Codman & Shurtleff, Pc Stretch resistant embolic coil delivery system with mechanical release mechanism
US7799052B2 (en) 2005-06-02 2010-09-21 Codman & Shurtleff, Inc. Stretch resistant embolic coil delivery system with mechanical release mechanism
US20080255603A1 (en) * 2005-06-10 2008-10-16 Sagax, Inc. Implant Device Particularly Useful For Implantation In the Intravascular System For Diverting Emboli
US8435279B2 (en) 2005-06-14 2013-05-07 Advanced Cardiovascular Systems, Inc. Delivery system for a device such as a stent
US7963988B2 (en) * 2005-06-23 2011-06-21 Boston Scientific Scimed, Inc. ePTFE lamination—resizing ePTFE tubing
US20080058856A1 (en) * 2005-06-28 2008-03-06 Venkatesh Ramaiah Non-occluding dilation device
WO2007002863A2 (en) * 2005-06-28 2007-01-04 Venkatesh Ramaiah Non-occlusive, retrievable dilation system
US20080114439A1 (en) 2005-06-28 2008-05-15 Venkatesh Ramaiah Non-occluding dilation device
WO2007006139A1 (en) 2005-07-12 2007-01-18 Smart Biotech Inc. Aneurysm occlusion device
US20070014831A1 (en) 2005-07-12 2007-01-18 Hsing-Wen Sung Biodegradable occlusive device with moisture memory
WO2007013977A2 (en) * 2005-07-21 2007-02-01 The Research Foundation Of State University Of New York Stent vascular intervention device and methods for treating aneurysms
WO2007021759A2 (en) 2005-08-10 2007-02-22 Nfocus Neuromedical Inc. Anti-restenotic therapeutic device
US8187318B2 (en) 2005-08-31 2012-05-29 Advanced Bio Prosthetic Surfaces, Ltd. Covered stent with proximal and distal attachment, delivery catheter, and method of making same
FR2890306B1 (en) 2005-09-08 2007-11-02 Beatrix Jean DEVICE FOR THE TREATMENT OF A VASCULAR POCKET
US7972359B2 (en) 2005-09-16 2011-07-05 Atritech, Inc. Intracardiac cage and method of delivering same
EP1769774A1 (en) * 2005-10-03 2007-04-04 Noureddine Frid Radiopaque endoprostheses
US7550053B2 (en) * 2006-01-26 2009-06-23 Ilh, Llc Catheters with lubricious linings and methods for making and using them
WO2007039678A1 (en) 2005-10-05 2007-04-12 Balt Extrusion Safety catheter for fluid injection
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
KR101334502B1 (en) 2005-10-19 2013-12-05 펄사 배스큘러, 아이엔씨. Method and systems for endovascularly clipping and repairing lumen and tissue defects
US8545530B2 (en) 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
CA2627554A1 (en) 2005-10-27 2007-05-03 Martin S. Dieck Partially covered stent devices and methods of use
US8042548B2 (en) 2005-10-31 2011-10-25 Ethicon, Inc. Occlusion of fallopian tubes
US20070100414A1 (en) 2005-11-02 2007-05-03 Cardiomind, Inc. Indirect-release electrolytic implant delivery systems
US7665466B2 (en) * 2005-11-14 2010-02-23 Occlutech Gmbh Self-expanding medical occlusion device
CA2630021C (en) 2005-11-17 2013-08-13 Microvention, Inc. Three-dimensional complex coil
US20070135826A1 (en) 2005-12-01 2007-06-14 Steve Zaver Method and apparatus for delivering an implant without bias to a left atrial appendage
WO2007076480A2 (en) 2005-12-23 2007-07-05 Levy Elad I Bifurcated aneurysm treatment arrangement
US20070167877A1 (en) 2006-01-17 2007-07-19 Euteneuer Charles L Medical catheters and methods
US20070167972A1 (en) 2006-01-17 2007-07-19 Euteneuer Charles L Balloon apparatus and methods
US20070167876A1 (en) 2006-01-17 2007-07-19 Euteneuer Charles L Occluding guidewire and methods
US7744652B2 (en) 2006-01-23 2010-06-29 Hesham Morsi Aneurysm sealing device
US20080033366A1 (en) 2006-01-30 2008-02-07 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
US7942894B2 (en) 2006-01-31 2011-05-17 Codman & Shurtleff, Inc. Embolic device delivery system
US7691124B2 (en) * 2006-01-31 2010-04-06 Codman & Shurtleff, Inc. Delivery of therapeutic devices
US9538996B2 (en) 2006-01-31 2017-01-10 Cook Biotech Incorporated Fistula grafts and related methods and systems for treating fistulae
US20070185444A1 (en) 2006-02-03 2007-08-09 Starfire Medical, Inc. Vascular clip-on occlusion system
US20070185443A1 (en) 2006-02-03 2007-08-09 Starfire Medical, Inc. Vascular therapy delivery system
US20070185457A1 (en) 2006-02-03 2007-08-09 Starfire Medical, Inc. Vascular occlusion delivery
US20070185442A1 (en) 2006-02-03 2007-08-09 Starfire Medical, Inc. Rapid balloon coupling system
US20070198076A1 (en) 2006-02-13 2007-08-23 Stephen Hebert System for delivering a stent
US7344558B2 (en) * 2006-02-28 2008-03-18 Cordis Development Corporation Embolic device delivery system
US8801777B2 (en) 2007-04-18 2014-08-12 David Elmaleh Intravascular device with netting system
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
CA2647321A1 (en) 2006-03-24 2008-05-02 Biomerix Corp Self-expandable endovascular device for aneurysm occlusion
DE102006013770A1 (en) 2006-03-24 2007-09-27 Occlutech Gmbh Occlusion instrument and method for its production
US20070233244A1 (en) 2006-03-28 2007-10-04 Depuy Spine, Inc. Artificial Disc Replacement Using Posterior Approach
US8092508B2 (en) 2006-03-30 2012-01-10 Stryker Corporation Implantable medical endoprosthesis delivery system
CN101415380B (en) 2006-04-07 2012-06-20 半影公司 Aneurysm occlusion device
EP2015683B1 (en) * 2006-04-17 2015-12-09 Covidien LP System for mechanically positioning intravascular implants
US8777979B2 (en) * 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
EP1849440A1 (en) * 2006-04-28 2007-10-31 Younes Boudjemline Vascular stents with varying diameter
US20070288083A1 (en) 2006-05-12 2007-12-13 Hines Richard A Exclusion Device and System For Delivery
US20070276427A1 (en) 2006-05-26 2007-11-29 Charles Louis Euteneuer Torquable balloon catheters and methods
US20070276426A1 (en) 2006-05-26 2007-11-29 Charles Louis Euteneuer Steerable balloon catheters and methods
US20070293935A1 (en) 2006-06-07 2007-12-20 Cook Incorporated Stent deployment anchoring device
CA2655026C (en) 2006-06-15 2016-08-02 Microvention, Inc. Embolization device constructed from expansible polymer
EP2460544A1 (en) 2006-06-30 2012-06-06 Tyco Healthcare Group LP Medical Devices with Amorphous Metals and Methods Therefor
US7906066B2 (en) * 2006-06-30 2011-03-15 Abbott Cardiovascular Systems, Inc. Method of making a balloon catheter shaft having high strength and flexibility
CA2654703A1 (en) 2006-07-07 2008-01-10 Boston Scientific Limited Endoprosthesis delivery system with stent holder
US8062325B2 (en) * 2006-07-31 2011-11-22 Codman & Shurtleff, Inc. Implantable medical device detachment system and methods of using the same
EP2056746A2 (en) 2006-08-17 2009-05-13 NFOCUS Neuromedical Inc. Aneurysm covering devices and delivery devices
CA2660851A1 (en) 2006-08-17 2008-02-21 Nfocus Neuromedical, Inc. Isolation devices for the treatment of aneurysms
WO2008021570A2 (en) 2006-08-18 2008-02-21 Abbott Laboratories Bifurcation stent delivery catheter and method
US8460335B2 (en) * 2006-09-11 2013-06-11 Embrella Cardiovascular, Inc. Method of deflecting emboli from the cerebral circulation
US8454681B2 (en) 2006-09-13 2013-06-04 Boston Scientific Scimed, Inc. Bifurcation delivery systems and methods
US7557167B2 (en) 2006-09-28 2009-07-07 Gore Enterprise Holdings, Inc. Polyester compositions, methods of manufacturing said compositions, and articles made therefrom
US7901444B2 (en) * 2006-09-29 2011-03-08 Codman & Shurtleff, Inc. Embolic coil delivery system with mechanical release mechanism
US8372114B2 (en) 2006-11-13 2013-02-12 Electroformed Stents, Inc. Over-the-wire exclusion device and system for delivery
WO2008064206A2 (en) 2006-11-20 2008-05-29 Boston Scientific Scimed, Inc. Mechanically detachable vaso-occlusive device
EP2263605A1 (en) * 2006-11-20 2010-12-22 SeptRx, Inc. Device and method for preventing the undesired passage of emboli from a venous blood pool to an arterial blood pool
WO2008074027A1 (en) 2006-12-13 2008-06-19 Biomerix Corporation Aneurysm occlusion devices
US20080154286A1 (en) 2006-12-21 2008-06-26 Ryan Abbott Systems and Methods for Treating Septal Defects with Capture Devices and Other Devices
WO2008085290A2 (en) * 2006-12-28 2008-07-17 Vibrynt, Inc. Devices and methods for treatment of obesity
US8333783B2 (en) 2007-02-16 2012-12-18 Reverse Medical Corporation Occlusion device and method of use
ATE469608T1 (en) 2007-03-05 2010-06-15 Boston Scient Scimed Inc DEPOSIT OF EMBOLIC COILS
EP2124814B1 (en) 2007-03-20 2015-05-20 Minvasys Apparatus and methods for stent delivery with embolic protection
US20080243226A1 (en) 2007-03-30 2008-10-02 Fernandez Jose E Implantable stents with radiopaque markers and methods for manufacturing the same
WO2008124603A1 (en) 2007-04-05 2008-10-16 Nmt Medical, Inc. Septal closure device with centering mechanism
EP2150259A1 (en) 2007-04-27 2010-02-10 Wisconsin Alumni Research Foundation Bioactive and biocompatible polyurethane-butanediol-glycosaminoglycan salt copolymers
EP2157937B1 (en) 2007-06-04 2017-03-22 Sequent Medical, Inc. Devices for treatment of vascular defects
WO2008157507A2 (en) 2007-06-15 2008-12-24 Nfocus Neuromedical, Inc. Blood flow diverters and aneurysm covering devices
US20080319533A1 (en) 2007-06-22 2008-12-25 Neurovasx, Inc. Aneurysm occlusion assist device
US8540760B2 (en) 2007-07-11 2013-09-24 Cook Medical Technologies Llc Tubular devices having reversible components for deployment of endoluminal occluders and related methods and systems
AU2008276344A1 (en) * 2007-07-13 2009-01-22 Stryker Corporation Hybrid and portable power supplies for electrolytically detaching implantable medical devices
US20090024224A1 (en) 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
AU2008279505A1 (en) * 2007-07-20 2009-01-29 Stryker Corporation Power supply using time varying signal for electrolytically detaching implantable device
US8361138B2 (en) 2007-07-25 2013-01-29 Aga Medical Corporation Braided occlusion device having repeating expanded volume segments separated by articulation segments
US20090112251A1 (en) 2007-07-25 2009-04-30 Aga Medical Corporation Braided occlusion device having repeating expanded volume segments separated by articulation segments
CA2692962C (en) * 2007-07-27 2016-09-13 Microvention, Inc. Detachable coil incorporating stretch resistance
EP2180839A4 (en) 2007-08-06 2013-08-28 Michael R Henson Thrombectomy system and method
US8100129B2 (en) 2007-08-28 2012-01-24 Conceptus, Inc. Methods and devices for occluding an ovarian pathway
WO2009036219A1 (en) 2007-09-11 2009-03-19 Nfocus Neuromedical Inc. Aneurysm cover device for embolic delivery and retention
US20090082803A1 (en) 2007-09-26 2009-03-26 Aga Medical Corporation Braided vascular devices having no end clamps
US9414842B2 (en) 2007-10-12 2016-08-16 St. Jude Medical, Cardiology Division, Inc. Multi-component vascular device
DE102008028308A1 (en) 2007-10-18 2009-04-23 Acandis Gmbh & Co. Kg Vascular implant for treating cerebral posterior circulation aneurysm, has lattice structure with deflection unit forming cone with apex that faces structure or three-dimensional curvature that extends towards axial end of structure
WO2009052432A2 (en) 2007-10-19 2009-04-23 Coherex Medical, Inc. Medical device for modification of left atrial appendange and related systems and methods
US8980299B2 (en) 2007-10-31 2015-03-17 Cordis Corporation Method of making a vascular closure device
US20090118811A1 (en) 2007-11-05 2009-05-07 Medtronic Vascular, Inc. Globe Stent
US20090125094A1 (en) 2007-11-06 2009-05-14 Angiotech Pharmaceuticals, Inc. Sheath for intravascular inflatable structures, for example to expand stents
US9492149B2 (en) 2007-11-13 2016-11-15 Cook Biotech Incorporated Fistula grafts and related methods and systems useful for treating gastrointestinal and other fistulae
AU2008329705A1 (en) 2007-11-30 2009-06-04 Cook Biotech Incorporated Expandable plugs and related delivery apparatuses and methods
AU2008334083B2 (en) 2007-11-30 2013-11-28 Cook Medical Technologies Llc Method and device for vascular therapy
US8298276B2 (en) 2007-12-03 2012-10-30 Olympus Medical Systems Corp. Stent delivery system, stent placement method, and stent attachment method
EP2217151A1 (en) 2007-12-03 2010-08-18 Kolo Technologies, Inc. Ultrasound scanner built with capacitive micromachined ultrasonic transducers (cmuts)
US8728141B2 (en) 2007-12-11 2014-05-20 Cornell University Method and apparatus for sealing an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while maintaining substantially normal flow through the body lumen
US8460258B2 (en) 2008-01-08 2013-06-11 Southeastern Medical Technologies, Llc Methods and apparatuses for the treatment of wounds with pressures altered from atmospheric
US9743918B2 (en) 2008-01-18 2017-08-29 St. Jude Medical, Cardiology Division, Inc. Percutaneous catheter directed intravascular occlusion device
US20100030220A1 (en) * 2008-07-31 2010-02-04 Dfine, Inc. Bone treatment systems and methods
US8545573B2 (en) 2008-02-12 2013-10-01 Cook Medical Technologies Llc Spiral occluding device with an occlusion sail
US8163004B2 (en) 2008-02-18 2012-04-24 Aga Medical Corporation Stent graft for reinforcement of vascular abnormalities and associated method
AU2009219005B2 (en) 2008-02-29 2013-07-11 Edwards Lifesciences Corporation Expandable member for deploying a prosthetic device
US20090228029A1 (en) 2008-03-05 2009-09-10 Neuro Vasx, Inc. Aneurysm shield anchoring device
CN101965163A (en) 2008-03-10 2011-02-02 纽福克斯神经医疗公司 Support and stent graft
DE102008015781B4 (en) 2008-03-26 2011-09-29 Malte Neuss Device for sealing defects in the vascular system
US20090264978A1 (en) 2008-03-27 2009-10-22 Dieck Martin S Friction-Release Distal Latch Implant Delivery System and Components
JP2011517424A (en) 2008-04-08 2011-06-09 リバース メディカル コーポレイション Occlusion device and method of use
WO2009132045A2 (en) 2008-04-21 2009-10-29 Nfocus Neuromedical, Inc. Braid-ball embolic devices and delivery systems
WO2009132141A1 (en) 2008-04-22 2009-10-29 Coherex Medical, Inc. Device, system and method for aneurysm embolization
CN102083493A (en) 2008-05-01 2011-06-01 安纽克罗斯有限责任公司 Aneurysm occlusion device
US20160206321A1 (en) 2008-05-01 2016-07-21 Aneuclose Llc Aneurysm Occlusion Device with Sequence of Shape-Changing Embolic Members
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
WO2009135166A2 (en) 2008-05-02 2009-11-05 Sequent Medical Inc. Filamentary devices for treatment of vascular defects
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US8128617B2 (en) 2008-05-27 2012-03-06 Boston Scientific Scimed, Inc. Electrical mapping and cryo ablating with a balloon catheter
US20090318892A1 (en) 2008-06-20 2009-12-24 Maria Aboytes Removable Core Implant Delivery Catheter
US7869889B2 (en) * 2008-07-02 2011-01-11 Saudi Arabian Oil Company Distributed and adaptive smart logic with multi-communication apparatus for reliable safety system shutdown
US8043313B2 (en) 2008-07-03 2011-10-25 Hotspur Technologies, Inc Apparatus and methods for treating obstructions within body lumens
US8333796B2 (en) 2008-07-15 2012-12-18 Penumbra, Inc. Embolic coil implant system and implantation method
CN102137626A (en) * 2008-07-22 2011-07-27 微治疗公司 Vascular remodeling device
US9351715B2 (en) * 2008-07-24 2016-05-31 St. Jude Medical, Cardiology Division, Inc. Multi-layered medical device for treating a target site and associated method
US9232992B2 (en) * 2008-07-24 2016-01-12 Aga Medical Corporation Multi-layered medical device for treating a target site and associated method
GB0813542D0 (en) 2008-07-24 2008-08-27 Brightwake Ltd Material for use as a wound packing element in particulary negative pressure wound therapy (NPWT)
WO2010028300A1 (en) 2008-09-04 2010-03-11 Curaseal Inc. Inflatable device for enteric fistula treatment
AU2009289488B2 (en) 2008-09-05 2015-09-10 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
WO2010027363A1 (en) 2008-09-05 2010-03-11 Merlin Md Pte Ltd Endovascular device
US20100069948A1 (en) 2008-09-12 2010-03-18 Micrus Endovascular Corporation Self-expandable aneurysm filling device, system and method of placement
WO2010045079A1 (en) * 2008-10-13 2010-04-22 Boston Scientific Scimed, Inc. Vaso-occlusive coil delivery system
EP2522376B1 (en) 2008-10-17 2020-01-08 Sofradim Production Method for preparing auto-sealant matrix for tissue repair
WO2010048177A2 (en) 2008-10-20 2010-04-29 IMDS, Inc. Systems and methods for aneurysm treatment and vessel occlusion
US9211202B2 (en) 2008-10-24 2015-12-15 Wisconsin Alumni Research Foundation Apparatus and method for treating an aneurysm
WO2010056535A1 (en) 2008-10-29 2010-05-20 Cook Biotech Incorporated Vascular plugs
US8396108B2 (en) 2008-11-02 2013-03-12 Lg Electronics Inc. Transmitting/receiving system and method of processing broadcast signal in transmitting/receiving system
US20100131002A1 (en) 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
WO2010068467A1 (en) 2008-11-25 2010-06-17 Attenuex Technologies, Inc. Implant with high vapor pressure medium
EP2370237B1 (en) 2008-12-08 2015-12-02 Jeff Christian Micro-cutting machine for forming cuts in products
US10363389B2 (en) 2009-04-03 2019-07-30 Scientia Vascular, Llc Micro-fabricated guidewire devices having varying diameters
CN101779992B (en) 2009-01-19 2012-08-22 加奇生物科技(上海)有限公司 Conveying device for retrievable self-eject nervi cerebrales stent
AU2010206960A1 (en) 2009-01-22 2011-08-11 Cornell University Method and apparatus for restricting flow through the wall of a lumen
WO2010102254A2 (en) 2009-03-06 2010-09-10 The Regents Of The University Of California Thin film vascular stent and biocompatible surface treatment
US9980818B2 (en) 2009-03-31 2018-05-29 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
EP2413840B1 (en) * 2009-04-02 2016-08-17 Endoshape, Inc. Vascular occlusion devices
US20100256603A1 (en) 2009-04-03 2010-10-07 Scientia Vascular, Llc Micro-fabricated Catheter Devices Formed Having Elastomeric Fill Compositions
US9067333B2 (en) 2009-04-03 2015-06-30 Scientia Vascular, Llc Micro-fabricated guidewire devices having elastomeric fill compositions
US9950137B2 (en) 2009-04-03 2018-04-24 Scientia Vascular, Llc Micro-fabricated guidewire devices formed with hybrid materials
US9616195B2 (en) 2009-04-03 2017-04-11 Scientia Vascular, Llc Micro-fabricated catheter devices having varying diameters
US9067332B2 (en) 2009-04-03 2015-06-30 Scientia Vascular, Llc Micro-fabricated catheter devices formed with hybrid materials
US20100256604A1 (en) 2009-04-03 2010-10-07 Scientia Vascular, Llc Micro-fabricated Catheter Devices Formed Having Elastomeric Compositions
WO2010115161A2 (en) 2009-04-03 2010-10-07 Reshape Medical Inc Improved intragastric space fillers and methods of manufacturing including in vitro testing
EP2419041B1 (en) 2009-04-15 2017-06-21 Microvention, Inc. Implant delivery system
CN102438533B (en) * 2009-04-20 2014-11-26 加奇生物科技(上海)有限公司 Delivery assembly for occlusion device using mechanical interlocking coupling mechanism
US20100274276A1 (en) 2009-04-22 2010-10-28 Ricky Chow Aneurysm treatment system, device and method
US8475490B2 (en) 2009-06-05 2013-07-02 Ethicon Endo-Surgery, Inc. Methods and devices for providing access through tissue to a surgical site
WO2010147808A1 (en) 2009-06-15 2010-12-23 Boston Scientific Scimed, Inc. Multiple stent delivery system
US8657870B2 (en) 2009-06-26 2014-02-25 Biosensors International Group, Ltd. Implant delivery apparatus and methods with electrolytic release
US20120010644A1 (en) 2009-07-09 2012-01-12 Sideris Eleftherios B Method and apparatus for occluding a physiological opening
US8118817B2 (en) * 2009-07-21 2012-02-21 Cook Medical Technologies Llc Detachable embolization coil
JP5701874B2 (en) 2009-07-21 2015-04-15 クゥアルコム・インコーポレイテッドQualcomm Incorporated Method and system for video image detection and enhancement
US20110077620A1 (en) 2009-09-30 2011-03-31 Debeer Nicholas C Guide Catheters
US20110106234A1 (en) 2009-10-30 2011-05-05 Axel Grandt Interluminal medical treatment devices and methods
BR112012010758A2 (en) 2009-11-05 2019-09-24 Sequent Medical Inc multilayer filament devices for treatment of vascular defects
US20110202085A1 (en) 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
US9814562B2 (en) 2009-11-09 2017-11-14 Covidien Lp Interference-relief type delivery detachment systems
US8137293B2 (en) 2009-11-17 2012-03-20 Boston Scientific Scimed, Inc. Guidewires including a porous nickel-titanium alloy
DE102009056449A1 (en) 2009-12-01 2011-06-09 Acandis Gmbh & Co. Kg Medical device
US20110144689A1 (en) * 2009-12-15 2011-06-16 Med Institute, Inc. Occlusion Device
US8016872B2 (en) 2009-12-22 2011-09-13 Cook Medical Technologies Llc Deployment and dilation with an expandable roll sock delivery system
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
WO2011094638A1 (en) 2010-01-28 2011-08-04 Micro Therapeutics, Inc. Vascular remodeling device
WO2011094634A1 (en) 2010-01-28 2011-08-04 Micro Therapeutics, Inc. Vascular remodeling device
WO2011095966A1 (en) 2010-02-08 2011-08-11 Surpass Medical Ltd. Method and device for treating cerebrovascular pathologies and delivery system therefor
EP2558000B1 (en) 2010-04-14 2019-09-04 MicroVention, Inc. Implant delivery device
US20110301630A1 (en) 2010-06-02 2011-12-08 Cook Incorporated Occlusion device
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
US20120116350A1 (en) 2010-07-07 2012-05-10 Reverse Medical Corporation Translation dilator and stand alone vascular guide catheter
US20130066357A1 (en) * 2010-09-10 2013-03-14 Maria Aboytes Devices and methods for the treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US8974512B2 (en) 2010-09-10 2015-03-10 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
ES2566166T3 (en) 2010-10-20 2016-04-11 Stryker Corporation Stent delivery catheter with rapid exchange capabilities
DE102010050569A1 (en) 2010-11-05 2012-05-10 Acandis Gmbh & Co. Kg Device for discharging a self-expanding medical functional element
US20120191174A1 (en) 2010-11-16 2012-07-26 Trivascular, Inc. Advanced endovascular graft and delivery system
US20120143243A1 (en) 2010-12-03 2012-06-07 Boston Scientific Scimed, Inc. Closure devices
WO2012078678A1 (en) 2010-12-06 2012-06-14 Tyco Healthcare Group Lp Vascular remodeling device
US11484318B2 (en) 2011-01-17 2022-11-01 Artio Medical, Inc. Expandable body device and method of use
CA2822311C (en) 2011-01-17 2021-10-19 Novita Therapeutics, Llc Detachable metal balloon delivery device and method
DE102011011510B4 (en) 2011-02-17 2022-12-29 Acandis Gmbh Medical device for removing calculus and system with such a medical device
WO2012112749A2 (en) 2011-02-18 2012-08-23 Sequent Medical, Inc. Blood flow disruption devices and methods for the treatment of vascular defects
DE102011011869A1 (en) 2011-02-22 2012-08-23 Phenox Gmbh implant
US20120226343A1 (en) 2011-03-04 2012-09-06 Stryker Nv Operations Limited Stent delivery system
EP3871617A1 (en) 2011-03-09 2021-09-01 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US20120245674A1 (en) 2011-03-25 2012-09-27 Tyco Healthcare Group Lp Vascular remodeling device
US10028745B2 (en) 2011-03-30 2018-07-24 Noha, Llc Advanced endovascular clip and method of using same
EP2693981A4 (en) 2011-04-01 2015-07-01 Univ Cornell Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US20120283768A1 (en) 2011-05-05 2012-11-08 Sequent Medical Inc. Method and apparatus for the treatment of large and giant vascular defects
DE102011102933B4 (en) 2011-05-31 2018-05-03 Acandis Gmbh & Co. Kg Medical implant for placement within a hollow body, in particular an aneurysm
EP2713961B1 (en) 2011-06-03 2016-09-28 Covidien LP Embolic implant
EP2717790B1 (en) 2011-06-06 2019-08-21 Muffin Incorporated Vascular occlusion devices
US20120316632A1 (en) 2011-06-13 2012-12-13 Bulang Gao Retrievable covered stent for bifurcation aneurysms
WO2012174234A2 (en) 2011-06-14 2012-12-20 Cook Medical Technologies Llc Fistula closure devices and methods
US20120330341A1 (en) 2011-06-22 2012-12-27 Becking Frank P Folded-Flat Aneurysm Embolization Devices
US20130018451A1 (en) 2011-07-12 2013-01-17 Boston Scientific Scimed, Inc. Delivery System
WO2013049448A1 (en) 2011-09-29 2013-04-04 Covidien Lp Vascular remodeling device
US8261648B1 (en) 2011-10-17 2012-09-11 Sequent Medical Inc. Braiding mechanism and methods of use
US8826791B2 (en) 2011-10-17 2014-09-09 Sequent Medical, Inc. Braiding mechanism and methods of use
AU2013211873B2 (en) 2012-01-26 2018-04-26 Endoshape, Inc. Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control
US9072519B2 (en) 2012-03-14 2015-07-07 Gyrus Acmi, Inc. Anti-retropulsion systems and methods
CA2867130C (en) 2012-03-15 2019-02-12 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US9011513B2 (en) 2012-05-09 2015-04-21 Abbott Cardiovascular Systems Inc. Catheter having hydraulic actuator
US9211132B2 (en) 2012-06-27 2015-12-15 MicoVention, Inc. Obstruction removal system
WO2014028913A1 (en) 2012-08-17 2014-02-20 The Regents Of The University Of California Dual rotational stent apparatus and method for endovascular treatment of aneurysms
KR102156453B1 (en) 2012-08-22 2020-09-16 페녹시 게엠베하 Implant
RU2664174C2 (en) 2012-10-31 2018-08-15 Эваск Ньюроваскулар Лимитед Партнершип Endovascular prosthesis and method for delivery of endovascular prosthesis
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
KR102309795B1 (en) 2012-11-13 2021-10-08 코비디엔 엘피 Occlusive devices
US20140316012A1 (en) 2013-03-15 2014-10-23 Toby Freyman In-Situ Forming Foams for Embolizing or Occluding a Cavity
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
WO2014144980A1 (en) 2013-03-15 2014-09-18 Covidien Lp Occlusive device
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
GB2520482B (en) 2013-11-15 2015-12-23 Cook Medical Technologies Llc Aneurysm closure device
JP5695259B1 (en) 2014-02-19 2015-04-01 株式会社World Medish High flexibility stent
US20160066921A1 (en) 2014-02-21 2016-03-10 Neuravi Limited DEVICE AND METHOD FOR ENDOVASCULAR TREATMENT OF ANEURYSMS USING EMBOLIC ePTFE
EP3142600A4 (en) 2014-05-12 2018-01-03 Jeffrey E. Thomas Photon-activatable gel coated intracranial stent and embolic coil
US10182801B2 (en) 2014-05-16 2019-01-22 Silk Road Medical, Inc. Vessel access and closure assist system and method
US10595875B2 (en) 2014-12-31 2020-03-24 Endostream Medical Ltd. Device for restricting blood flow to aneurysms
US9999413B2 (en) 2015-01-20 2018-06-19 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
CN107530523B (en) 2015-02-25 2021-03-19 盖乐西医疗公司 System for treating aneurysm
US10814045B2 (en) 2015-10-30 2020-10-27 Balt Usa Devices and methods for aneurysm treatment
US10743883B2 (en) 2015-12-30 2020-08-18 Stryker European Holdings I, Llc Embolic devices and methods of manufacturing same
US20180049859A1 (en) 2016-08-16 2018-02-22 Spartan Micro, Inc. Intravascular flow diversion devices
CA3034356A1 (en) 2016-09-14 2018-03-22 Medinol Ltd. Aneurysm closure device
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
CN108056798B (en) 2016-11-08 2021-06-04 艾柯医疗器械(北京)有限公司 Support pushing system, corresponding blood flow guiding device and blood flow guiding device assembling method
US20180193024A1 (en) 2016-12-05 2018-07-12 Daniel E. Walzman Alternative us of hydrogel intrasaccular occlusion device with center supporting bar for structrual support
WO2018112203A1 (en) 2016-12-14 2018-06-21 eLum Technologies, Inc. Electrospun stents, flow diverters, and occlusion devices and methods of making the same
JP7264581B2 (en) 2017-01-06 2023-04-25 インセプト、リミテッド、ライアビリティ、カンパニー Antithrombotic coating for aneurysm treatment devices
GB2558920A (en) 2017-01-20 2018-07-25 Cook Medical Technologies Llc Aneurysm treatment apparatus
ES2929060T3 (en) 2017-08-17 2022-11-24 Arissa Medical Inc flow attenuation device

Also Published As

Publication number Publication date
AU2009239424B9 (en) 2014-10-09
EP2387959A2 (en) 2011-11-23
EP2460478B1 (en) 2021-09-08
CN106798586A (en) 2017-06-06
AU2009239424B2 (en) 2014-06-05
EP2404558A2 (en) 2012-01-11
ES2438519T3 (en) 2014-01-17
US20110208227A1 (en) 2011-08-25
US8142456B2 (en) 2012-03-27
JP2011518023A (en) 2011-06-23
EP2460477B1 (en) 2018-04-11
EP2387958B1 (en) 2013-08-21
EP2387958A3 (en) 2012-06-06
EP2387958A2 (en) 2011-11-23
US9039726B2 (en) 2015-05-26
EA201071225A1 (en) 2011-06-30
CA2722037A1 (en) 2009-10-29
EP2387959A3 (en) 2012-06-06
ATE533414T1 (en) 2011-12-15
ES2675394T3 (en) 2018-07-11
US20110265943A1 (en) 2011-11-03
SG189809A1 (en) 2013-05-31
EP2633823B1 (en) 2016-06-01
EP2387959B1 (en) 2013-11-13
US20090287294A1 (en) 2009-11-19
US20120316598A1 (en) 2012-12-13
CN102940514A (en) 2013-02-27
US20170156733A1 (en) 2017-06-08
EP2404558B1 (en) 2013-10-16
US20130085522A1 (en) 2013-04-04
US11844528B2 (en) 2023-12-19
JP5610542B2 (en) 2014-10-22
CA2722037C (en) 2016-03-22
US9585669B2 (en) 2017-03-07
US20130123830A1 (en) 2013-05-16
ES2430117T3 (en) 2013-11-19
US20120330347A1 (en) 2012-12-27
EP2265193B1 (en) 2011-11-16
US20200367904A1 (en) 2020-11-26
CN102014769B (en) 2012-12-12
US20130066360A1 (en) 2013-03-14
US20220022886A1 (en) 2022-01-27
EP2265193A2 (en) 2010-12-29
AU2009239424A1 (en) 2009-10-29
EP2633823A1 (en) 2013-09-04
DK2265193T3 (en) 2012-01-23
US8747597B2 (en) 2014-06-10
EP2460477A1 (en) 2012-06-06
EP2420192A2 (en) 2012-02-22
CN106798586B (en) 2020-06-19
US8696701B2 (en) 2014-04-15
EP3970633A1 (en) 2022-03-23
CN102014769A (en) 2011-04-13
EP2460478A1 (en) 2012-06-06
ZA201007444B (en) 2011-06-29
US20090287291A1 (en) 2009-11-19
EP2404558A3 (en) 2012-10-03
WO2009132045A3 (en) 2010-03-04
WO2009132045A2 (en) 2009-10-29
EP2420192A3 (en) 2012-06-06
CN102940514B (en) 2017-04-12
EP2420192B1 (en) 2016-03-16
IL208659A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
ES2436590T3 (en) Embolic braid ball devices and placement systems
US10806610B2 (en) Stent
JP7469323B2 (en) Filamentous Devices for the Treatment of Vascular Disorders - Patent application
US20120271407A1 (en) Stent system having interlocking side extension members
JP7483743B2 (en) Filamentous devices with flexible joints for the treatment of vascular disorders - Patents.com
JP7483744B2 (en) Filamentous Devices for the Treatment of Vascular Disorders - Patent application